{
  "markdown": "<a id='d049e39a-c94f-4c82-99c0-8bce010a7715'></a>\n\nNUTRITION SUPPORT CERTIFICATE\n\n<a id='cfefbf72-26fb-4401-a4c9-b22243437fb9'></a>\n\nFluids & Sodium\nDisorders\n\n<a id='11965d6d-6c35-4e5d-a77f-573500394dcb'></a>\n\n<::logo: ASHP\nashp\nThe logo features the stylized blue text \"ashp\" in blue with an orange swoosh above the 'h' and 'p', and a registered trademark symbol.::>\n\n<a id='81e53325-9b14-47b5-8863-d65a78e294a5'></a>\n\nCAPTION ERROR\n\n<a id='30de0ff1-ff7b-4b42-a0bc-66433204b260'></a>\n\nPlanned by the American Society of Health-System Pharmacists (ASHP) in collaboration with the American Society for Parenteral and Enteral Nutrition (ASPEN).\n\n<a id='36df49d8-c092-4592-b44e-c5924c0089b1'></a>\n\n&#169;2022 American Society of Health-System Pharmacists, Inc. All rights reserved.\nNo part of this publication may be reproduced or transmitted in any form or by any means, electronic or\nmechanical, including photocopying, microfilming, and recording, or by any information storage and retrieval\nsystem, without written permission from the American Society of Health-System Pharmacists.\n\n<a id='e38ce2a1-beb1-4f57-ad80-03c4a4c2f1be'></a>\n\nNUTRITION SUPPORT\nCOMPLICATIONS:\nFLUIDS & SODIUM\nDISORDERS\n\nAnne M. Tucker, Pharm.D., BCNSP\nUniversity of Texas MD Anderson Cancer Center\n\n<::Illustration of a human head and torso receiving intravenous fluids from an IV bag and enteral feeding via a tube, depicted in white outline. : figure::>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\nashp aspen\n\n<a id='798bcf7c-e18d-4d82-bf6b-1019c4444d65'></a>\n\nRELEVANT FINANCIAL\nRELATIONSHIP DISCLOSURE\n\nThe following persons in control of this activity's content have relevant financial relationships:\n\n- Jay Mirtallo: Fresenius Kabi, consultant\n\nAll other persons in control of content do not have any relevant financial relationships with an ineligible company.\n\n<a id='1f13f8e3-5976-4d56-885b-207758b37bff'></a>\n\nAs defined by the Standards of Integrity and Independence definition of ineligible company. All relevant\nfinancial relationships have been mitigated prior to the CPE activity.\n\n<a id='6e976e6d-beaa-41a9-9210-ee0a66809435'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='5e9745a6-93cb-4111-a57d-5ebb909a7097'></a>\n\n# LEARNING OBJECTIVES\n\n*   Analyze patient information to determine the type of fluid & sodium disorder.\n*   Describe common etiologies of fluid & sodium disorders and their impact on the nutrition prescription.\n*   Design recommendations for the prevention and management of fluid and sodium disorders.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='7e7f090a-19f8-4af7-97d2-e7247135f55d'></a>\n\nKEY ABBREVIATIONS\n\n*   AdjBW: adjusted body weight\n*   BUN: blood urea nitrogen\n*   CO2: carbon dioxide\n*   ECF: extracellular fluid\n*   IBW: ideal body weight\n*   ICF: intracellular fluid\n*   PN: parenteral nutrition\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='28315dce-2718-4e57-be54-1dd8247be5e5'></a>\n\n# KEY ABBREVIATIONS\n\n*   SIAD: syndrome of inappropriate antidiuresis\n*   sOsm: serum osmolality\n*   TBW: total body water\n*   uNa: urine sodium\n*   uOsm: urine osmolality\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='a1ee380f-036f-4d1a-b8ed-c1616394a409'></a>\n\n## SELF-ASSESSMENT #1\n\n*   MN is a 72 year-old female who is admitted to the medicine service for a non-specific complaint of general malaise. On physical exam, she has dry mucous membranes and exhibits poor skin turgor.\n*   Past medical history: HTN, osteoarthritis, and hyperlipidemia\n*   Home medications: hydrochlorothiazide, aspirin, simvastatin, calcium carbonate, vitamin D\n*   Vital signs: BP 96/52, HR 100, RR 14, Temp 37 C\n*   Laboratory values: Na 122 mEq/L, K 4 mEq/L, CI 101 mEq/L, CO2 19 mEq/L, BUN 45 mg/dL, Cr 1.5 mg/dL, glucose 115 mg/dL, magnesium 2.4 mg/dL, urine osmolality 450 mOsm/L\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='7ff14278-eb74-4149-a5ed-b621975de052'></a>\n\nSELF-ASSESSMENT #1, CONT.\n\nWhich of the following is the most likely diagnosis for this patient's hyponatremia?\n\nA. Hypertonic\nB. Hypovolemic hypotonic\nC. Euvolemic hypotonic\nD. Hypervolemic hypotonic\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='b9dc5873-bd29-4f2f-9a3b-d8a2fa9bb58a'></a>\n\nFLUID AND SODIUM\nDISORDERS\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='4b8dde8d-2aa7-486f-b44e-3a864b8abc8a'></a>\n\nTOTAL BODY WATER (TBW)\n\n*   Water content of the body\n    *   60% lean body mass for males\n    *   50% lean body mass for females\n*   Body composition influence on TBW\n    *   Water content of fat ~10%\n    *   Water content of muscle ~75%\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='b2d284ac-571b-4892-b804-7b25250ef495'></a>\n\n# BODY FLUID DISTRIBUTION\n\n*   Intracellular fluid (ICF)\n    *   2/3 total body water\n    *   Potassium, magnesium phosphorus\n*   Extracellular fluid (ECF)\n    *   1/3 total body water\n    *   Sodium, chloride, bicarbonate\n    *   Subdivisions\n        *   3/4 ECF – Interstitial fluid\n        *   1/4 ECF – Intravascular fluid\n*   Transcellular fluid\n\n<::transcription of the content\n: pie chart labeled \"%TBW\" showing the distribution of body fluids. The chart includes segments for \"Interstitial\" and \"Intravascular\" fluids, with a legend indicating \"ICF\" and \"ECF\".::>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='4b201591-309b-4671-b647-dcd63921df30'></a>\n\nBODY FLUID MAINTENANCE\n\n*   Normal cellular function\n*   Tight regulation\n    *   Serum osmolality (sOsm)\n        *   Important determinant of intracellular volume\n        *   sOsm = 2 x [Na] + [glucose/18] + [BUN/2.8]\n        *   Alterations ⇒ neurological symptoms\n    *   Blood volume\n        *   Determinant of effective tissue perfusion\n        *   Plasma proteins play role in oncotic pressure\n        *   Oxygen & nutrient delivery\n        *   Metabolic waste removal\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='c0aa90b4-71d2-453a-9737-7d67bf4aa61f'></a>\n\nFLUID REQUIREMENTS\n\n*   Weight and age based\n    *   Ages 18-55 years: 35 mL/kg/day\n    *   Ages 56-75 years: 30 mL/kg/day\n    *   Ages > 75 years: 25 mL/kg/day\n    *   Fluid-restricted adults: ≤ 25 mL/kg/day\n\nCanada TW et al. ASPEN Adult Nutrition Support Core Curriculum.\n3rd ed. 2017:113-37.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='1e3adae9-3144-4b02-9283-5c693c3be28c'></a>\n\nFLUID REQUIREMENTS, CONT.\n\n*   Adjusted Holiday-Segar formula\n    *   1500 mL for the first 20 kg of body weight, then ADD\n        *   Ages <= 50 years: 20 mL per kg of remaining body weight\n        *   Ages > 50 years: 15 mL per kg of remaining body weight\n*   1 mL/kcal ingested\n*   1500-1600 mL/m² per 24 hours\n\n<a id='e48bf804-3ebb-448b-8621-25ee5095bb49'></a>\n\nCanada TW et al. ASPEN Adult Nutrition Support Core Curriculum.\n3rd ed. 2017:113-37.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='0bf0a6d7-6016-4ffe-a95d-e7d7fc2806d2'></a>\n\nASSESSING FLUID BALANCE\n\n*   Physical exam (mucous membranes, skin turgor, edema)\n*   Urine output (0.5-2 mL/kg/hour)\n*   Weight changes\n*   Temperature\n*   Vital signs (blood pressure, heart rate)\n*   Intake and output records\n*   Insensible losses\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='73a8742f-ee06-42e5-8fcb-e32550380010'></a>\n\n<::logo: Gastrointestinal Losses\nGASTROINTESTINAL LOSSES\nA brown rectangular banner features white text and a white line-art illustration of a human head with an IV drip and a nasogastric tube.::>\n\n<a id='acdf7869-baee-4aaf-a27c-41d1560ee0cd'></a>\n\n<table id=\"8-1\">\n<tr><td id=\"8-2\" rowspan=\"2\">Body Fluid Type</td><td id=\"8-3\" colspan=\"4\">mEq/L</td></tr>\n<tr><td id=\"8-4\">Na</td><td id=\"8-5\">Cl</td><td id=\"8-6\">K</td><td id=\"8-7\">HCO3</td></tr>\n<tr><td id=\"8-8\">Stomach</td><td id=\"8-9\">60</td><td id=\"8-a\">130</td><td id=\"8-b\">15</td><td id=\"8-c\">0</td></tr>\n<tr><td id=\"8-d\">Duodenum</td><td id=\"8-e\">140</td><td id=\"8-f\">80</td><td id=\"8-g\">5</td><td id=\"8-h\">0</td></tr>\n<tr><td id=\"8-i\">Pancreas</td><td id=\"8-j\">140</td><td id=\"8-k\">75</td><td id=\"8-l\">5</td><td id=\"8-m\">115</td></tr>\n<tr><td id=\"8-n\">Bile</td><td id=\"8-o\">145</td><td id=\"8-p\">100</td><td id=\"8-q\">5</td><td id=\"8-r\">35</td></tr>\n<tr><td id=\"8-s\">Ileum</td><td id=\"8-t\">140</td><td id=\"8-u\">104</td><td id=\"8-v\">5</td><td id=\"8-w\">30</td></tr>\n<tr><td id=\"8-x\">Colon</td><td id=\"8-y\">60</td><td id=\"8-z\">40</td><td id=\"8-A\">30</td><td id=\"8-B\">0</td></tr>\n</table>\n\n<a id='e5a86d90-1748-4268-977c-4ecbce64ab84'></a>\n\nASPEN Adult Nutrition Support Core Curriculum 3rd edition, 2017:113-137.\n\n<a id='a8d1ac93-d7a6-4b22-9a5c-e09847b9369e'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='94969f52-4c4b-4d9d-83f6-ae18c960b1a5'></a>\n\n<::logo: Not identified\nGASTROINTESTINAL LOSSES\nThe logo features white outline illustrations of a human head with a tube inserted into the nose/mouth, connected to an IV bag, all set against a brown rectangular background.::>\n\n<a id='ef862032-fff5-4a23-92e3-abf7164aba20'></a>\n\n<table id=\"8-C\">\n<tr><td id=\"8-D\" rowspan=\"2\">Body Fluid Type</td><td id=\"8-E\" colspan=\"4\">mEq/L</td></tr>\n<tr><td id=\"8-F\">Na</td><td id=\"8-G\">Cl</td><td id=\"8-H\">K</td><td id=\"8-I\">HCO3</td></tr>\n<tr><td id=\"8-J\">Stomach</td><td id=\"8-K\">60</td><td id=\"8-L\">130</td><td id=\"8-M\">15</td><td id=\"8-N\">0</td></tr>\n<tr><td id=\"8-O\">Duodenum</td><td id=\"8-P\">140</td><td id=\"8-Q\">80</td><td id=\"8-R\">5</td><td id=\"8-S\">0</td></tr>\n<tr><td id=\"8-T\">Pancreas</td><td id=\"8-U\">140</td><td id=\"8-V\">75</td><td id=\"8-W\">5</td><td id=\"8-X\">115</td></tr>\n<tr><td id=\"8-Y\">Bile</td><td id=\"8-Z\">145</td><td id=\"8-10\">100</td><td id=\"8-11\">5</td><td id=\"8-12\">35</td></tr>\n<tr><td id=\"8-13\">Ileum</td><td id=\"8-14\">140</td><td id=\"8-15\">104</td><td id=\"8-16\">5</td><td id=\"8-17\">30</td></tr>\n<tr><td id=\"8-18\">Colon</td><td id=\"8-19\">60</td><td id=\"8-1a\">40</td><td id=\"8-1b\">30</td><td id=\"8-1c\">0</td></tr>\n</table>\n\n<a id='241fd44b-4cca-4bb8-b0f9-121e49f9c264'></a>\n\nASPEN Adult Nutrition Support Core Curriculum, 3rd edition, 2017:113-137.\n\n<a id='8c68e89c-8a54-4673-9876-2f0e049fc5dd'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='0976ad3d-ecb2-4c8d-b680-9c6f4e1bb726'></a>\n\nREPLACEMENT FLUIDS\n\n*   Based upon specific losses\n*   Gastric and colonic fluid losses\n    *   0.45% NaCl (1/2 Normal Saline) + 10-20 mEq KCI/L\n*   Small bowel fluid losses\n    *   0.9% NaCl (Normal Saline)\n    *   Bicarbonate or acetate-based customized fluid\n    *   Balanced crystalloid (e.g., Ringers Lactate)\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='1598e825-27cf-47b8-96ff-66b1cdcfc71c'></a>\n\nNORMAL ELECTROLYTE\nCONCENTRATIONS\n\n<table id=\"9-1\">\n<tr><td id=\"9-2\">Electrolyte</td><td id=\"9-3\">Adult</td></tr>\n<tr><td id=\"9-4\">Sodium</td><td id=\"9-5\">135-145 mEq/L</td></tr>\n<tr><td id=\"9-6\">Potassium</td><td id=\"9-7\">3.5-5 mEq/L</td></tr>\n<tr><td id=\"9-8\">Chloride</td><td id=\"9-9\">98-108 mEq/L</td></tr>\n<tr><td id=\"9-a\">CO₂</td><td id=\"9-b\">23-30 mEq/L</td></tr>\n<tr><td id=\"9-c\">Calcium</td><td id=\"9-d\">9-10.5 mg/dL</td></tr>\n<tr><td id=\"9-e\">Phosphorus</td><td id=\"9-f\">2.5-4.5 mg/dL</td></tr>\n<tr><td id=\"9-g\">Magnesium</td><td id=\"9-h\">1.7-2.4 mg/dL</td></tr>\n<tr><td id=\"9-i\" colspan=\"2\">*Variations in lab values exist between institutions</td></tr>\n</table>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='1ec6b493-2bfd-40df-9925-a5468d31d580'></a>\n\nCAPTION ERROR\n\n<a id='b03361c1-1dbb-4120-a810-311b697e341a'></a>\n\n<table id=\"10-1\">\n<tr><td id=\"10-2\">Electrolyte</td><td id=\"10-3\">Requirements</td></tr>\n<tr><td id=\"10-4\">Sodium</td><td id=\"10-5\">60-100 mEq/day or 1-2 mEq/kg/day</td></tr>\n<tr><td id=\"10-6\">Potassium</td><td id=\"10-7\">60-100 mEq/day or 1-2mEq/kg/day</td></tr>\n<tr><td id=\"10-8\">Chloride</td><td id=\"10-9\">As needed to maintain acid-base balance</td></tr>\n<tr><td id=\"10-a\">Acetate</td><td id=\"10-b\">As needed to maintain acid-base balance</td></tr>\n<tr><td id=\"10-c\">Calcium</td><td id=\"10-d\">10-15 mEq/day</td></tr>\n<tr><td id=\"10-e\">Phosphorus</td><td id=\"10-f\">20-40 mmol/dayor 0.25-0.5 mmol/kg/day</td></tr>\n<tr><td id=\"10-g\">Magnesium</td><td id=\"10-h\">8-20 mEq/day or 0.25-0.5 mEq/kg/day</td></tr>\n<tr><td id=\"10-i\" colspan=\"2\">*Consider lower doses for those with renal insufficiency</td></tr>\n</table>\n\n<a id='4498d3ff-bac7-418d-a93a-8bf6cf2a6e84'></a>\n\nMirtallo J et al. JPEN J Parent Enteral Nutr. 2004; 28:S39-S70.\n\n<a id='25f08d59-53cb-4fdc-8562-be73ac932cdb'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='b7dede06-35b2-465d-85fb-0d195ce4e034'></a>\n\n<::logo: Not identified\nELECTROLYTE DOSING CONSIDERATIONS\nThe logo features white text on a brown rectangular background, accompanied by a white outline illustration of an IV drip connected to a human head/throat.::>\n\n<a id='e8d4f140-6265-4af0-a93f-f890e5a44964'></a>\n\n▪ Electrolyte disorders\n  - Acute (< 48 hours) vs. chronic (> 48 hours)\n  - Rate of development, degree of abnormality and/or symptoms\n▪ Renal dysfunction\n  - Empiric dose - 50% recommended dose\n▪ Obesity\n  - Adjusted body weight (AdjBW) for weight-based electrolyte dosing\n  - AdjBW = [(weight in kg - IBW) x 0.25] + IBW\n\n<a id='febb6d3f-3744-4923-a077-313cc676c4d9'></a>\n\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82.\n\n<a id='5cd37089-ff8f-4028-a276-57e06e3cf11b'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='d4710f52-8be6-406d-91e3-362bf657848f'></a>\n\n# SODIUM\n\n*   Most abundant extracellular cation\n*   Normal serum sodium 135-145 mEq/L\n*   Primary influence on serum osmolality\n*   Changes in serum sodium are due to water balance changes\n*   Water flows from areas of lower osmolality to higher osmolality\n*   Sodium disorder diagnosis\n    *   History and physical\n    *   Laboratory analysis (serum, urine)\n    *   **Serum osmolality**\n    *   **Volume status of the patient**\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='27694181-0bf0-46e6-81b1-e2c227f1284c'></a>\n\n# HYPONATREMIA (NA < 135 MEQ/L)\n\n*   Common electrolyte disorder\n    *   28% hospitalized patients\n    *   17.2% critically ill patients\n*   Up to 6-fold increase in morbidity and mortality\n*   Wide symptomatology – neurologic in nature\n    *   None\n    *   Moderate: headache, nausea, confusion\n    *   Severe: vomiting, obtunded, seizures, coma\n\nMannesse CK et al. Ageing Res Rev. 2013; 12(1):165-73.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='50940c4e-f9af-413c-93d4-6d5a0f91c842'></a>\n\n<::DIAGNOSTIC ALGORITHM\n: flowchart::>\nNa correction for hyperglycemia = serum Na + 0.016 (serum glucose - 100)\n\nHyponatremia (Na < 135 mEq/L)\n↓\nSerum Osmolality (sOsm)\n\nBranches:\n1. Hypertonic (sOsm > 290 mOsm/kg)\n   ↓\n   Hyperglycemia\n   Mannitol infusions\n\n2. Hypotonic (sOsm < 275 mOsm/kg)\n   ↓\n   Determine volume status of the patient (next slide)\n\n3. Isotonic (sOsm 275-290 mOsm/kg)\n   ↓\n   Hyperlipidemia\n   Hyperproteinemia\n<::\nVerbalis JG et al. AmJ Med. 2013; 126:S1-S42.\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82.\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='032be8e0-4e68-4de0-aacb-34b1d720859a'></a>\n\n<::DIAGNOSTIC ALGORITHM\n: flowchart::>\n<::Hypotonic hyponatremia\n(Na < 135 mEq/L, sOsm < 275 mOsm/kg)\n: flowchart::>\n\n<::Volume status\nof the patient\n: flowchart::>\n\n<::From \"Volume status of the patient\" to three branches:\n\nBranch 1:\nHypovolemia\n↓TBW, ↓↓Total body Na\n\n  From \"Hypovolemia\" to two sub-branches:\n\n  Sub-branch 1.1:\n  Renal losses\n  uNa >20 mEq/L\n  Diuretics (thiazides)\n  Osmotic diuresis\n  Adrenal insufficiency\n  Salt-wasting nephropathy\n  Cerebral salt wasting\n\n  Sub-branch 1.2:\n  Extrarenal losses\n  uNa <20 mEq/L\n  Vomiting\n  Diarrhea\n  Third spacing\n  Pancreatitis\n  Burns/open wounds\n  Excessive sweating\n\nBranch 2:\nEuvolemia\n↑TBW, ↔Total body Na\n\n  From \"Euvolemia\" to one sub-branch:\n\n  Sub-branch 2.1:\n  uNa >20 mEq/L\n  uOsm >100 mOsm/L\n  Syndrome of inappropriate antidiuresis (SIAD)\n  Hypothyroid\n  Glucocorticoid deficiency\n\nBranch 3:\nHypervolemia\n↑↑TBW, ↑Total body Na\n\n  From \"Hypervolemia\" to two sub-branches:\n\n  Sub-branch 3.1:\n  uNa >20 mEq/L\n  Acute kidney injury\n  Chronic kidney disease\n\n  Sub-branch 3.2:\n  uNa <20 mEq/L\n  Cirrhosis\n  Nephrotic syndrome\n  Heart failure\n\nNUTRITION SUPPORT\nCERTIFICATE\n: flowchart::>\n\n<a id='42b570fa-7f18-4094-b615-04a4fcb21346'></a>\n\n<::A brown banner with the text \"SIAD\" in white on the left side. On the right side, there is a white outline illustration of a human head in profile, with an IV drip bag connected to it, suggesting a medical or healthcare context.\n: figure::>\n\n<a id='22096ca4-3d2c-47a6-970f-1fd7e7f5ea06'></a>\n\nSustained or intermittently elevated antidiuretic hormone (ADH) level inappropriate for osmotic and volume status which normally inhibits ADH secretion\n\n<a id='6ee7f8bb-803e-46ca-be3a-7aceaf899b91'></a>\n\n<table id=\"13-1\">\n<tr><td id=\"13-2\">Essential Criteria</td><td id=\"13-3\">Supplemental Criteria</td></tr>\n<tr><td id=\"13-4\">Effective sOsm <275 mOsm/kg</td><td id=\"13-5\">Serum uric acid < 0.24 mmol/L (< 4 mg/dL)</td></tr>\n<tr><td id=\"13-6\">uOsm > 100 mOsm/kg at some level of decreased</td><td id=\"13-7\">Fractional excretion of uric acid > 12%</td></tr>\n<tr><td id=\"13-8\">effective osmolality</td><td id=\"13-9\">Serum urea <3.6 mmol/L (<21.6 mg/dL)</td></tr>\n<tr><td id=\"13-a\">Clinical euvolemia</td><td id=\"13-b\">Fractional excretion of urea > 55%</td></tr>\n<tr><td id=\"13-c\">uNa > 30 mEq/L (normal sodium & water intake)</td><td id=\"13-d\">Fractional excretion of Na > 0.5%</td></tr>\n<tr><td id=\"13-e\">No adrenal, thyroid, pituitary or renal insufficiency</td><td id=\"13-f\">No change in serum Na with 0.9% NaCl administration</td></tr>\n<tr><td id=\"13-g\">No recent diuretic use</td><td id=\"13-h\">Na correction with fluid restriction</td></tr>\n</table>\n\n<a id='8c4532e2-8e79-4d68-ab8d-78d0786dbd74'></a>\n\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. AmJ Health-Syst Pharm 2005; 62:1663-82.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='a8645af1-14cf-4ad6-af59-e903279482ec'></a>\n\n# CAUSES OF SIAD\n\n*   Diagnosis of exclusion\n*   Causes\n    *   Pulmonary (small cell lung cancer, pneumonia, abscess, tuberculosis)\n    *   Neurologic (tumors, trauma, meningitis, abscess, subarachnoid hemorrhage, pain, anxiety, nausea)\n    *   Hypothyroidism\n    *   Medications\n\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. Am J Health-Syst Pharm. 2005; 62:1663-82.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='9ae21f6f-706d-40b0-82b7-51db9692d5fc'></a>\n\n<::SIAD: MEDICATIONS ASSOCIATED\n: An illustration depicting a person receiving medication through an IV drip and a nasal spray.::>\n\n<a id='a170457b-5603-4e7c-a80e-164d77a2dd25'></a>\n\n- Anticancer agents: cyclophosphamide, ifosfamide, vincristine\n- Anticonvulsants: carbamazepine, oxcarbazepine\n- Antidepressants: SSRIs, TCADs, MAOI, venlafaxine\n- Antidiabetic agent: chlorpropamide\n- Antipsychotics: phenothiazines\n- Miscellaneous: opiates, 3,4-methylenedioxy-methamphetamine (MDMA), non-steroidal anti-inflammatory drugs\n- Vasopressin analogs: desmopressin, oxytocin, terlipressin, vasopressin\n\n<a id='0e233f41-e037-4258-b347-1d6f511dfaf3'></a>\n\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='0df216f7-d596-4719-ad8e-772f094f25cb'></a>\n\n# HYPONATREMIA MANAGEMENT\n\n*   Focus on treatment of underlying cause\n*   Discontinuation of hypotonic fluids\n*   Replace sodium deficit or water excess\n    *   Change in serum Na = (infusate Na – serum Na) / (TBW + 1)\n*   Hypertonic saline for symptomatic patients\n*   Sodium correction limited to 8-10 mEq per Liter per day\n    *   Prevention of central pontine myelinolysis\n    *   Gradual onset of neurologic alterations\n\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='c9622815-d0fc-4731-8c62-5eb7a8d1b5e0'></a>\n\nCAPTION ERROR\n\n<a id='a9e4e492-a17a-4258-8a05-f69a1f361704'></a>\n\n<table id=\"15-1\">\n<tr><td id=\"15-2\">Hyponatremia Type</td><td id=\"15-3\">Treatment (plus treat or remove underlying cause)</td></tr>\n<tr><td id=\"15-4\">Hypertonic</td><td id=\"15-5\">Insulin (hyperglycemia), discontinue mannitol</td></tr>\n<tr><td id=\"15-6\" colspan=\"2\">Hypotonic</td></tr>\n<tr><td id=\"15-7\">Hypovolemic</td><td id=\"15-8\">Isotonic fluids (0.9% sodium chloride, lactated ringers), discontinue diuretics, steroids (adrenal insufficiency)</td></tr>\n<tr><td id=\"15-9\">Euvolemic</td><td id=\"15-a\">Fluid restriction ± loop diuretics, concentrate PN, ensure at least isotonic fluids, vaptan (SIAD); glucocorticoids (deficiency); thyroid hormone replacement (hypothyroid)</td></tr>\n<tr><td id=\"15-b\">Hypervolemic</td><td id=\"15-c\">Sodium and fluid restriction, vaptans, diuretics</td></tr>\n</table>\n\n<a id='179f8e36-441a-4fc8-90b4-6a40672e8f42'></a>\n\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82.\n---\n\n<a id='0702fd84-f360-4785-b999-49af0b23c935'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='69338f78-93be-4f34-ad44-7822924638c7'></a>\n\nSELF-ASSESSMENT #2\n\nWhich of the following medications increases the risk of developing hypotonic euvolemic hyponatremia?\n\nA. Hydrochlorothiazide\nB. Ondansetron\nC. Sertraline\nD. Spironolactone\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='361646a5-a30e-4cfe-a173-5f537a20d940'></a>\n\nSELF-ASSESSMENT #3\n\nWhich of the following sodium concentrations (mEq/L) is the most appropriate choice to use when formulating a parenteral nutrition plan for a patient with heart failure with hyponatremia, shortness of breath, and edema?\n\noption A. 38.5 mEq sodium per Liter: [ ]\noption B. 77 mEq sodium per Liter: [ ]\noption C. 115 mEq sodium per Liter: [ ]\noption D. 154 mEq sodium per Liter: [ ]\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='a77eb05a-ba9d-43a7-a75a-1975b50d6897'></a>\n\nHYPERNATREMIA (NA > 145 MEQ/L)\n\n*   All cases are hypertonic\n*   Less common than hyponatremia\n    *   1-7.9% hospitalized patients\n*   Up to 70% increase in mortality\n*   Symptoms – neurologic in nature\n    *   Thirst, dry mucus membranes\n    *   Mild-moderate: lethargy, weakness, confusion, irritability\n    *   Severe: twitching, seizures, coma\n\n<a id='3e9ac45e-c3cc-4f7a-8e82-6d76b9ac4c65'></a>\n\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82\n\n<a id='9dd8cd1c-bb55-4701-bb57-51f447b95973'></a>\n\nCAPTION ERROR\n\n<a id='2daf2933-be4a-4702-a5d2-ce033c786bf3'></a>\n\nDIAGNOSTIC ALGORITHM\n<::Hypernatremia (Na > 145 mEq/L)\n\nVolume status of the patient\n\nHypovolemia:\nOsmotic / Solute diuresis (hyperglycemia, mannitol, excessive protein provision)\nPost-obstructive diuresis\nVomiting\nDiarrhea or excess laxative use\nInsensible losses\n\nEuvolemia:\nCentral diabetes insipidus\nNephrogenic diabetes insipidus\nPrimary polydipsia\n\nHypervolemia:\nHypertonic saline solutions\nSodium bicarbonate solutions\nHyperaldosteronism\n: flowchart::>\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82.\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='4d178aaa-8827-42e8-91cc-f638c5e42a34'></a>\n\n# DIABETES INSIPIDUS\n\n*   Condition resulting in imbalance of water in the body due to large amounts of dilute urine excretion\n*   Central diabetes insipidus: lack of or decrease in antidiuretic hormone secretion\n*   Nephrogenic diabetes insipidus: decreased renal response to antidiuretic hormone\n    *   Medication and electrolyte causes of nephrogenic diabetes insipidus\n        *   Amphotericin B, cidofovir, foscarnet, demeclocycline, lithium toxicity\n        *   Hypercalcemia, hypokalemia\n\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. Am J Health-Syst Pharm. 2005; 62:1663-82.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='9a1a0dc6-dc54-4901-8959-b59add1f0612'></a>\n\n# HYPERNATREMIA MANAGEMENT\n\n*   Focus on treatment of underlying cause\n*   Discontinuation of hypertonic fluids\n*   Correct water deficit with hypotonic fluids\n    *   Water deficit (L) = TBW x [1 - (serum Na/140)]\n    *   Administer 50% in first 24 hours, remainder in next 48-72 hours\n*   Isotonic fluids for hemodynamic instability\n*   Sodium correction limited to 8-10 mEq per Liter per day\n    *   Prevention of cerebral edema\n\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='e540373b-4624-4da8-bc6b-1bbf6437c2cc'></a>\n\nHYPERNATREMIA MANAGEMENT\n<table id=\"18-1\">\n<tr><td id=\"18-2\" colspan=\"2\">Hypernatremia Type</td></tr>\n<tr><td id=\"18-3\">Hypovolemic</td><td id=\"18-4\">Oral water, enteral water flushes, hypotonic fluids (dextrose 5% in water, 0.45% sodium chloride, addition of sterile water to PN), insulin (hyperglycemia), amino acid dose reduction (solute diuresis)</td></tr>\n<tr><td id=\"18-5\">Euvolemic</td><td id=\"18-6\">Desmopressin (central diabetes insipidus) Thiazide diuretics, sodium restriction, calcium or potassium supplementation (nephrogenic diabetes insipidus)</td></tr>\n<tr><td id=\"18-7\">Hypervolemic</td><td id=\"18-8\">Loop diuretic, hypotonic fluids (sodium overload), adrenalectomy or spironolactone (hyperaldosteronism)</td></tr>\n</table>\n\n<a id='df9bbbc0-c13a-4379-b2ca-e59c8ff6d3a5'></a>\n\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82.\n\n<a id='4668c1e4-df58-40d1-b90c-606187ecb351'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='42c6a93f-46f8-44e2-b177-ea5e619d9729'></a>\n\nSELF-ASSESSMENT #4\n\n*   TT is a 65-year-old patient with enterocutaneous fistula who is on parenteral nutrition providing 28 kcal/kg/day and 3 g protein/kg/day\n*   Vital signs: BP 102/62, HR 85, RR 20, Temp 38 C\n*   Physical exam: +thirst and dry mucous membranes\n*   Basic metabolic panel: Na 154 mEq/L, K 3.2 mEq/L, CI 118 mEq/L, CO₂ 23 mEq/L, BUN 30 mg/dL, Cr 0.9 mg/dL, glucose 82 mg/dL, urine urea nitrogen > 700 mg/dL\n*   Input: 2200 mL/day (31 mL/kg/day)\n*   Urine output: 5400 mL/ day (3.2 mL/kg/hour)\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='32c6e580-a16f-4528-b9b8-0bef3947e1af'></a>\n\n## SELF-ASSESSMENT #4\n\nWhich of the following is the likely type and cause of TT's hypernatremia?\n\nA. Hypervolemic hypernatremia due to excessive fluid administration\nB. Nephrogenic diabetes insipidus\nC. Syndrome of inappropriate antidiuresis (SIAD)\nD. Hypovolemic hypernatremia due to solute diuresis\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='19e9440e-94a3-4cb0-abe3-62285f4713c1'></a>\n\n<::logo: N/A\nN/A\nA white outline drawing on a brown background depicts a human head in profile with a nasal swab and an IV drip.::>\n\n<a id='5d6f7e4d-9eed-44c3-a2e6-a2545cae31e1'></a>\n\nSelf Assessment Questions and Answers\n\n<a id='0b9ec25c-d6f9-4c10-adeb-2ab4c8317ab1'></a>\n\n# SELF-ASSESSMENT #1\n\n*   MN is a 72 year-old female who is admitted to the medicine service for a non-specific complaint of general malaise. On physical exam, she has dry mucous membranes and exhibits poor skin turgor.\n*   Past medical history: HTN, osteoarthritis, and hyperlipidemia\n*   Home medications: hydrochlorothiazide, aspirin, simvastatin, calcium carbonate, vitamin D\n*   Vital signs: BP 96/52, HR 100, RR 14, Temp 37 C\n*   Laboratory values: Na 122 mEq/L, K 4 mEq/L, CI 101 mEq/L, CO2 19 mEq/L, BUN 45 mg/dL, Cr 1.5 mg/dL, glucose 115 mg/dL, magnesium 2.4 mg/dL, urine osmolality 450 mOsm/L\n\n<a id='4f5ece54-5a8f-432f-80db-ef62c71d78ed'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='33cddc38-b61e-4433-9a91-c0025f0841c8'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='f8e6fe35-393e-4fb7-8168-d0a4b5ee6f55'></a>\n\nSELF-ASSESSMENT #1, CONT.\n\nWhich of the following is the most likely diagnosis for this patient's hyponatremia?\n\nA. Hypertonic\nB. Hypovolemic hypotonic\nC. Euvolemic hypotonic\nD. Hypervolemic hypotonic\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='ceee40c9-8345-4a60-a6c5-cf246a552352'></a>\n\nSELF-ASSESSMENT #1, CONT.\n\nWhich of the following is the most likely diagnosis for this patient's hyponatremia?\n\noption A. Hypertonic: [ ]\noption B. Hypovolemic hypotonic: [x]\noption C. Euvolemic hypotonic: [ ]\noption D. Hypervolemic hypotonic: [ ]\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='f8b35dfd-beb6-4581-8231-9421b46dc7c1'></a>\n\nSELF-ASSESSMENT #2 <::A white line-art illustration of a human head in profile with a feeding tube inserted through the nose, connected to an IV bag or feeding bag. This visual represents nutrition support.: figure::>\nWhich of the following medications increases the risk of developing hypotonic\neuvolemic hyponatremia?\nA. Hydrochlorothiazide\nB. Ondansetron\nC. Sertraline\nD. Spironolactone\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='5bbb55e7-c050-4935-bf60-b43ae6786ade'></a>\n\n## SELF-ASSESSMENT #2\n\nWhich of the following medications increases the risk of developing hypotonic euvolemic hyponatremia?\n\nA. Hydrochlorothiazide\nB. Ondansetron\nC. **Sertraline**\nD. Spironolactone\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='4b34e393-d430-47cd-93f9-844797677a51'></a>\n\nSELF-ASSESSMENT #3\n\nWhich of the following sodium concentrations (mEq/L) is the most appropriate choice to use when formulating a parenteral nutrition plan for a patient with heart failure with hyponatremia, shortness of breath, and edema?\n\nA. 38.5 mEq sodium per Liter\nB. 77 mEq sodium per Liter\nC. 115 mEq sodium per Liter\nD. 154 mEq sodium per Liter\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='252f7d81-664b-4dc3-87fb-e68fa40da916'></a>\n\n## SELF-ASSESSMENT #3\n\nWhich of the following sodium concentrations (mEq/L) is the most appropriate choice to use when formulating a parenteral nutrition plan for a patient with heart failure with hyponatremia, shortness of breath, and edema?\n\noption A. 38.5 mEq sodium per Liter: [x]\noption B. 77 mEq sodium per Liter: [ ]\noption C. 115 mEq sodium per Liter: [ ]\noption D. 154 mEq sodium per Liter: [ ]\n\nNUTRITION SUPPORT CERTIFICATE\n\n<a id='efe4c8b7-311a-4c9c-bb16-8b178482ebfd'></a>\n\nSELF-ASSESSMENT #4\n\n*   TT is a 65-year-old patient with enterocutaneous fistula who is on parenteral nutrition providing 28 kcal/kg/day and 3 g protein/kg/day\n*   Vital signs: BP 102/62, HR 85, RR 20, Temp 38 C\n*   Physical exam: +thirst and dry mucous membranes\n*   Basic metabolic panel: Na 154 mEq/L, K 3.2 mEq/L, CI 118 mEq/L, CO₂ 23 mEq/L, BUN 30 mg/dL, Cr 0.9 mg/dL, glucose 82 mg/dL, urine urea nitrogen > 700 mg/dL\n*   Input: 2200 mL/day (31 mL/kg/day)\n*   Urine output: 5400 mL/ day (3.2 mL/kg/hour)\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='d2f286db-1a9c-4735-8c68-15183cfbaefb'></a>\n\n## SELF-ASSESSMENT #4\n\nWhich of the following is the likely type and cause of TT's hypernatremia?\n\nA. Hypervolemic hypernatremia due to excessive fluid administration\nB. Nephrogenic diabetes insipidus\nC. Syndrome of inappropriate antidiuresis (SIAD)\nD. Hypovolemic hypernatremia due to solute diuresis\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='38b6c60a-bc53-4e0e-853c-e580271cf8c2'></a>\n\n## SELF-ASSESSMENT #4\n\nWhich of the following is the likely type and cause of TT's hypernatremia?\n\noption A. Hypervolemic hypernatremia due to excessive fluid administration: [ ]\noption B. Nephrogenic diabetes insipidus: [ ]\noption C. Syndrome of inappropriate antidiuresis (SIAD): [ ]\noption D. Hypovolemic hypernatremia due to solute diuresis: [x]\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='cf11c058-bac1-4b5f-bb12-e1e1171da971'></a>\n\nCONCLUSIONS\n\n*   A thorough history and physical, including medication review, is important for identification and diagnosis of fluid & sodium disorders.\n*   Knowledge of causes of fluid & sodium disorders will help in determining appropriate prevention and treatment plan development.\n*   Development of a nutrition care plan should be done using a systematic approach including comorbid states, medication therapy, and changes in clinical status.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='44bd7443-1170-4b1d-b40c-233bff61138d'></a>\n\nREFERENCES\n\n*   Braun MM, Barstow CH, Pyzocha NJ. Diagnosis and management of sodium disorders: hyponatremia and hypernatremia. Am Fam Physician. 2015; 91:299-307.\n*   Canada TW, Lord LM. Chapter 7 Fluid, Electrolytes, and Acid-Base Disorders. In: Mueller CM, ed. The A.S.P.E.N. Adult Nutrition Support Core Curriculum. 3rd ed. Maryland: A.S.P.E.N.; 2017:113-37.\n*   Kraft MD, Btaiche IF, Sacks GS, Kudsk KA. Treatment of electrolytes disorders in adult patients in the intensive care unit. Am J Health-Syst Pharm. 2005; 62:1663-82.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='c5cb51bf-48d5-4702-b981-234d63bcd838'></a>\n\n## REFERENCES, CONT.\n\n*   Mannesse CK, Vondeling AM, van Marum RJ et al. Prevalence of hyponatremia on geriatric wards compared to other settings over four decades: a systematic review. *Ageing Res Rev*. 2013; 12(1):165-173.\n*   Mirtallo J, Canada T, Johnson D et al. Safe practices for parenteral nutrition. *JPEN J Parent Enteral Nutr*. 2004; 28:S39-S70.\n*   Verbalis JG, Goldsmith, SR, Greenberg A et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. *Am J Med*. 2013; 126:S1-S42.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='4dad45b2-2dab-4b44-addc-a2aa09751132'></a>\n\n<::A stylized illustration on a brown background depicts medical nutrition support. On the left, a white outline of a human head in profile shows an oral feeding tube extending into the esophagus. On the right, a white outline of an IV bag with tubing is connected to a person's arm. Faint, ghosted versions of these illustrations are visible in the background. Below these illustrations, on a white and brown diagonal band, are two logos: \"ashp\" and \"aspen\".\n: illustration::>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='81f6a452-235e-4d5e-ad54-a26ccdcba39d'></a>\n\n<::transcription of the content\n: figure::>\n\nAnne M. Tucker, Pharm.D., BCNSP\nClinical pharmacy Specialist\nUniversity of Texas MD Anderson Cancer Center\nHouston, Texas\n\nAnne M. Tucker is clinical pharmacy specialist at the MD Anderson Cancer\nCenter, Houston, Texas. She received her BS in Chemistry from the\nUniversity of Arkansas, Pharm.D. from the University of Arkansas for Medical\nSciences (UAMS) where she also completed residency training. Dr. Tucker has\nover 20 years of experience in critical care and nutrition support practice and\nparticipates in didactic and experiential training of students and post-graduate trainees. Her areas of\ninterest include fluid and electrolyte disorders, nutrition support in critically ill cancer patients, and the\npromotion of safe parenteral nutrition practices.\n\n<a id='2b2f678e-50b4-41d5-bfce-2b01a6b446b4'></a>\n\nDr. Tucker is currently the Chair of the American Society for Parenteral and Enteral Nutrition (ASPEN) Abstract Review Committee and President of the Texas Gulf Coast ASPEN Chapter. She is also a member and abstract reviewer for American Society of Health-System Pharmacists and Society of Critical Care Medicine. Past leadership includes Chair and member for the Board of Pharmacy Specialties Nutrition Support Specialty Council, Chair and Secretary of the ASPEN Pharmacy Practice Section, Chair of the ASPEN Self-Assessment Committee, Chair for the ASPEN Task Force for Revision of Nutrition Support Pharmacist Standards, and member of the ASPEN Parenteral Nutrition Safety Committee. She is a regular presenter at Clinical Nutrition Week and was most recently involved as an editor and author of the ASPEN Fluid, Electrolytes and Acid-Base Disorders Handbook.\n\n<a id='19de4395-ed5a-4891-a827-513dc02b9a7d'></a>\n\n## Relevant Financial Relationship Disclosure\n\nIn accordance with our accreditor's Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.\n\nAn ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.\n\n<a id='4a9ffc47-5272-47f5-b48a-d775bcf72877'></a>\n\nThe following persons in control of this activity's content have relevant financial relationships:\n* Phil Ayers: Fresenius Kabi, consultant and speaker\n* David Evans: Fresenius Kabi, consultant and speaker; Abbott Laboratories, consultant and speaker; CVS/OptionCare, consultant; Alcresta, consultant and speaker\n* Andrew Mays: Fresenius Kabi, speaker\n* Jay Mirtallo: Fresenius Kabi, consultant\n* Kris Mogensen: Baxter, speaker; Thrive Rx, advisory board; Pfizer, advisory board\n\n<a id='77b8b272-671f-4fb6-9f67-f0f0c328981f'></a>\n\nAll other persons in control of content do not have any relevant financial relationships with an ineligible company.\n\n<a id='193cc645-9b87-49a9-8634-c01ea4d9ad02'></a>\n\nAs required by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company, all relevant financial relationships have been mitigated prior to the CPE activity.\n\n<a id='211eb738-b192-4453-b094-e56019317b29'></a>\n\n### Methods and CE Requirements\n---\nThis online activity consists of a combined total of 12 learning modules. Pharmacists and physicians are eligible to receive a total of 20 hours of continuing education credit by completing all 12 modules within this certificate.\n\n<a id='0a3c85d9-6cbc-4e95-a393-21c4f8ab9477'></a>\n\nParticipants must participate in the entire activity, complete the evaluation and all required components to claim continuing pharmacy education credit online at ASHP Learning Center http://elearning.ashp.org. Follow the prompts to claim credit and view your statement of credit within 60 days after completing the activity.\n\n<a id='50719092-f550-47b6-ac36-87953d107e56'></a>\n\n**Important Note–ACPE 60 Day Deadline:**\nPer ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, check your NABP eProfile account to validate that your credits were transferred successfully before the ACPE 60-day deadline. After the 60 day deadline, ASHP will no longer be able to award credit for this activity.\n\n<a id='f94e68a5-d97d-448b-9a8c-e2b0560563e1'></a>\n\n## System Technical Requirements\n---\nCourses and learning activities are delivered via your Web browser and Acrobat PDF. Users should have a basic comfort level using a computer and navigating websites.\n\n<a id='52a26de7-2bd8-4bb2-986d-fc6145ae1b06'></a>\n\nView Frequently Asked Questions for more information.",
  "chunks": [
    {
      "markdown": "<a id='d049e39a-c94f-4c82-99c0-8bce010a7715'></a>\n\nNUTRITION SUPPORT CERTIFICATE",
      "type": "text",
      "id": "d049e39a-c94f-4c82-99c0-8bce010a7715",
      "grounding": {
        "box": {
          "left": 0.20875120162963867,
          "top": 0.09559591114521027,
          "right": 0.7846815586090088,
          "bottom": 0.13833053410053253
        },
        "page": 0
      }
    },
    {
      "markdown": "<a id='cfefbf72-26fb-4401-a4c9-b22243437fb9'></a>\n\nFluids & Sodium\nDisorders",
      "type": "text",
      "id": "cfefbf72-26fb-4401-a4c9-b22243437fb9",
      "grounding": {
        "box": {
          "left": 0.22389516234397888,
          "top": 0.24062179028987885,
          "right": 0.7693560123443604,
          "bottom": 0.37845247983932495
        },
        "page": 0
      }
    },
    {
      "markdown": "<a id='11965d6d-6c35-4e5d-a77f-573500394dcb'></a>\n\n<::logo: ASHP\nashp\nThe logo features the stylized blue text \"ashp\" in blue with an orange swoosh above the 'h' and 'p', and a registered trademark symbol.::>",
      "type": "logo",
      "id": "11965d6d-6c35-4e5d-a77f-573500394dcb",
      "grounding": {
        "box": {
          "left": 0.11857008188962936,
          "top": 0.522024929523468,
          "right": 0.3557589054107666,
          "bottom": 0.6223649382591248
        },
        "page": 0
      }
    },
    {
      "markdown": "<a id='81e53325-9b14-47b5-8863-d65a78e294a5'></a>\n\nCAPTION ERROR",
      "type": "logo",
      "id": "81e53325-9b14-47b5-8863-d65a78e294a5",
      "grounding": {
        "box": {
          "left": 0.4000250995159149,
          "top": 0.5069605112075806,
          "right": 0.8807059526443481,
          "bottom": 0.6218569278717041
        },
        "page": 0
      }
    },
    {
      "markdown": "<a id='30de0ff1-ff7b-4b42-a0bc-66433204b260'></a>\n\nPlanned by the American Society of Health-System Pharmacists (ASHP) in collaboration with the American Society for Parenteral and Enteral Nutrition (ASPEN).",
      "type": "text",
      "id": "30de0ff1-ff7b-4b42-a0bc-66433204b260",
      "grounding": {
        "box": {
          "left": 0.11710125207901001,
          "top": 0.6758202314376831,
          "right": 0.8817834854125977,
          "bottom": 0.7209265232086182
        },
        "page": 0
      }
    },
    {
      "markdown": "<a id='36df49d8-c092-4592-b44e-c5924c0089b1'></a>\n\n&#169;2022 American Society of Health-System Pharmacists, Inc. All rights reserved.\nNo part of this publication may be reproduced or transmitted in any form or by any means, electronic or\nmechanical, including photocopying, microfilming, and recording, or by any information storage and retrieval\nsystem, without written permission from the American Society of Health-System Pharmacists.",
      "type": "text",
      "id": "36df49d8-c092-4592-b44e-c5924c0089b1",
      "grounding": {
        "box": {
          "left": 0.1258067786693573,
          "top": 0.7430411577224731,
          "right": 0.8735208511352539,
          "bottom": 0.8151071071624756
        },
        "page": 0
      }
    },
    {
      "markdown": "<a id='e38ce2a1-beb1-4f57-ad80-03c4a4c2f1be'></a>\n\nNUTRITION SUPPORT\nCOMPLICATIONS:\nFLUIDS & SODIUM\nDISORDERS\n\nAnne M. Tucker, Pharm.D., BCNSP\nUniversity of Texas MD Anderson Cancer Center\n\n<::Illustration of a human head and torso receiving intravenous fluids from an IV bag and enteral feeding via a tube, depicted in white outline. : figure::>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\nashp aspen",
      "type": "text",
      "id": "e38ce2a1-beb1-4f57-ad80-03c4a4c2f1be",
      "grounding": {
        "box": {
          "left": 0.06453770399093628,
          "top": 0.0957910418510437,
          "right": 0.938981831073761,
          "bottom": 0.4703899025917053
        },
        "page": 1
      }
    },
    {
      "markdown": "<a id='798bcf7c-e18d-4d82-bf6b-1019c4444d65'></a>\n\nRELEVANT FINANCIAL\nRELATIONSHIP DISCLOSURE\n\nThe following persons in control of this activity's content have relevant financial relationships:\n\n- Jay Mirtallo: Fresenius Kabi, consultant\n\nAll other persons in control of content do not have any relevant financial relationships with an ineligible company.",
      "type": "text",
      "id": "798bcf7c-e18d-4d82-bf6b-1019c4444d65",
      "grounding": {
        "box": {
          "left": 0.0651770830154419,
          "top": 0.5295377373695374,
          "right": 0.9373146295547485,
          "bottom": 0.795698344707489
        },
        "page": 1
      }
    },
    {
      "markdown": "<a id='1f13f8e3-5976-4d56-885b-207758b37bff'></a>\n\nAs defined by the Standards of Integrity and Independence definition of ineligible company. All relevant\nfinancial relationships have been mitigated prior to the CPE activity.",
      "type": "text",
      "id": "1f13f8e3-5976-4d56-885b-207758b37bff",
      "grounding": {
        "box": {
          "left": 0.07552486658096313,
          "top": 0.8207365274429321,
          "right": 0.9221546649932861,
          "bottom": 0.8654313087463379
        },
        "page": 1
      }
    },
    {
      "markdown": "<a id='6e976e6d-beaa-41a9-9210-ee0a66809435'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "6e976e6d-beaa-41a9-9210-ee0a66809435",
      "grounding": {
        "box": {
          "left": 0.7795380353927612,
          "top": 0.8655372858047485,
          "right": 0.9287168979644775,
          "bottom": 0.89451003074646
        },
        "page": 1
      }
    },
    {
      "markdown": "<a id='5e9745a6-93cb-4111-a57d-5ebb909a7097'></a>\n\n# LEARNING OBJECTIVES\n\n*   Analyze patient information to determine the type of fluid & sodium disorder.\n*   Describe common etiologies of fluid & sodium disorders and their impact on the nutrition prescription.\n*   Design recommendations for the prevention and management of fluid and sodium disorders.\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "5e9745a6-93cb-4111-a57d-5ebb909a7097",
      "grounding": {
        "box": {
          "left": 0.06258279085159302,
          "top": 0.09448324143886566,
          "right": 0.9389452338218689,
          "bottom": 0.4703078269958496
        },
        "page": 2
      }
    },
    {
      "markdown": "<a id='7e7f090a-19f8-4af7-97d2-e7247135f55d'></a>\n\nKEY ABBREVIATIONS\n\n*   AdjBW: adjusted body weight\n*   BUN: blood urea nitrogen\n*   CO2: carbon dioxide\n*   ECF: extracellular fluid\n*   IBW: ideal body weight\n*   ICF: intracellular fluid\n*   PN: parenteral nutrition\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "7e7f090a-19f8-4af7-97d2-e7247135f55d",
      "grounding": {
        "box": {
          "left": 0.0628879964351654,
          "top": 0.5290356278419495,
          "right": 0.9385209083557129,
          "bottom": 0.9052333235740662
        },
        "page": 2
      }
    },
    {
      "markdown": "<a id='28315dce-2718-4e57-be54-1dd8247be5e5'></a>\n\n# KEY ABBREVIATIONS\n\n*   SIAD: syndrome of inappropriate antidiuresis\n*   sOsm: serum osmolality\n*   TBW: total body water\n*   uNa: urine sodium\n*   uOsm: urine osmolality\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "28315dce-2718-4e57-be54-1dd8247be5e5",
      "grounding": {
        "box": {
          "left": 0.06294694542884827,
          "top": 0.09469668567180634,
          "right": 0.9388382434844971,
          "bottom": 0.4695681929588318
        },
        "page": 3
      }
    },
    {
      "markdown": "<a id='a1ee380f-036f-4d1a-b8ed-c1616394a409'></a>\n\n## SELF-ASSESSMENT #1\n\n*   MN is a 72 year-old female who is admitted to the medicine service for a non-specific complaint of general malaise. On physical exam, she has dry mucous membranes and exhibits poor skin turgor.\n*   Past medical history: HTN, osteoarthritis, and hyperlipidemia\n*   Home medications: hydrochlorothiazide, aspirin, simvastatin, calcium carbonate, vitamin D\n*   Vital signs: BP 96/52, HR 100, RR 14, Temp 37 C\n*   Laboratory values: Na 122 mEq/L, K 4 mEq/L, CI 101 mEq/L, CO2 19 mEq/L, BUN 45 mg/dL, Cr 1.5 mg/dL, glucose 115 mg/dL, magnesium 2.4 mg/dL, urine osmolality 450 mOsm/L\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "a1ee380f-036f-4d1a-b8ed-c1616394a409",
      "grounding": {
        "box": {
          "left": 0.06304481625556946,
          "top": 0.5298891663551331,
          "right": 0.9379253387451172,
          "bottom": 0.9036560654640198
        },
        "page": 3
      }
    },
    {
      "markdown": "<a id='7ff14278-eb74-4149-a5ed-b621975de052'></a>\n\nSELF-ASSESSMENT #1, CONT.\n\nWhich of the following is the most likely diagnosis for this patient's hyponatremia?\n\nA. Hypertonic\nB. Hypovolemic hypotonic\nC. Euvolemic hypotonic\nD. Hypervolemic hypotonic\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "7ff14278-eb74-4149-a5ed-b621975de052",
      "grounding": {
        "box": {
          "left": 0.06262132525444031,
          "top": 0.09409670531749725,
          "right": 0.938776969909668,
          "bottom": 0.4705467224121094
        },
        "page": 4
      }
    },
    {
      "markdown": "<a id='b9dc5873-bd29-4f2f-9a3b-d8a2fa9bb58a'></a>\n\nFLUID AND SODIUM\nDISORDERS\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "b9dc5873-bd29-4f2f-9a3b-d8a2fa9bb58a",
      "grounding": {
        "box": {
          "left": 0.06324514746665955,
          "top": 0.5289539098739624,
          "right": 0.9380829334259033,
          "bottom": 0.9052681922912598
        },
        "page": 4
      }
    },
    {
      "markdown": "<a id='4b8dde8d-2aa7-486f-b44e-3a864b8abc8a'></a>\n\nTOTAL BODY WATER (TBW)\n\n*   Water content of the body\n    *   60% lean body mass for males\n    *   50% lean body mass for females\n*   Body composition influence on TBW\n    *   Water content of fat ~10%\n    *   Water content of muscle ~75%\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "4b8dde8d-2aa7-486f-b44e-3a864b8abc8a",
      "grounding": {
        "box": {
          "left": 0.06209683418273926,
          "top": 0.09425055980682373,
          "right": 0.939359188079834,
          "bottom": 0.47037220001220703
        },
        "page": 5
      }
    },
    {
      "markdown": "<a id='b2d284ac-571b-4892-b804-7b25250ef495'></a>\n\n# BODY FLUID DISTRIBUTION\n\n*   Intracellular fluid (ICF)\n    *   2/3 total body water\n    *   Potassium, magnesium phosphorus\n*   Extracellular fluid (ECF)\n    *   1/3 total body water\n    *   Sodium, chloride, bicarbonate\n    *   Subdivisions\n        *   3/4 ECF – Interstitial fluid\n        *   1/4 ECF – Intravascular fluid\n*   Transcellular fluid\n\n<::transcription of the content\n: pie chart labeled \"%TBW\" showing the distribution of body fluids. The chart includes segments for \"Interstitial\" and \"Intravascular\" fluids, with a legend indicating \"ICF\" and \"ECF\".::>\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "figure",
      "id": "b2d284ac-571b-4892-b804-7b25250ef495",
      "grounding": {
        "box": {
          "left": 0.0628797709941864,
          "top": 0.5290794372558594,
          "right": 0.9391229152679443,
          "bottom": 0.9054017066955566
        },
        "page": 5
      }
    },
    {
      "markdown": "<a id='4b201591-309b-4671-b647-dcd63921df30'></a>\n\nBODY FLUID MAINTENANCE\n\n*   Normal cellular function\n*   Tight regulation\n    *   Serum osmolality (sOsm)\n        *   Important determinant of intracellular volume\n        *   sOsm = 2 x [Na] + [glucose/18] + [BUN/2.8]\n        *   Alterations ⇒ neurological symptoms\n    *   Blood volume\n        *   Determinant of effective tissue perfusion\n        *   Plasma proteins play role in oncotic pressure\n        *   Oxygen & nutrient delivery\n        *   Metabolic waste removal\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "4b201591-309b-4671-b647-dcd63921df30",
      "grounding": {
        "box": {
          "left": 0.0625944435596466,
          "top": 0.09476169943809509,
          "right": 0.9387773275375366,
          "bottom": 0.4698048532009125
        },
        "page": 6
      }
    },
    {
      "markdown": "<a id='c0aa90b4-71d2-453a-9737-7d67bf4aa61f'></a>\n\nFLUID REQUIREMENTS\n\n*   Weight and age based\n    *   Ages 18-55 years: 35 mL/kg/day\n    *   Ages 56-75 years: 30 mL/kg/day\n    *   Ages > 75 years: 25 mL/kg/day\n    *   Fluid-restricted adults: ≤ 25 mL/kg/day\n\nCanada TW et al. ASPEN Adult Nutrition Support Core Curriculum.\n3rd ed. 2017:113-37.\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "c0aa90b4-71d2-453a-9737-7d67bf4aa61f",
      "grounding": {
        "box": {
          "left": 0.06313711404800415,
          "top": 0.5295124053955078,
          "right": 0.9384127259254456,
          "bottom": 0.904965877532959
        },
        "page": 6
      }
    },
    {
      "markdown": "<a id='1e3adae9-3144-4b02-9283-5c693c3be28c'></a>\n\nFLUID REQUIREMENTS, CONT.\n\n*   Adjusted Holiday-Segar formula\n    *   1500 mL for the first 20 kg of body weight, then ADD\n        *   Ages <= 50 years: 20 mL per kg of remaining body weight\n        *   Ages > 50 years: 15 mL per kg of remaining body weight\n*   1 mL/kcal ingested\n*   1500-1600 mL/m² per 24 hours",
      "type": "text",
      "id": "1e3adae9-3144-4b02-9283-5c693c3be28c",
      "grounding": {
        "box": {
          "left": 0.06376007199287415,
          "top": 0.09513792395591736,
          "right": 0.9389923810958862,
          "bottom": 0.4094916880130768
        },
        "page": 7
      }
    },
    {
      "markdown": "<a id='e48bf804-3ebb-448b-8621-25ee5095bb49'></a>\n\nCanada TW et al. ASPEN Adult Nutrition Support Core Curriculum.\n3rd ed. 2017:113-37.\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "e48bf804-3ebb-448b-8621-25ee5095bb49",
      "grounding": {
        "box": {
          "left": 0.06640496850013733,
          "top": 0.42754074931144714,
          "right": 0.9364492893218994,
          "bottom": 0.4669046700000763
        },
        "page": 7
      }
    },
    {
      "markdown": "<a id='0bf0a6d7-6016-4ffe-a95d-e7d7fc2806d2'></a>\n\nASSESSING FLUID BALANCE\n\n*   Physical exam (mucous membranes, skin turgor, edema)\n*   Urine output (0.5-2 mL/kg/hour)\n*   Weight changes\n*   Temperature\n*   Vital signs (blood pressure, heart rate)\n*   Intake and output records\n*   Insensible losses\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "0bf0a6d7-6016-4ffe-a95d-e7d7fc2806d2",
      "grounding": {
        "box": {
          "left": 0.06191912293434143,
          "top": 0.5285632610321045,
          "right": 0.9397450685501099,
          "bottom": 0.9057590961456299
        },
        "page": 7
      }
    },
    {
      "markdown": "<a id='73a8742f-ee06-42e5-8fcb-e32550380010'></a>\n\n<::logo: Gastrointestinal Losses\nGASTROINTESTINAL LOSSES\nA brown rectangular banner features white text and a white line-art illustration of a human head with an IV drip and a nasogastric tube.::>",
      "type": "logo",
      "id": "73a8742f-ee06-42e5-8fcb-e32550380010",
      "grounding": {
        "box": {
          "left": 0.0657937228679657,
          "top": 0.09638155996799469,
          "right": 0.9358233213424683,
          "bottom": 0.17702965438365936
        },
        "page": 8
      }
    },
    {
      "markdown": "<a id='acdf7869-baee-4aaf-a27c-41d1560ee0cd'></a>\n\n<table id=\"8-1\">\n<tr><td id=\"8-2\" rowspan=\"2\">Body Fluid Type</td><td id=\"8-3\" colspan=\"4\">mEq/L</td></tr>\n<tr><td id=\"8-4\">Na</td><td id=\"8-5\">Cl</td><td id=\"8-6\">K</td><td id=\"8-7\">HCO3</td></tr>\n<tr><td id=\"8-8\">Stomach</td><td id=\"8-9\">60</td><td id=\"8-a\">130</td><td id=\"8-b\">15</td><td id=\"8-c\">0</td></tr>\n<tr><td id=\"8-d\">Duodenum</td><td id=\"8-e\">140</td><td id=\"8-f\">80</td><td id=\"8-g\">5</td><td id=\"8-h\">0</td></tr>\n<tr><td id=\"8-i\">Pancreas</td><td id=\"8-j\">140</td><td id=\"8-k\">75</td><td id=\"8-l\">5</td><td id=\"8-m\">115</td></tr>\n<tr><td id=\"8-n\">Bile</td><td id=\"8-o\">145</td><td id=\"8-p\">100</td><td id=\"8-q\">5</td><td id=\"8-r\">35</td></tr>\n<tr><td id=\"8-s\">Ileum</td><td id=\"8-t\">140</td><td id=\"8-u\">104</td><td id=\"8-v\">5</td><td id=\"8-w\">30</td></tr>\n<tr><td id=\"8-x\">Colon</td><td id=\"8-y\">60</td><td id=\"8-z\">40</td><td id=\"8-A\">30</td><td id=\"8-B\">0</td></tr>\n</table>",
      "type": "table",
      "id": "acdf7869-baee-4aaf-a27c-41d1560ee0cd",
      "grounding": {
        "box": {
          "left": 0.1372840404510498,
          "top": 0.1871037632226944,
          "right": 0.8630800247192383,
          "bottom": 0.41513538360595703
        },
        "page": 8
      }
    },
    {
      "markdown": "<a id='e5a86d90-1748-4268-977c-4ecbce64ab84'></a>\n\nASPEN Adult Nutrition Support Core Curriculum 3rd edition, 2017:113-137.",
      "type": "text",
      "id": "e5a86d90-1748-4268-977c-4ecbce64ab84",
      "grounding": {
        "box": {
          "left": 0.08522365987300873,
          "top": 0.44122186303138733,
          "right": 0.5378010869026184,
          "bottom": 0.45916083455085754
        },
        "page": 8
      }
    },
    {
      "markdown": "<a id='a8d1ac93-d7a6-4b22-9a5c-e09847b9369e'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "a8d1ac93-d7a6-4b22-9a5c-e09847b9369e",
      "grounding": {
        "box": {
          "left": 0.7876595258712769,
          "top": 0.4322252869606018,
          "right": 0.9246684312820435,
          "bottom": 0.4553985595703125
        },
        "page": 8
      }
    },
    {
      "markdown": "<a id='94969f52-4c4b-4d9d-83f6-ae18c960b1a5'></a>\n\n<::logo: Not identified\nGASTROINTESTINAL LOSSES\nThe logo features white outline illustrations of a human head with a tube inserted into the nose/mouth, connected to an IV bag, all set against a brown rectangular background.::>",
      "type": "logo",
      "id": "94969f52-4c4b-4d9d-83f6-ae18c960b1a5",
      "grounding": {
        "box": {
          "left": 0.0674339234828949,
          "top": 0.5318315029144287,
          "right": 0.9355016946792603,
          "bottom": 0.6117472648620605
        },
        "page": 8
      }
    },
    {
      "markdown": "<a id='ef862032-fff5-4a23-92e3-abf7164aba20'></a>\n\n<table id=\"8-C\">\n<tr><td id=\"8-D\" rowspan=\"2\">Body Fluid Type</td><td id=\"8-E\" colspan=\"4\">mEq/L</td></tr>\n<tr><td id=\"8-F\">Na</td><td id=\"8-G\">Cl</td><td id=\"8-H\">K</td><td id=\"8-I\">HCO3</td></tr>\n<tr><td id=\"8-J\">Stomach</td><td id=\"8-K\">60</td><td id=\"8-L\">130</td><td id=\"8-M\">15</td><td id=\"8-N\">0</td></tr>\n<tr><td id=\"8-O\">Duodenum</td><td id=\"8-P\">140</td><td id=\"8-Q\">80</td><td id=\"8-R\">5</td><td id=\"8-S\">0</td></tr>\n<tr><td id=\"8-T\">Pancreas</td><td id=\"8-U\">140</td><td id=\"8-V\">75</td><td id=\"8-W\">5</td><td id=\"8-X\">115</td></tr>\n<tr><td id=\"8-Y\">Bile</td><td id=\"8-Z\">145</td><td id=\"8-10\">100</td><td id=\"8-11\">5</td><td id=\"8-12\">35</td></tr>\n<tr><td id=\"8-13\">Ileum</td><td id=\"8-14\">140</td><td id=\"8-15\">104</td><td id=\"8-16\">5</td><td id=\"8-17\">30</td></tr>\n<tr><td id=\"8-18\">Colon</td><td id=\"8-19\">60</td><td id=\"8-1a\">40</td><td id=\"8-1b\">30</td><td id=\"8-1c\">0</td></tr>\n</table>",
      "type": "table",
      "id": "ef862032-fff5-4a23-92e3-abf7164aba20",
      "grounding": {
        "box": {
          "left": 0.1388932168483734,
          "top": 0.6234468817710876,
          "right": 0.861810564994812,
          "bottom": 0.8474008440971375
        },
        "page": 8
      }
    },
    {
      "markdown": "<a id='241fd44b-4cca-4bb8-b0f9-121e49f9c264'></a>\n\nASPEN Adult Nutrition Support Core Curriculum, 3rd edition, 2017:113-137.",
      "type": "text",
      "id": "241fd44b-4cca-4bb8-b0f9-121e49f9c264",
      "grounding": {
        "box": {
          "left": 0.08483690023422241,
          "top": 0.8770254850387573,
          "right": 0.53560471534729,
          "bottom": 0.8942703008651733
        },
        "page": 8
      }
    },
    {
      "markdown": "<a id='8c68e89c-8a54-4673-9876-2f0e049fc5dd'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "8c68e89c-8a54-4673-9876-2f0e049fc5dd",
      "grounding": {
        "box": {
          "left": 0.788041353225708,
          "top": 0.8677130341529846,
          "right": 0.923505425453186,
          "bottom": 0.8900489211082458
        },
        "page": 8
      }
    },
    {
      "markdown": "<a id='0976ad3d-ecb2-4c8d-b680-9c6f4e1bb726'></a>\n\nREPLACEMENT FLUIDS\n\n*   Based upon specific losses\n*   Gastric and colonic fluid losses\n    *   0.45% NaCl (1/2 Normal Saline) + 10-20 mEq KCI/L\n*   Small bowel fluid losses\n    *   0.9% NaCl (Normal Saline)\n    *   Bicarbonate or acetate-based customized fluid\n    *   Balanced crystalloid (e.g., Ringers Lactate)\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "0976ad3d-ecb2-4c8d-b680-9c6f4e1bb726",
      "grounding": {
        "box": {
          "left": 0.06264296174049377,
          "top": 0.09452053904533386,
          "right": 0.9393056631088257,
          "bottom": 0.470132440328598
        },
        "page": 9
      }
    },
    {
      "markdown": "<a id='1598e825-27cf-47b8-96ff-66b1cdcfc71c'></a>\n\nNORMAL ELECTROLYTE\nCONCENTRATIONS\n\n<table id=\"9-1\">\n<tr><td id=\"9-2\">Electrolyte</td><td id=\"9-3\">Adult</td></tr>\n<tr><td id=\"9-4\">Sodium</td><td id=\"9-5\">135-145 mEq/L</td></tr>\n<tr><td id=\"9-6\">Potassium</td><td id=\"9-7\">3.5-5 mEq/L</td></tr>\n<tr><td id=\"9-8\">Chloride</td><td id=\"9-9\">98-108 mEq/L</td></tr>\n<tr><td id=\"9-a\">CO₂</td><td id=\"9-b\">23-30 mEq/L</td></tr>\n<tr><td id=\"9-c\">Calcium</td><td id=\"9-d\">9-10.5 mg/dL</td></tr>\n<tr><td id=\"9-e\">Phosphorus</td><td id=\"9-f\">2.5-4.5 mg/dL</td></tr>\n<tr><td id=\"9-g\">Magnesium</td><td id=\"9-h\">1.7-2.4 mg/dL</td></tr>\n<tr><td id=\"9-i\" colspan=\"2\">*Variations in lab values exist between institutions</td></tr>\n</table>\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "table",
      "id": "1598e825-27cf-47b8-96ff-66b1cdcfc71c",
      "grounding": {
        "box": {
          "left": 0.06333649158477783,
          "top": 0.5300447344779968,
          "right": 0.9375557899475098,
          "bottom": 0.904021680355072
        },
        "page": 9
      }
    },
    {
      "markdown": "<a id='1ec6b493-2bfd-40df-9925-a5468d31d580'></a>\n\nCAPTION ERROR",
      "type": "logo",
      "id": "1ec6b493-2bfd-40df-9925-a5468d31d580",
      "grounding": {
        "box": {
          "left": 0.06579214334487915,
          "top": 0.09647855162620544,
          "right": 0.9356541037559509,
          "bottom": 0.17716392874717712
        },
        "page": 10
      }
    },
    {
      "markdown": "<a id='b03361c1-1dbb-4120-a810-311b697e341a'></a>\n\n<table id=\"10-1\">\n<tr><td id=\"10-2\">Electrolyte</td><td id=\"10-3\">Requirements</td></tr>\n<tr><td id=\"10-4\">Sodium</td><td id=\"10-5\">60-100 mEq/day or 1-2 mEq/kg/day</td></tr>\n<tr><td id=\"10-6\">Potassium</td><td id=\"10-7\">60-100 mEq/day or 1-2mEq/kg/day</td></tr>\n<tr><td id=\"10-8\">Chloride</td><td id=\"10-9\">As needed to maintain acid-base balance</td></tr>\n<tr><td id=\"10-a\">Acetate</td><td id=\"10-b\">As needed to maintain acid-base balance</td></tr>\n<tr><td id=\"10-c\">Calcium</td><td id=\"10-d\">10-15 mEq/day</td></tr>\n<tr><td id=\"10-e\">Phosphorus</td><td id=\"10-f\">20-40 mmol/dayor 0.25-0.5 mmol/kg/day</td></tr>\n<tr><td id=\"10-g\">Magnesium</td><td id=\"10-h\">8-20 mEq/day or 0.25-0.5 mEq/kg/day</td></tr>\n<tr><td id=\"10-i\" colspan=\"2\">*Consider lower doses for those with renal insufficiency</td></tr>\n</table>",
      "type": "table",
      "id": "b03361c1-1dbb-4120-a810-311b697e341a",
      "grounding": {
        "box": {
          "left": 0.1919654905796051,
          "top": 0.18737369775772095,
          "right": 0.806923508644104,
          "bottom": 0.4101400375366211
        },
        "page": 10
      }
    },
    {
      "markdown": "<a id='4498d3ff-bac7-418d-a93a-8bf6cf2a6e84'></a>\n\nMirtallo J et al. JPEN J Parent Enteral Nutr. 2004; 28:S39-S70.",
      "type": "text",
      "id": "4498d3ff-bac7-418d-a93a-8bf6cf2a6e84",
      "grounding": {
        "box": {
          "left": 0.09273004531860352,
          "top": 0.4317761957645416,
          "right": 0.5081067085266113,
          "bottom": 0.45236000418663025
        },
        "page": 10
      }
    },
    {
      "markdown": "<a id='25f08d59-53cb-4fdc-8562-be73ac932cdb'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "25f08d59-53cb-4fdc-8562-be73ac932cdb",
      "grounding": {
        "box": {
          "left": 0.7860541343688965,
          "top": 0.4306129217147827,
          "right": 0.9255611896514893,
          "bottom": 0.4564812183380127
        },
        "page": 10
      }
    },
    {
      "markdown": "<a id='b7dede06-35b2-465d-85fb-0d195ce4e034'></a>\n\n<::logo: Not identified\nELECTROLYTE DOSING CONSIDERATIONS\nThe logo features white text on a brown rectangular background, accompanied by a white outline illustration of an IV drip connected to a human head/throat.::>",
      "type": "logo",
      "id": "b7dede06-35b2-465d-85fb-0d195ce4e034",
      "grounding": {
        "box": {
          "left": 0.06531158089637756,
          "top": 0.5312110781669617,
          "right": 0.9366475343704224,
          "bottom": 0.6131035685539246
        },
        "page": 10
      }
    },
    {
      "markdown": "<a id='e8d4f140-6265-4af0-a93f-f890e5a44964'></a>\n\n▪ Electrolyte disorders\n  - Acute (< 48 hours) vs. chronic (> 48 hours)\n  - Rate of development, degree of abnormality and/or symptoms\n▪ Renal dysfunction\n  - Empiric dose - 50% recommended dose\n▪ Obesity\n  - Adjusted body weight (AdjBW) for weight-based electrolyte dosing\n  - AdjBW = [(weight in kg - IBW) x 0.25] + IBW",
      "type": "text",
      "id": "e8d4f140-6265-4af0-a93f-f890e5a44964",
      "grounding": {
        "box": {
          "left": 0.08082202076911926,
          "top": 0.6183733940124512,
          "right": 0.8099700212478638,
          "bottom": 0.8207000494003296
        },
        "page": 10
      }
    },
    {
      "markdown": "<a id='febb6d3f-3744-4923-a077-313cc676c4d9'></a>\n\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82.",
      "type": "text",
      "id": "febb6d3f-3744-4923-a077-313cc676c4d9",
      "grounding": {
        "box": {
          "left": 0.09175556898117065,
          "top": 0.8661300539970398,
          "right": 0.4874323010444641,
          "bottom": 0.8883256316184998
        },
        "page": 10
      }
    },
    {
      "markdown": "<a id='5cd37089-ff8f-4028-a276-57e06e3cf11b'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "5cd37089-ff8f-4028-a276-57e06e3cf11b",
      "grounding": {
        "box": {
          "left": 0.7824414372444153,
          "top": 0.8641707301139832,
          "right": 0.9270482659339905,
          "bottom": 0.892541229724884
        },
        "page": 10
      }
    },
    {
      "markdown": "<a id='d4710f52-8be6-406d-91e3-362bf657848f'></a>\n\n# SODIUM\n\n*   Most abundant extracellular cation\n*   Normal serum sodium 135-145 mEq/L\n*   Primary influence on serum osmolality\n*   Changes in serum sodium are due to water balance changes\n*   Water flows from areas of lower osmolality to higher osmolality\n*   Sodium disorder diagnosis\n    *   History and physical\n    *   Laboratory analysis (serum, urine)\n    *   **Serum osmolality**\n    *   **Volume status of the patient**\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "d4710f52-8be6-406d-91e3-362bf657848f",
      "grounding": {
        "box": {
          "left": 0.06303399801254272,
          "top": 0.09528505802154541,
          "right": 0.9384981989860535,
          "bottom": 0.4692738652229309
        },
        "page": 11
      }
    },
    {
      "markdown": "<a id='27694181-0bf0-46e6-81b1-e2c227f1284c'></a>\n\n# HYPONATREMIA (NA < 135 MEQ/L)\n\n*   Common electrolyte disorder\n    *   28% hospitalized patients\n    *   17.2% critically ill patients\n*   Up to 6-fold increase in morbidity and mortality\n*   Wide symptomatology – neurologic in nature\n    *   None\n    *   Moderate: headache, nausea, confusion\n    *   Severe: vomiting, obtunded, seizures, coma\n\nMannesse CK et al. Ageing Res Rev. 2013; 12(1):165-73.\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "27694181-0bf0-46e6-81b1-e2c227f1284c",
      "grounding": {
        "box": {
          "left": 0.06334662437438965,
          "top": 0.5305432081222534,
          "right": 0.938200831413269,
          "bottom": 0.8992806673049927
        },
        "page": 11
      }
    },
    {
      "markdown": "<a id='50940c4e-f9af-413c-93d4-6d5a0f91c842'></a>\n\n<::DIAGNOSTIC ALGORITHM\n: flowchart::>\nNa correction for hyperglycemia = serum Na + 0.016 (serum glucose - 100)\n\nHyponatremia (Na < 135 mEq/L)\n↓\nSerum Osmolality (sOsm)\n\nBranches:\n1. Hypertonic (sOsm > 290 mOsm/kg)\n   ↓\n   Hyperglycemia\n   Mannitol infusions\n\n2. Hypotonic (sOsm < 275 mOsm/kg)\n   ↓\n   Determine volume status of the patient (next slide)\n\n3. Isotonic (sOsm 275-290 mOsm/kg)\n   ↓\n   Hyperlipidemia\n   Hyperproteinemia\n<::\nVerbalis JG et al. AmJ Med. 2013; 126:S1-S42.\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82.\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "figure",
      "id": "50940c4e-f9af-413c-93d4-6d5a0f91c842",
      "grounding": {
        "box": {
          "left": 0.06331431865692139,
          "top": 0.09521609544754028,
          "right": 0.9388338327407837,
          "bottom": 0.46918177604675293
        },
        "page": 12
      }
    },
    {
      "markdown": "<a id='032be8e0-4e68-4de0-aacb-34b1d720859a'></a>\n\n<::DIAGNOSTIC ALGORITHM\n: flowchart::>\n<::Hypotonic hyponatremia\n(Na < 135 mEq/L, sOsm < 275 mOsm/kg)\n: flowchart::>\n\n<::Volume status\nof the patient\n: flowchart::>\n\n<::From \"Volume status of the patient\" to three branches:\n\nBranch 1:\nHypovolemia\n↓TBW, ↓↓Total body Na\n\n  From \"Hypovolemia\" to two sub-branches:\n\n  Sub-branch 1.1:\n  Renal losses\n  uNa >20 mEq/L\n  Diuretics (thiazides)\n  Osmotic diuresis\n  Adrenal insufficiency\n  Salt-wasting nephropathy\n  Cerebral salt wasting\n\n  Sub-branch 1.2:\n  Extrarenal losses\n  uNa <20 mEq/L\n  Vomiting\n  Diarrhea\n  Third spacing\n  Pancreatitis\n  Burns/open wounds\n  Excessive sweating\n\nBranch 2:\nEuvolemia\n↑TBW, ↔Total body Na\n\n  From \"Euvolemia\" to one sub-branch:\n\n  Sub-branch 2.1:\n  uNa >20 mEq/L\n  uOsm >100 mOsm/L\n  Syndrome of inappropriate antidiuresis (SIAD)\n  Hypothyroid\n  Glucocorticoid deficiency\n\nBranch 3:\nHypervolemia\n↑↑TBW, ↑Total body Na\n\n  From \"Hypervolemia\" to two sub-branches:\n\n  Sub-branch 3.1:\n  uNa >20 mEq/L\n  Acute kidney injury\n  Chronic kidney disease\n\n  Sub-branch 3.2:\n  uNa <20 mEq/L\n  Cirrhosis\n  Nephrotic syndrome\n  Heart failure\n\nNUTRITION SUPPORT\nCERTIFICATE\n: flowchart::>",
      "type": "figure",
      "id": "032be8e0-4e68-4de0-aacb-34b1d720859a",
      "grounding": {
        "box": {
          "left": 0.06435686349868774,
          "top": 0.5299934148788452,
          "right": 0.938022792339325,
          "bottom": 0.9045591354370117
        },
        "page": 12
      }
    },
    {
      "markdown": "<a id='42b570fa-7f18-4094-b615-04a4fcb21346'></a>\n\n<::A brown banner with the text \"SIAD\" in white on the left side. On the right side, there is a white outline illustration of a human head in profile, with an IV drip bag connected to it, suggesting a medical or healthcare context.\n: figure::>",
      "type": "figure",
      "id": "42b570fa-7f18-4094-b615-04a4fcb21346",
      "grounding": {
        "box": {
          "left": 0.06477341055870056,
          "top": 0.09655529260635376,
          "right": 0.9372446537017822,
          "bottom": 0.17785784602165222
        },
        "page": 13
      }
    },
    {
      "markdown": "<a id='22096ca4-3d2c-47a6-970f-1fd7e7f5ea06'></a>\n\nSustained or intermittently elevated antidiuretic hormone (ADH) level inappropriate for osmotic and volume status which normally inhibits ADH secretion",
      "type": "text",
      "id": "22096ca4-3d2c-47a6-970f-1fd7e7f5ea06",
      "grounding": {
        "box": {
          "left": 0.08040511608123779,
          "top": 0.18647649884223938,
          "right": 0.9216471910476685,
          "bottom": 0.23641112446784973
        },
        "page": 13
      }
    },
    {
      "markdown": "<a id='6ee7f8bb-803e-46ca-be3a-7aceaf899b91'></a>\n\n<table id=\"13-1\">\n<tr><td id=\"13-2\">Essential Criteria</td><td id=\"13-3\">Supplemental Criteria</td></tr>\n<tr><td id=\"13-4\">Effective sOsm <275 mOsm/kg</td><td id=\"13-5\">Serum uric acid < 0.24 mmol/L (< 4 mg/dL)</td></tr>\n<tr><td id=\"13-6\">uOsm > 100 mOsm/kg at some level of decreased</td><td id=\"13-7\">Fractional excretion of uric acid > 12%</td></tr>\n<tr><td id=\"13-8\">effective osmolality</td><td id=\"13-9\">Serum urea <3.6 mmol/L (<21.6 mg/dL)</td></tr>\n<tr><td id=\"13-a\">Clinical euvolemia</td><td id=\"13-b\">Fractional excretion of urea > 55%</td></tr>\n<tr><td id=\"13-c\">uNa > 30 mEq/L (normal sodium & water intake)</td><td id=\"13-d\">Fractional excretion of Na > 0.5%</td></tr>\n<tr><td id=\"13-e\">No adrenal, thyroid, pituitary or renal insufficiency</td><td id=\"13-f\">No change in serum Na with 0.9% NaCl administration</td></tr>\n<tr><td id=\"13-g\">No recent diuretic use</td><td id=\"13-h\">Na correction with fluid restriction</td></tr>\n</table>",
      "type": "table",
      "id": "6ee7f8bb-803e-46ca-be3a-7aceaf899b91",
      "grounding": {
        "box": {
          "left": 0.0829605758190155,
          "top": 0.23706842958927155,
          "right": 0.924452543258667,
          "bottom": 0.4231433868408203
        },
        "page": 13
      }
    },
    {
      "markdown": "<a id='8c4532e2-8e79-4d68-ab8d-78d0786dbd74'></a>\n\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. AmJ Health-Syst Pharm 2005; 62:1663-82.\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "8c4532e2-8e79-4d68-ab8d-78d0786dbd74",
      "grounding": {
        "box": {
          "left": 0.08753782510757446,
          "top": 0.4269363284111023,
          "right": 0.9287866950035095,
          "bottom": 0.4651517868041992
        },
        "page": 13
      }
    },
    {
      "markdown": "<a id='a8645af1-14cf-4ad6-af59-e903279482ec'></a>\n\n# CAUSES OF SIAD\n\n*   Diagnosis of exclusion\n*   Causes\n    *   Pulmonary (small cell lung cancer, pneumonia, abscess, tuberculosis)\n    *   Neurologic (tumors, trauma, meningitis, abscess, subarachnoid hemorrhage, pain, anxiety, nausea)\n    *   Hypothyroidism\n    *   Medications\n\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. Am J Health-Syst Pharm. 2005; 62:1663-82.\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "a8645af1-14cf-4ad6-af59-e903279482ec",
      "grounding": {
        "box": {
          "left": 0.06293344497680664,
          "top": 0.530025839805603,
          "right": 0.938734769821167,
          "bottom": 0.9049234390258789
        },
        "page": 13
      }
    },
    {
      "markdown": "<a id='9ae21f6f-706d-40b0-82b7-51db9692d5fc'></a>\n\n<::SIAD: MEDICATIONS ASSOCIATED\n: An illustration depicting a person receiving medication through an IV drip and a nasal spray.::>",
      "type": "figure",
      "id": "9ae21f6f-706d-40b0-82b7-51db9692d5fc",
      "grounding": {
        "box": {
          "left": 0.0636759102344513,
          "top": 0.0951918363571167,
          "right": 0.9378472566604614,
          "bottom": 0.17834696173667908
        },
        "page": 14
      }
    },
    {
      "markdown": "<a id='a170457b-5603-4e7c-a80e-164d77a2dd25'></a>\n\n- Anticancer agents: cyclophosphamide, ifosfamide, vincristine\n- Anticonvulsants: carbamazepine, oxcarbazepine\n- Antidepressants: SSRIs, TCADs, MAOI, venlafaxine\n- Antidiabetic agent: chlorpropamide\n- Antipsychotics: phenothiazines\n- Miscellaneous: opiates, 3,4-methylenedioxy-methamphetamine (MDMA), non-steroidal anti-inflammatory drugs\n- Vasopressin analogs: desmopressin, oxytocin, terlipressin, vasopressin",
      "type": "text",
      "id": "a170457b-5603-4e7c-a80e-164d77a2dd25",
      "grounding": {
        "box": {
          "left": 0.08277922868728638,
          "top": 0.18640479445457458,
          "right": 0.8779597878456116,
          "bottom": 0.3864469826221466
        },
        "page": 14
      }
    },
    {
      "markdown": "<a id='0e233f41-e037-4258-b347-1d6f511dfaf3'></a>\n\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82.\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "0e233f41-e037-4258-b347-1d6f511dfaf3",
      "grounding": {
        "box": {
          "left": 0.08465972542762756,
          "top": 0.42300909757614136,
          "right": 0.9236479997634888,
          "bottom": 0.4665048122406006
        },
        "page": 14
      }
    },
    {
      "markdown": "<a id='0df216f7-d596-4719-ad8e-772f094f25cb'></a>\n\n# HYPONATREMIA MANAGEMENT\n\n*   Focus on treatment of underlying cause\n*   Discontinuation of hypotonic fluids\n*   Replace sodium deficit or water excess\n    *   Change in serum Na = (infusate Na – serum Na) / (TBW + 1)\n*   Hypertonic saline for symptomatic patients\n*   Sodium correction limited to 8-10 mEq per Liter per day\n    *   Prevention of central pontine myelinolysis\n    *   Gradual onset of neurologic alterations\n\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82.\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "0df216f7-d596-4719-ad8e-772f094f25cb",
      "grounding": {
        "box": {
          "left": 0.06350347399711609,
          "top": 0.5301626920700073,
          "right": 0.9383875131607056,
          "bottom": 0.898675799369812
        },
        "page": 14
      }
    },
    {
      "markdown": "<a id='c9622815-d0fc-4731-8c62-5eb7a8d1b5e0'></a>\n\nCAPTION ERROR",
      "type": "logo",
      "id": "c9622815-d0fc-4731-8c62-5eb7a8d1b5e0",
      "grounding": {
        "box": {
          "left": 0.06617411971092224,
          "top": 0.09613700956106186,
          "right": 0.9355430603027344,
          "bottom": 0.17769384384155273
        },
        "page": 15
      }
    },
    {
      "markdown": "<a id='a9e4e492-a17a-4258-8a05-f69a1f361704'></a>\n\n<table id=\"15-1\">\n<tr><td id=\"15-2\">Hyponatremia Type</td><td id=\"15-3\">Treatment (plus treat or remove underlying cause)</td></tr>\n<tr><td id=\"15-4\">Hypertonic</td><td id=\"15-5\">Insulin (hyperglycemia), discontinue mannitol</td></tr>\n<tr><td id=\"15-6\" colspan=\"2\">Hypotonic</td></tr>\n<tr><td id=\"15-7\">Hypovolemic</td><td id=\"15-8\">Isotonic fluids (0.9% sodium chloride, lactated ringers), discontinue diuretics, steroids (adrenal insufficiency)</td></tr>\n<tr><td id=\"15-9\">Euvolemic</td><td id=\"15-a\">Fluid restriction ± loop diuretics, concentrate PN, ensure at least isotonic fluids, vaptan (SIAD); glucocorticoids (deficiency); thyroid hormone replacement (hypothyroid)</td></tr>\n<tr><td id=\"15-b\">Hypervolemic</td><td id=\"15-c\">Sodium and fluid restriction, vaptans, diuretics</td></tr>\n</table>",
      "type": "table",
      "id": "a9e4e492-a17a-4258-8a05-f69a1f361704",
      "grounding": {
        "box": {
          "left": 0.09159040451049805,
          "top": 0.18790757656097412,
          "right": 0.9082233309745789,
          "bottom": 0.3972018361091614
        },
        "page": 15
      }
    },
    {
      "markdown": "<a id='179f8e36-441a-4fc8-90b4-6a40672e8f42'></a>\n\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82.\n---",
      "type": "text",
      "id": "179f8e36-441a-4fc8-90b4-6a40672e8f42",
      "grounding": {
        "box": {
          "left": 0.09239499270915985,
          "top": 0.4265393614768982,
          "right": 0.49225807189941406,
          "bottom": 0.4645478129386902
        },
        "page": 15
      }
    },
    {
      "markdown": "<a id='0702fd84-f360-4785-b999-49af0b23c935'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "0702fd84-f360-4785-b999-49af0b23c935",
      "grounding": {
        "box": {
          "left": 0.7859569191932678,
          "top": 0.43030476570129395,
          "right": 0.9267774224281311,
          "bottom": 0.45616400241851807
        },
        "page": 15
      }
    },
    {
      "markdown": "<a id='69338f78-93be-4f34-ad44-7822924638c7'></a>\n\nSELF-ASSESSMENT #2\n\nWhich of the following medications increases the risk of developing hypotonic euvolemic hyponatremia?\n\nA. Hydrochlorothiazide\nB. Ondansetron\nC. Sertraline\nD. Spironolactone\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "69338f78-93be-4f34-ad44-7822924638c7",
      "grounding": {
        "box": {
          "left": 0.06350037455558777,
          "top": 0.5296798944473267,
          "right": 0.9379252195358276,
          "bottom": 0.9049233198165894
        },
        "page": 15
      }
    },
    {
      "markdown": "<a id='361646a5-a30e-4cfe-a173-5f537a20d940'></a>\n\nSELF-ASSESSMENT #3\n\nWhich of the following sodium concentrations (mEq/L) is the most appropriate choice to use when formulating a parenteral nutrition plan for a patient with heart failure with hyponatremia, shortness of breath, and edema?\n\noption A. 38.5 mEq sodium per Liter: [ ]\noption B. 77 mEq sodium per Liter: [ ]\noption C. 115 mEq sodium per Liter: [ ]\noption D. 154 mEq sodium per Liter: [ ]\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "361646a5-a30e-4cfe-a173-5f537a20d940",
      "grounding": {
        "box": {
          "left": 0.06251713633537292,
          "top": 0.09433616697788239,
          "right": 0.93919837474823,
          "bottom": 0.4700559377670288
        },
        "page": 16
      }
    },
    {
      "markdown": "<a id='a77eb05a-ba9d-43a7-a75a-1975b50d6897'></a>\n\nHYPERNATREMIA (NA > 145 MEQ/L)\n\n*   All cases are hypertonic\n*   Less common than hyponatremia\n    *   1-7.9% hospitalized patients\n*   Up to 70% increase in mortality\n*   Symptoms – neurologic in nature\n    *   Thirst, dry mucus membranes\n    *   Mild-moderate: lethargy, weakness, confusion, irritability\n    *   Severe: twitching, seizures, coma",
      "type": "text",
      "id": "a77eb05a-ba9d-43a7-a75a-1975b50d6897",
      "grounding": {
        "box": {
          "left": 0.06417819857597351,
          "top": 0.5302128791809082,
          "right": 0.9384031295776367,
          "bottom": 0.8322700262069702
        },
        "page": 16
      }
    },
    {
      "markdown": "<a id='3e9ac45e-c3cc-4f7a-8e82-6d76b9ac4c65'></a>\n\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82",
      "type": "text",
      "id": "3e9ac45e-c3cc-4f7a-8e82-6d76b9ac4c65",
      "grounding": {
        "box": {
          "left": 0.09160895645618439,
          "top": 0.8663098216056824,
          "right": 0.48693811893463135,
          "bottom": 0.8883495926856995
        },
        "page": 16
      }
    },
    {
      "markdown": "<a id='9dd8cd1c-bb55-4701-bb57-51f447b95973'></a>\n\nCAPTION ERROR",
      "type": "marginalia",
      "id": "9dd8cd1c-bb55-4701-bb57-51f447b95973",
      "grounding": {
        "box": {
          "left": 0.7848127484321594,
          "top": 0.8649399876594543,
          "right": 0.9261509776115417,
          "bottom": 0.8929563164710999
        },
        "page": 16
      }
    },
    {
      "markdown": "<a id='2daf2933-be4a-4702-a5d2-ce033c786bf3'></a>\n\nDIAGNOSTIC ALGORITHM\n<::Hypernatremia (Na > 145 mEq/L)\n\nVolume status of the patient\n\nHypovolemia:\nOsmotic / Solute diuresis (hyperglycemia, mannitol, excessive protein provision)\nPost-obstructive diuresis\nVomiting\nDiarrhea or excess laxative use\nInsensible losses\n\nEuvolemia:\nCentral diabetes insipidus\nNephrogenic diabetes insipidus\nPrimary polydipsia\n\nHypervolemia:\nHypertonic saline solutions\nSodium bicarbonate solutions\nHyperaldosteronism\n: flowchart::>\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82.\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "figure",
      "id": "2daf2933-be4a-4702-a5d2-ce033c786bf3",
      "grounding": {
        "box": {
          "left": 0.06284677982330322,
          "top": 0.09455594420433044,
          "right": 0.9392791986465454,
          "bottom": 0.47010764479637146
        },
        "page": 17
      }
    },
    {
      "markdown": "<a id='4d178aaa-8827-42e8-91cc-f638c5e42a34'></a>\n\n# DIABETES INSIPIDUS\n\n*   Condition resulting in imbalance of water in the body due to large amounts of dilute urine excretion\n*   Central diabetes insipidus: lack of or decrease in antidiuretic hormone secretion\n*   Nephrogenic diabetes insipidus: decreased renal response to antidiuretic hormone\n    *   Medication and electrolyte causes of nephrogenic diabetes insipidus\n        *   Amphotericin B, cidofovir, foscarnet, demeclocycline, lithium toxicity\n        *   Hypercalcemia, hypokalemia\n\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. Am J Health-Syst Pharm. 2005; 62:1663-82.\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "4d178aaa-8827-42e8-91cc-f638c5e42a34",
      "grounding": {
        "box": {
          "left": 0.06357371807098389,
          "top": 0.529935359954834,
          "right": 0.9381731748580933,
          "bottom": 0.9047203063964844
        },
        "page": 17
      }
    },
    {
      "markdown": "<a id='9a1a0dc6-dc54-4901-8959-b59add1f0612'></a>\n\n# HYPERNATREMIA MANAGEMENT\n\n*   Focus on treatment of underlying cause\n*   Discontinuation of hypertonic fluids\n*   Correct water deficit with hypotonic fluids\n    *   Water deficit (L) = TBW x [1 - (serum Na/140)]\n    *   Administer 50% in first 24 hours, remainder in next 48-72 hours\n*   Isotonic fluids for hemodynamic instability\n*   Sodium correction limited to 8-10 mEq per Liter per day\n    *   Prevention of cerebral edema\n\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82.\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "9a1a0dc6-dc54-4901-8959-b59add1f0612",
      "grounding": {
        "box": {
          "left": 0.0632266104221344,
          "top": 0.09594038128852844,
          "right": 0.9390454292297363,
          "bottom": 0.4677693545818329
        },
        "page": 18
      }
    },
    {
      "markdown": "<a id='e540373b-4624-4da8-bc6b-1bbf6437c2cc'></a>\n\nHYPERNATREMIA MANAGEMENT\n<table id=\"18-1\">\n<tr><td id=\"18-2\" colspan=\"2\">Hypernatremia Type</td></tr>\n<tr><td id=\"18-3\">Hypovolemic</td><td id=\"18-4\">Oral water, enteral water flushes, hypotonic fluids (dextrose 5% in water, 0.45% sodium chloride, addition of sterile water to PN), insulin (hyperglycemia), amino acid dose reduction (solute diuresis)</td></tr>\n<tr><td id=\"18-5\">Euvolemic</td><td id=\"18-6\">Desmopressin (central diabetes insipidus) Thiazide diuretics, sodium restriction, calcium or potassium supplementation (nephrogenic diabetes insipidus)</td></tr>\n<tr><td id=\"18-7\">Hypervolemic</td><td id=\"18-8\">Loop diuretic, hypotonic fluids (sodium overload), adrenalectomy or spironolactone (hyperaldosteronism)</td></tr>\n</table>",
      "type": "table",
      "id": "e540373b-4624-4da8-bc6b-1bbf6437c2cc",
      "grounding": {
        "box": {
          "left": 0.06413790583610535,
          "top": 0.5311951041221619,
          "right": 0.9376298189163208,
          "bottom": 0.8037055134773254
        },
        "page": 18
      }
    },
    {
      "markdown": "<a id='df9bbbc0-c13a-4379-b2ca-e59c8ff6d3a5'></a>\n\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82.",
      "type": "text",
      "id": "df9bbbc0-c13a-4379-b2ca-e59c8ff6d3a5",
      "grounding": {
        "box": {
          "left": 0.08890548348426819,
          "top": 0.8602660894393921,
          "right": 0.49039706587791443,
          "bottom": 0.8997459411621094
        },
        "page": 18
      }
    },
    {
      "markdown": "<a id='4668c1e4-df58-40d1-b90c-606187ecb351'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "4668c1e4-df58-40d1-b90c-606187ecb351",
      "grounding": {
        "box": {
          "left": 0.53205806016922,
          "top": 0.8627275228500366,
          "right": 0.9275971055030823,
          "bottom": 0.9004011154174805
        },
        "page": 18
      }
    },
    {
      "markdown": "<a id='42c6a93f-46f8-44e2-b177-ea5e619d9729'></a>\n\nSELF-ASSESSMENT #4\n\n*   TT is a 65-year-old patient with enterocutaneous fistula who is on parenteral nutrition providing 28 kcal/kg/day and 3 g protein/kg/day\n*   Vital signs: BP 102/62, HR 85, RR 20, Temp 38 C\n*   Physical exam: +thirst and dry mucous membranes\n*   Basic metabolic panel: Na 154 mEq/L, K 3.2 mEq/L, CI 118 mEq/L, CO₂ 23 mEq/L, BUN 30 mg/dL, Cr 0.9 mg/dL, glucose 82 mg/dL, urine urea nitrogen > 700 mg/dL\n*   Input: 2200 mL/day (31 mL/kg/day)\n*   Urine output: 5400 mL/ day (3.2 mL/kg/hour)\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "42c6a93f-46f8-44e2-b177-ea5e619d9729",
      "grounding": {
        "box": {
          "left": 0.06379100680351257,
          "top": 0.0969223827123642,
          "right": 0.9379626512527466,
          "bottom": 0.46621227264404297
        },
        "page": 19
      }
    },
    {
      "markdown": "<a id='32c6e580-a16f-4528-b9b8-0bef3947e1af'></a>\n\n## SELF-ASSESSMENT #4\n\nWhich of the following is the likely type and cause of TT's hypernatremia?\n\nA. Hypervolemic hypernatremia due to excessive fluid administration\nB. Nephrogenic diabetes insipidus\nC. Syndrome of inappropriate antidiuresis (SIAD)\nD. Hypovolemic hypernatremia due to solute diuresis\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "32c6e580-a16f-4528-b9b8-0bef3947e1af",
      "grounding": {
        "box": {
          "left": 0.06367683410644531,
          "top": 0.529608428478241,
          "right": 0.937857985496521,
          "bottom": 0.9051029086112976
        },
        "page": 19
      }
    },
    {
      "markdown": "<a id='19e9440e-94a3-4cb0-abe3-62285f4713c1'></a>\n\n<::logo: N/A\nN/A\nA white outline drawing on a brown background depicts a human head in profile with a nasal swab and an IV drip.::>",
      "type": "logo",
      "id": "19e9440e-94a3-4cb0-abe3-62285f4713c1",
      "grounding": {
        "box": {
          "left": 0.7803124785423279,
          "top": 0.0976814404129982,
          "right": 0.9350668787956238,
          "bottom": 0.17684128880500793
        },
        "page": 20
      }
    },
    {
      "markdown": "<a id='5d6f7e4d-9eed-44c3-a2e6-a2545cae31e1'></a>\n\nSelf Assessment Questions and Answers",
      "type": "text",
      "id": "5d6f7e4d-9eed-44c3-a2e6-a2545cae31e1",
      "grounding": {
        "box": {
          "left": 0.12714621424674988,
          "top": 0.2526681125164032,
          "right": 0.772436261177063,
          "bottom": 0.2917487919330597
        },
        "page": 20
      }
    },
    {
      "markdown": "<a id='0b9ec25c-d6f9-4c10-adeb-2ab4c8317ab1'></a>\n\n# SELF-ASSESSMENT #1\n\n*   MN is a 72 year-old female who is admitted to the medicine service for a non-specific complaint of general malaise. On physical exam, she has dry mucous membranes and exhibits poor skin turgor.\n*   Past medical history: HTN, osteoarthritis, and hyperlipidemia\n*   Home medications: hydrochlorothiazide, aspirin, simvastatin, calcium carbonate, vitamin D\n*   Vital signs: BP 96/52, HR 100, RR 14, Temp 37 C\n*   Laboratory values: Na 122 mEq/L, K 4 mEq/L, CI 101 mEq/L, CO2 19 mEq/L, BUN 45 mg/dL, Cr 1.5 mg/dL, glucose 115 mg/dL, magnesium 2.4 mg/dL, urine osmolality 450 mOsm/L",
      "type": "text",
      "id": "0b9ec25c-d6f9-4c10-adeb-2ab4c8317ab1",
      "grounding": {
        "box": {
          "left": 0.0698113739490509,
          "top": 0.5297843813896179,
          "right": 0.9364829063415527,
          "bottom": 0.8478476405143738
        },
        "page": 20
      }
    },
    {
      "markdown": "<a id='4f5ece54-5a8f-432f-80db-ef62c71d78ed'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "4f5ece54-5a8f-432f-80db-ef62c71d78ed",
      "grounding": {
        "box": {
          "left": 0.5093552470207214,
          "top": 0.863138735294342,
          "right": 0.9279194474220276,
          "bottom": 0.8987649083137512
        },
        "page": 20
      }
    },
    {
      "markdown": "<a id='33cddc38-b61e-4433-9a91-c0025f0841c8'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "33cddc38-b61e-4433-9a91-c0025f0841c8",
      "grounding": {
        "box": {
          "left": 0.7851835489273071,
          "top": 0.4297361373901367,
          "right": 0.9263993501663208,
          "bottom": 0.4562538266181946
        },
        "page": 20
      }
    },
    {
      "markdown": "<a id='f8e6fe35-393e-4fb7-8168-d0a4b5ee6f55'></a>\n\nSELF-ASSESSMENT #1, CONT.\n\nWhich of the following is the most likely diagnosis for this patient's hyponatremia?\n\nA. Hypertonic\nB. Hypovolemic hypotonic\nC. Euvolemic hypotonic\nD. Hypervolemic hypotonic\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "f8e6fe35-393e-4fb7-8168-d0a4b5ee6f55",
      "grounding": {
        "box": {
          "left": 0.06273356080055237,
          "top": 0.09420780837535858,
          "right": 0.9388109445571899,
          "bottom": 0.47049015760421753
        },
        "page": 21
      }
    },
    {
      "markdown": "<a id='ceee40c9-8345-4a60-a6c5-cf246a552352'></a>\n\nSELF-ASSESSMENT #1, CONT.\n\nWhich of the following is the most likely diagnosis for this patient's hyponatremia?\n\noption A. Hypertonic: [ ]\noption B. Hypovolemic hypotonic: [x]\noption C. Euvolemic hypotonic: [ ]\noption D. Hypervolemic hypotonic: [ ]\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "ceee40c9-8345-4a60-a6c5-cf246a552352",
      "grounding": {
        "box": {
          "left": 0.06288021802902222,
          "top": 0.5288068652153015,
          "right": 0.9384861588478088,
          "bottom": 0.9055830836296082
        },
        "page": 21
      }
    },
    {
      "markdown": "<a id='f8b35dfd-beb6-4581-8231-9421b46dc7c1'></a>\n\nSELF-ASSESSMENT #2 <::A white line-art illustration of a human head in profile with a feeding tube inserted through the nose, connected to an IV bag or feeding bag. This visual represents nutrition support.: figure::>\nWhich of the following medications increases the risk of developing hypotonic\neuvolemic hyponatremia?\nA. Hydrochlorothiazide\nB. Ondansetron\nC. Sertraline\nD. Spironolactone\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "figure",
      "id": "f8b35dfd-beb6-4581-8231-9421b46dc7c1",
      "grounding": {
        "box": {
          "left": 0.06288734078407288,
          "top": 0.09432494640350342,
          "right": 0.9387069940567017,
          "bottom": 0.4703223705291748
        },
        "page": 22
      }
    },
    {
      "markdown": "<a id='5bbb55e7-c050-4935-bf60-b43ae6786ade'></a>\n\n## SELF-ASSESSMENT #2\n\nWhich of the following medications increases the risk of developing hypotonic euvolemic hyponatremia?\n\nA. Hydrochlorothiazide\nB. Ondansetron\nC. **Sertraline**\nD. Spironolactone\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "5bbb55e7-c050-4935-bf60-b43ae6786ade",
      "grounding": {
        "box": {
          "left": 0.06319141387939453,
          "top": 0.5288724303245544,
          "right": 0.9381179809570312,
          "bottom": 0.9053660035133362
        },
        "page": 22
      }
    },
    {
      "markdown": "<a id='4b34e393-d430-47cd-93f9-844797677a51'></a>\n\nSELF-ASSESSMENT #3\n\nWhich of the following sodium concentrations (mEq/L) is the most appropriate choice to use when formulating a parenteral nutrition plan for a patient with heart failure with hyponatremia, shortness of breath, and edema?\n\nA. 38.5 mEq sodium per Liter\nB. 77 mEq sodium per Liter\nC. 115 mEq sodium per Liter\nD. 154 mEq sodium per Liter\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "4b34e393-d430-47cd-93f9-844797677a51",
      "grounding": {
        "box": {
          "left": 0.06254515051841736,
          "top": 0.0940939337015152,
          "right": 0.9391641616821289,
          "bottom": 0.47028690576553345
        },
        "page": 23
      }
    },
    {
      "markdown": "<a id='252f7d81-664b-4dc3-87fb-e68fa40da916'></a>\n\n## SELF-ASSESSMENT #3\n\nWhich of the following sodium concentrations (mEq/L) is the most appropriate choice to use when formulating a parenteral nutrition plan for a patient with heart failure with hyponatremia, shortness of breath, and edema?\n\noption A. 38.5 mEq sodium per Liter: [x]\noption B. 77 mEq sodium per Liter: [ ]\noption C. 115 mEq sodium per Liter: [ ]\noption D. 154 mEq sodium per Liter: [ ]\n\nNUTRITION SUPPORT CERTIFICATE",
      "type": "text",
      "id": "252f7d81-664b-4dc3-87fb-e68fa40da916",
      "grounding": {
        "box": {
          "left": 0.06313422322273254,
          "top": 0.529196560382843,
          "right": 0.9380542039871216,
          "bottom": 0.9051079154014587
        },
        "page": 23
      }
    },
    {
      "markdown": "<a id='efe4c8b7-311a-4c9c-bb16-8b178482ebfd'></a>\n\nSELF-ASSESSMENT #4\n\n*   TT is a 65-year-old patient with enterocutaneous fistula who is on parenteral nutrition providing 28 kcal/kg/day and 3 g protein/kg/day\n*   Vital signs: BP 102/62, HR 85, RR 20, Temp 38 C\n*   Physical exam: +thirst and dry mucous membranes\n*   Basic metabolic panel: Na 154 mEq/L, K 3.2 mEq/L, CI 118 mEq/L, CO₂ 23 mEq/L, BUN 30 mg/dL, Cr 0.9 mg/dL, glucose 82 mg/dL, urine urea nitrogen > 700 mg/dL\n*   Input: 2200 mL/day (31 mL/kg/day)\n*   Urine output: 5400 mL/ day (3.2 mL/kg/hour)\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "efe4c8b7-311a-4c9c-bb16-8b178482ebfd",
      "grounding": {
        "box": {
          "left": 0.06379100680351257,
          "top": 0.0969223827123642,
          "right": 0.9379626512527466,
          "bottom": 0.46621227264404297
        },
        "page": 24
      }
    },
    {
      "markdown": "<a id='d2f286db-1a9c-4735-8c68-15183cfbaefb'></a>\n\n## SELF-ASSESSMENT #4\n\nWhich of the following is the likely type and cause of TT's hypernatremia?\n\nA. Hypervolemic hypernatremia due to excessive fluid administration\nB. Nephrogenic diabetes insipidus\nC. Syndrome of inappropriate antidiuresis (SIAD)\nD. Hypovolemic hypernatremia due to solute diuresis\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "d2f286db-1a9c-4735-8c68-15183cfbaefb",
      "grounding": {
        "box": {
          "left": 0.06367683410644531,
          "top": 0.529608428478241,
          "right": 0.937857985496521,
          "bottom": 0.9051029086112976
        },
        "page": 24
      }
    },
    {
      "markdown": "<a id='38b6c60a-bc53-4e0e-853c-e580271cf8c2'></a>\n\n## SELF-ASSESSMENT #4\n\nWhich of the following is the likely type and cause of TT's hypernatremia?\n\noption A. Hypervolemic hypernatremia due to excessive fluid administration: [ ]\noption B. Nephrogenic diabetes insipidus: [ ]\noption C. Syndrome of inappropriate antidiuresis (SIAD): [ ]\noption D. Hypovolemic hypernatremia due to solute diuresis: [x]\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "38b6c60a-bc53-4e0e-853c-e580271cf8c2",
      "grounding": {
        "box": {
          "left": 0.06225937604904175,
          "top": 0.09369246661663055,
          "right": 0.9394111037254333,
          "bottom": 0.47075510025024414
        },
        "page": 25
      }
    },
    {
      "markdown": "<a id='cf11c058-bac1-4b5f-bb12-e1e1171da971'></a>\n\nCONCLUSIONS\n\n*   A thorough history and physical, including medication review, is important for identification and diagnosis of fluid & sodium disorders.\n*   Knowledge of causes of fluid & sodium disorders will help in determining appropriate prevention and treatment plan development.\n*   Development of a nutrition care plan should be done using a systematic approach including comorbid states, medication therapy, and changes in clinical status.\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "cf11c058-bac1-4b5f-bb12-e1e1171da971",
      "grounding": {
        "box": {
          "left": 0.06241345405578613,
          "top": 0.5289883017539978,
          "right": 0.938665509223938,
          "bottom": 0.9056381583213806
        },
        "page": 25
      }
    },
    {
      "markdown": "<a id='44bd7443-1170-4b1d-b40c-233bff61138d'></a>\n\nREFERENCES\n\n*   Braun MM, Barstow CH, Pyzocha NJ. Diagnosis and management of sodium disorders: hyponatremia and hypernatremia. Am Fam Physician. 2015; 91:299-307.\n*   Canada TW, Lord LM. Chapter 7 Fluid, Electrolytes, and Acid-Base Disorders. In: Mueller CM, ed. The A.S.P.E.N. Adult Nutrition Support Core Curriculum. 3rd ed. Maryland: A.S.P.E.N.; 2017:113-37.\n*   Kraft MD, Btaiche IF, Sacks GS, Kudsk KA. Treatment of electrolytes disorders in adult patients in the intensive care unit. Am J Health-Syst Pharm. 2005; 62:1663-82.\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "44bd7443-1170-4b1d-b40c-233bff61138d",
      "grounding": {
        "box": {
          "left": 0.0627744197845459,
          "top": 0.09519116580486298,
          "right": 0.9387767314910889,
          "bottom": 0.46940308809280396
        },
        "page": 26
      }
    },
    {
      "markdown": "<a id='c5cb51bf-48d5-4702-b981-234d63bcd838'></a>\n\n## REFERENCES, CONT.\n\n*   Mannesse CK, Vondeling AM, van Marum RJ et al. Prevalence of hyponatremia on geriatric wards compared to other settings over four decades: a systematic review. *Ageing Res Rev*. 2013; 12(1):165-173.\n*   Mirtallo J, Canada T, Johnson D et al. Safe practices for parenteral nutrition. *JPEN J Parent Enteral Nutr*. 2004; 28:S39-S70.\n*   Verbalis JG, Goldsmith, SR, Greenberg A et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. *Am J Med*. 2013; 126:S1-S42.\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "text",
      "id": "c5cb51bf-48d5-4702-b981-234d63bcd838",
      "grounding": {
        "box": {
          "left": 0.06265199184417725,
          "top": 0.5297218561172485,
          "right": 0.9380775690078735,
          "bottom": 0.9049133062362671
        },
        "page": 26
      }
    },
    {
      "markdown": "<a id='4dad45b2-2dab-4b44-addc-a2aa09751132'></a>\n\n<::A stylized illustration on a brown background depicts medical nutrition support. On the left, a white outline of a human head in profile shows an oral feeding tube extending into the esophagus. On the right, a white outline of an IV bag with tubing is connected to a person's arm. Faint, ghosted versions of these illustrations are visible in the background. Below these illustrations, on a white and brown diagonal band, are two logos: \"ashp\" and \"aspen\".\n: illustration::>\n\nNUTRITION SUPPORT\nCERTIFICATE",
      "type": "figure",
      "id": "4dad45b2-2dab-4b44-addc-a2aa09751132",
      "grounding": {
        "box": {
          "left": 0.06393373012542725,
          "top": 0.09545104205608368,
          "right": 0.9391051530838013,
          "bottom": 0.469993531703949
        },
        "page": 27
      }
    },
    {
      "markdown": "<a id='81f6a452-235e-4d5e-ad54-a26ccdcba39d'></a>\n\n<::transcription of the content\n: figure::>\n\nAnne M. Tucker, Pharm.D., BCNSP\nClinical pharmacy Specialist\nUniversity of Texas MD Anderson Cancer Center\nHouston, Texas\n\nAnne M. Tucker is clinical pharmacy specialist at the MD Anderson Cancer\nCenter, Houston, Texas. She received her BS in Chemistry from the\nUniversity of Arkansas, Pharm.D. from the University of Arkansas for Medical\nSciences (UAMS) where she also completed residency training. Dr. Tucker has\nover 20 years of experience in critical care and nutrition support practice and\nparticipates in didactic and experiential training of students and post-graduate trainees. Her areas of\ninterest include fluid and electrolyte disorders, nutrition support in critically ill cancer patients, and the\npromotion of safe parenteral nutrition practices.",
      "type": "text",
      "id": "81f6a452-235e-4d5e-ad54-a26ccdcba39d",
      "grounding": {
        "box": {
          "left": 0.11184793710708618,
          "top": 0.0844382792711258,
          "right": 0.8806548714637756,
          "bottom": 0.3356732130050659
        },
        "page": 28
      }
    },
    {
      "markdown": "<a id='2b2f678e-50b4-41d5-bfce-2b01a6b446b4'></a>\n\nDr. Tucker is currently the Chair of the American Society for Parenteral and Enteral Nutrition (ASPEN) Abstract Review Committee and President of the Texas Gulf Coast ASPEN Chapter. She is also a member and abstract reviewer for American Society of Health-System Pharmacists and Society of Critical Care Medicine. Past leadership includes Chair and member for the Board of Pharmacy Specialties Nutrition Support Specialty Council, Chair and Secretary of the ASPEN Pharmacy Practice Section, Chair of the ASPEN Self-Assessment Committee, Chair for the ASPEN Task Force for Revision of Nutrition Support Pharmacist Standards, and member of the ASPEN Parenteral Nutrition Safety Committee. She is a regular presenter at Clinical Nutrition Week and was most recently involved as an editor and author of the ASPEN Fluid, Electrolytes and Acid-Base Disorders Handbook.",
      "type": "text",
      "id": "2b2f678e-50b4-41d5-bfce-2b01a6b446b4",
      "grounding": {
        "box": {
          "left": 0.1117754876613617,
          "top": 0.3475048243999481,
          "right": 0.8817732334136963,
          "bottom": 0.5240799784660339
        },
        "page": 28
      }
    },
    {
      "markdown": "<a id='19de4395-ed5a-4891-a827-513dc02b9a7d'></a>\n\n## Relevant Financial Relationship Disclosure\n\nIn accordance with our accreditor's Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.\n\nAn ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.",
      "type": "text",
      "id": "19de4395-ed5a-4891-a827-513dc02b9a7d",
      "grounding": {
        "box": {
          "left": 0.08083546161651611,
          "top": 0.08916962891817093,
          "right": 0.9192482233047485,
          "bottom": 0.2603312134742737
        },
        "page": 29
      }
    },
    {
      "markdown": "<a id='4a9ffc47-5272-47f5-b48a-d775bcf72877'></a>\n\nThe following persons in control of this activity's content have relevant financial relationships:\n* Phil Ayers: Fresenius Kabi, consultant and speaker\n* David Evans: Fresenius Kabi, consultant and speaker; Abbott Laboratories, consultant and speaker; CVS/OptionCare, consultant; Alcresta, consultant and speaker\n* Andrew Mays: Fresenius Kabi, speaker\n* Jay Mirtallo: Fresenius Kabi, consultant\n* Kris Mogensen: Baxter, speaker; Thrive Rx, advisory board; Pfizer, advisory board",
      "type": "text",
      "id": "4a9ffc47-5272-47f5-b48a-d775bcf72877",
      "grounding": {
        "box": {
          "left": 0.0807248055934906,
          "top": 0.2727087140083313,
          "right": 0.8903650045394897,
          "bottom": 0.40147292613983154
        },
        "page": 29
      }
    },
    {
      "markdown": "<a id='77b8b272-671f-4fb6-9f67-f0f0c328981f'></a>\n\nAll other persons in control of content do not have any relevant financial relationships with an ineligible company.",
      "type": "text",
      "id": "77b8b272-671f-4fb6-9f67-f0f0c328981f",
      "grounding": {
        "box": {
          "left": 0.08197873830795288,
          "top": 0.4104483723640442,
          "right": 0.8753352165222168,
          "bottom": 0.4323435425758362
        },
        "page": 29
      }
    },
    {
      "markdown": "<a id='193cc645-9b87-49a9-8634-c01ea4d9ad02'></a>\n\nAs required by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company, all relevant financial relationships have been mitigated prior to the CPE activity.",
      "type": "text",
      "id": "193cc645-9b87-49a9-8634-c01ea4d9ad02",
      "grounding": {
        "box": {
          "left": 0.08172187209129333,
          "top": 0.4442722499370575,
          "right": 0.9015690088272095,
          "bottom": 0.4840259850025177
        },
        "page": 29
      }
    },
    {
      "markdown": "<a id='211eb738-b192-4453-b094-e56019317b29'></a>\n\n### Methods and CE Requirements\n---\nThis online activity consists of a combined total of 12 learning modules. Pharmacists and physicians are eligible to receive a total of 20 hours of continuing education credit by completing all 12 modules within this certificate.",
      "type": "text",
      "id": "211eb738-b192-4453-b094-e56019317b29",
      "grounding": {
        "box": {
          "left": 0.08219799399375916,
          "top": 0.49649590253829956,
          "right": 0.9165530204772949,
          "bottom": 0.567567765712738
        },
        "page": 29
      }
    },
    {
      "markdown": "<a id='0a3c85d9-6cbc-4e95-a393-21c4f8ab9477'></a>\n\nParticipants must participate in the entire activity, complete the evaluation and all required components to claim continuing pharmacy education credit online at ASHP Learning Center http://elearning.ashp.org. Follow the prompts to claim credit and view your statement of credit within 60 days after completing the activity.",
      "type": "text",
      "id": "0a3c85d9-6cbc-4e95-a393-21c4f8ab9477",
      "grounding": {
        "box": {
          "left": 0.08215111494064331,
          "top": 0.5805759429931641,
          "right": 0.8971377611160278,
          "bottom": 0.6399573087692261
        },
        "page": 29
      }
    },
    {
      "markdown": "<a id='50719092-f550-47b6-ac36-87953d107e56'></a>\n\n**Important Note–ACPE 60 Day Deadline:**\nPer ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, check your NABP eProfile account to validate that your credits were transferred successfully before the ACPE 60-day deadline. After the 60 day deadline, ASHP will no longer be able to award credit for this activity.",
      "type": "text",
      "id": "50719092-f550-47b6-ac36-87953d107e56",
      "grounding": {
        "box": {
          "left": 0.08230695128440857,
          "top": 0.6474067568778992,
          "right": 0.9057470560073853,
          "bottom": 0.7413815855979919
        },
        "page": 29
      }
    },
    {
      "markdown": "<a id='f94e68a5-d97d-448b-9a8c-e2b0560563e1'></a>\n\n## System Technical Requirements\n---\nCourses and learning activities are delivered via your Web browser and Acrobat PDF. Users should have a basic comfort level using a computer and navigating websites.",
      "type": "text",
      "id": "f94e68a5-d97d-448b-9a8c-e2b0560563e1",
      "grounding": {
        "box": {
          "left": 0.08097496628761292,
          "top": 0.7661511301994324,
          "right": 0.9178322553634644,
          "bottom": 0.8384376168251038
        },
        "page": 29
      }
    },
    {
      "markdown": "<a id='52a26de7-2bd8-4bb2-986d-fc6145ae1b06'></a>\n\nView Frequently Asked Questions for more information.",
      "type": "text",
      "id": "52a26de7-2bd8-4bb2-986d-fc6145ae1b06",
      "grounding": {
        "box": {
          "left": 0.08358009159564972,
          "top": 0.845236599445343,
          "right": 0.5035179257392883,
          "bottom": 0.8677032589912415
        },
        "page": 29
      }
    }
  ],
  "splits": [
    {
      "class": "full",
      "identifier": "full",
      "pages": [
        0,
        1,
        2,
        3,
        4,
        5,
        6,
        7,
        8,
        9,
        10,
        11,
        12,
        13,
        14,
        15,
        16,
        17,
        18,
        19,
        20,
        21,
        22,
        23,
        24,
        25,
        26,
        27,
        28,
        29
      ],
      "markdown": "<a id='d049e39a-c94f-4c82-99c0-8bce010a7715'></a>\n\nNUTRITION SUPPORT CERTIFICATE\n\n<a id='cfefbf72-26fb-4401-a4c9-b22243437fb9'></a>\n\nFluids & Sodium\nDisorders\n\n<a id='11965d6d-6c35-4e5d-a77f-573500394dcb'></a>\n\n<::logo: ASHP\nashp\nThe logo features the stylized blue text \"ashp\" in blue with an orange swoosh above the 'h' and 'p', and a registered trademark symbol.::>\n\n<a id='81e53325-9b14-47b5-8863-d65a78e294a5'></a>\n\nCAPTION ERROR\n\n<a id='30de0ff1-ff7b-4b42-a0bc-66433204b260'></a>\n\nPlanned by the American Society of Health-System Pharmacists (ASHP) in collaboration with the American Society for Parenteral and Enteral Nutrition (ASPEN).\n\n<a id='36df49d8-c092-4592-b44e-c5924c0089b1'></a>\n\n&#169;2022 American Society of Health-System Pharmacists, Inc. All rights reserved.\nNo part of this publication may be reproduced or transmitted in any form or by any means, electronic or\nmechanical, including photocopying, microfilming, and recording, or by any information storage and retrieval\nsystem, without written permission from the American Society of Health-System Pharmacists.\n\n<a id='e38ce2a1-beb1-4f57-ad80-03c4a4c2f1be'></a>\n\nNUTRITION SUPPORT\nCOMPLICATIONS:\nFLUIDS & SODIUM\nDISORDERS\n\nAnne M. Tucker, Pharm.D., BCNSP\nUniversity of Texas MD Anderson Cancer Center\n\n<::Illustration of a human head and torso receiving intravenous fluids from an IV bag and enteral feeding via a tube, depicted in white outline. : figure::>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\nashp aspen\n\n<a id='798bcf7c-e18d-4d82-bf6b-1019c4444d65'></a>\n\nRELEVANT FINANCIAL\nRELATIONSHIP DISCLOSURE\n\nThe following persons in control of this activity's content have relevant financial relationships:\n\n- Jay Mirtallo: Fresenius Kabi, consultant\n\nAll other persons in control of content do not have any relevant financial relationships with an ineligible company.\n\n<a id='1f13f8e3-5976-4d56-885b-207758b37bff'></a>\n\nAs defined by the Standards of Integrity and Independence definition of ineligible company. All relevant\nfinancial relationships have been mitigated prior to the CPE activity.\n\n<a id='6e976e6d-beaa-41a9-9210-ee0a66809435'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='5e9745a6-93cb-4111-a57d-5ebb909a7097'></a>\n\n# LEARNING OBJECTIVES\n\n*   Analyze patient information to determine the type of fluid & sodium disorder.\n*   Describe common etiologies of fluid & sodium disorders and their impact on the nutrition prescription.\n*   Design recommendations for the prevention and management of fluid and sodium disorders.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='7e7f090a-19f8-4af7-97d2-e7247135f55d'></a>\n\nKEY ABBREVIATIONS\n\n*   AdjBW: adjusted body weight\n*   BUN: blood urea nitrogen\n*   CO2: carbon dioxide\n*   ECF: extracellular fluid\n*   IBW: ideal body weight\n*   ICF: intracellular fluid\n*   PN: parenteral nutrition\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='28315dce-2718-4e57-be54-1dd8247be5e5'></a>\n\n# KEY ABBREVIATIONS\n\n*   SIAD: syndrome of inappropriate antidiuresis\n*   sOsm: serum osmolality\n*   TBW: total body water\n*   uNa: urine sodium\n*   uOsm: urine osmolality\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='a1ee380f-036f-4d1a-b8ed-c1616394a409'></a>\n\n## SELF-ASSESSMENT #1\n\n*   MN is a 72 year-old female who is admitted to the medicine service for a non-specific complaint of general malaise. On physical exam, she has dry mucous membranes and exhibits poor skin turgor.\n*   Past medical history: HTN, osteoarthritis, and hyperlipidemia\n*   Home medications: hydrochlorothiazide, aspirin, simvastatin, calcium carbonate, vitamin D\n*   Vital signs: BP 96/52, HR 100, RR 14, Temp 37 C\n*   Laboratory values: Na 122 mEq/L, K 4 mEq/L, CI 101 mEq/L, CO2 19 mEq/L, BUN 45 mg/dL, Cr 1.5 mg/dL, glucose 115 mg/dL, magnesium 2.4 mg/dL, urine osmolality 450 mOsm/L\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='7ff14278-eb74-4149-a5ed-b621975de052'></a>\n\nSELF-ASSESSMENT #1, CONT.\n\nWhich of the following is the most likely diagnosis for this patient's hyponatremia?\n\nA. Hypertonic\nB. Hypovolemic hypotonic\nC. Euvolemic hypotonic\nD. Hypervolemic hypotonic\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='b9dc5873-bd29-4f2f-9a3b-d8a2fa9bb58a'></a>\n\nFLUID AND SODIUM\nDISORDERS\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='4b8dde8d-2aa7-486f-b44e-3a864b8abc8a'></a>\n\nTOTAL BODY WATER (TBW)\n\n*   Water content of the body\n    *   60% lean body mass for males\n    *   50% lean body mass for females\n*   Body composition influence on TBW\n    *   Water content of fat ~10%\n    *   Water content of muscle ~75%\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='b2d284ac-571b-4892-b804-7b25250ef495'></a>\n\n# BODY FLUID DISTRIBUTION\n\n*   Intracellular fluid (ICF)\n    *   2/3 total body water\n    *   Potassium, magnesium phosphorus\n*   Extracellular fluid (ECF)\n    *   1/3 total body water\n    *   Sodium, chloride, bicarbonate\n    *   Subdivisions\n        *   3/4 ECF – Interstitial fluid\n        *   1/4 ECF – Intravascular fluid\n*   Transcellular fluid\n\n<::transcription of the content\n: pie chart labeled \"%TBW\" showing the distribution of body fluids. The chart includes segments for \"Interstitial\" and \"Intravascular\" fluids, with a legend indicating \"ICF\" and \"ECF\".::>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='4b201591-309b-4671-b647-dcd63921df30'></a>\n\nBODY FLUID MAINTENANCE\n\n*   Normal cellular function\n*   Tight regulation\n    *   Serum osmolality (sOsm)\n        *   Important determinant of intracellular volume\n        *   sOsm = 2 x [Na] + [glucose/18] + [BUN/2.8]\n        *   Alterations ⇒ neurological symptoms\n    *   Blood volume\n        *   Determinant of effective tissue perfusion\n        *   Plasma proteins play role in oncotic pressure\n        *   Oxygen & nutrient delivery\n        *   Metabolic waste removal\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='c0aa90b4-71d2-453a-9737-7d67bf4aa61f'></a>\n\nFLUID REQUIREMENTS\n\n*   Weight and age based\n    *   Ages 18-55 years: 35 mL/kg/day\n    *   Ages 56-75 years: 30 mL/kg/day\n    *   Ages > 75 years: 25 mL/kg/day\n    *   Fluid-restricted adults: ≤ 25 mL/kg/day\n\nCanada TW et al. ASPEN Adult Nutrition Support Core Curriculum.\n3rd ed. 2017:113-37.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='1e3adae9-3144-4b02-9283-5c693c3be28c'></a>\n\nFLUID REQUIREMENTS, CONT.\n\n*   Adjusted Holiday-Segar formula\n    *   1500 mL for the first 20 kg of body weight, then ADD\n        *   Ages <= 50 years: 20 mL per kg of remaining body weight\n        *   Ages > 50 years: 15 mL per kg of remaining body weight\n*   1 mL/kcal ingested\n*   1500-1600 mL/m² per 24 hours\n\n<a id='e48bf804-3ebb-448b-8621-25ee5095bb49'></a>\n\nCanada TW et al. ASPEN Adult Nutrition Support Core Curriculum.\n3rd ed. 2017:113-37.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='0bf0a6d7-6016-4ffe-a95d-e7d7fc2806d2'></a>\n\nASSESSING FLUID BALANCE\n\n*   Physical exam (mucous membranes, skin turgor, edema)\n*   Urine output (0.5-2 mL/kg/hour)\n*   Weight changes\n*   Temperature\n*   Vital signs (blood pressure, heart rate)\n*   Intake and output records\n*   Insensible losses\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='73a8742f-ee06-42e5-8fcb-e32550380010'></a>\n\n<::logo: Gastrointestinal Losses\nGASTROINTESTINAL LOSSES\nA brown rectangular banner features white text and a white line-art illustration of a human head with an IV drip and a nasogastric tube.::>\n\n<a id='acdf7869-baee-4aaf-a27c-41d1560ee0cd'></a>\n\n<table id=\"8-1\">\n<tr><td id=\"8-2\" rowspan=\"2\">Body Fluid Type</td><td id=\"8-3\" colspan=\"4\">mEq/L</td></tr>\n<tr><td id=\"8-4\">Na</td><td id=\"8-5\">Cl</td><td id=\"8-6\">K</td><td id=\"8-7\">HCO3</td></tr>\n<tr><td id=\"8-8\">Stomach</td><td id=\"8-9\">60</td><td id=\"8-a\">130</td><td id=\"8-b\">15</td><td id=\"8-c\">0</td></tr>\n<tr><td id=\"8-d\">Duodenum</td><td id=\"8-e\">140</td><td id=\"8-f\">80</td><td id=\"8-g\">5</td><td id=\"8-h\">0</td></tr>\n<tr><td id=\"8-i\">Pancreas</td><td id=\"8-j\">140</td><td id=\"8-k\">75</td><td id=\"8-l\">5</td><td id=\"8-m\">115</td></tr>\n<tr><td id=\"8-n\">Bile</td><td id=\"8-o\">145</td><td id=\"8-p\">100</td><td id=\"8-q\">5</td><td id=\"8-r\">35</td></tr>\n<tr><td id=\"8-s\">Ileum</td><td id=\"8-t\">140</td><td id=\"8-u\">104</td><td id=\"8-v\">5</td><td id=\"8-w\">30</td></tr>\n<tr><td id=\"8-x\">Colon</td><td id=\"8-y\">60</td><td id=\"8-z\">40</td><td id=\"8-A\">30</td><td id=\"8-B\">0</td></tr>\n</table>\n\n<a id='e5a86d90-1748-4268-977c-4ecbce64ab84'></a>\n\nASPEN Adult Nutrition Support Core Curriculum 3rd edition, 2017:113-137.\n\n<a id='a8d1ac93-d7a6-4b22-9a5c-e09847b9369e'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='94969f52-4c4b-4d9d-83f6-ae18c960b1a5'></a>\n\n<::logo: Not identified\nGASTROINTESTINAL LOSSES\nThe logo features white outline illustrations of a human head with a tube inserted into the nose/mouth, connected to an IV bag, all set against a brown rectangular background.::>\n\n<a id='ef862032-fff5-4a23-92e3-abf7164aba20'></a>\n\n<table id=\"8-C\">\n<tr><td id=\"8-D\" rowspan=\"2\">Body Fluid Type</td><td id=\"8-E\" colspan=\"4\">mEq/L</td></tr>\n<tr><td id=\"8-F\">Na</td><td id=\"8-G\">Cl</td><td id=\"8-H\">K</td><td id=\"8-I\">HCO3</td></tr>\n<tr><td id=\"8-J\">Stomach</td><td id=\"8-K\">60</td><td id=\"8-L\">130</td><td id=\"8-M\">15</td><td id=\"8-N\">0</td></tr>\n<tr><td id=\"8-O\">Duodenum</td><td id=\"8-P\">140</td><td id=\"8-Q\">80</td><td id=\"8-R\">5</td><td id=\"8-S\">0</td></tr>\n<tr><td id=\"8-T\">Pancreas</td><td id=\"8-U\">140</td><td id=\"8-V\">75</td><td id=\"8-W\">5</td><td id=\"8-X\">115</td></tr>\n<tr><td id=\"8-Y\">Bile</td><td id=\"8-Z\">145</td><td id=\"8-10\">100</td><td id=\"8-11\">5</td><td id=\"8-12\">35</td></tr>\n<tr><td id=\"8-13\">Ileum</td><td id=\"8-14\">140</td><td id=\"8-15\">104</td><td id=\"8-16\">5</td><td id=\"8-17\">30</td></tr>\n<tr><td id=\"8-18\">Colon</td><td id=\"8-19\">60</td><td id=\"8-1a\">40</td><td id=\"8-1b\">30</td><td id=\"8-1c\">0</td></tr>\n</table>\n\n<a id='241fd44b-4cca-4bb8-b0f9-121e49f9c264'></a>\n\nASPEN Adult Nutrition Support Core Curriculum, 3rd edition, 2017:113-137.\n\n<a id='8c68e89c-8a54-4673-9876-2f0e049fc5dd'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='0976ad3d-ecb2-4c8d-b680-9c6f4e1bb726'></a>\n\nREPLACEMENT FLUIDS\n\n*   Based upon specific losses\n*   Gastric and colonic fluid losses\n    *   0.45% NaCl (1/2 Normal Saline) + 10-20 mEq KCI/L\n*   Small bowel fluid losses\n    *   0.9% NaCl (Normal Saline)\n    *   Bicarbonate or acetate-based customized fluid\n    *   Balanced crystalloid (e.g., Ringers Lactate)\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='1598e825-27cf-47b8-96ff-66b1cdcfc71c'></a>\n\nNORMAL ELECTROLYTE\nCONCENTRATIONS\n\n<table id=\"9-1\">\n<tr><td id=\"9-2\">Electrolyte</td><td id=\"9-3\">Adult</td></tr>\n<tr><td id=\"9-4\">Sodium</td><td id=\"9-5\">135-145 mEq/L</td></tr>\n<tr><td id=\"9-6\">Potassium</td><td id=\"9-7\">3.5-5 mEq/L</td></tr>\n<tr><td id=\"9-8\">Chloride</td><td id=\"9-9\">98-108 mEq/L</td></tr>\n<tr><td id=\"9-a\">CO₂</td><td id=\"9-b\">23-30 mEq/L</td></tr>\n<tr><td id=\"9-c\">Calcium</td><td id=\"9-d\">9-10.5 mg/dL</td></tr>\n<tr><td id=\"9-e\">Phosphorus</td><td id=\"9-f\">2.5-4.5 mg/dL</td></tr>\n<tr><td id=\"9-g\">Magnesium</td><td id=\"9-h\">1.7-2.4 mg/dL</td></tr>\n<tr><td id=\"9-i\" colspan=\"2\">*Variations in lab values exist between institutions</td></tr>\n</table>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='1ec6b493-2bfd-40df-9925-a5468d31d580'></a>\n\nCAPTION ERROR\n\n<a id='b03361c1-1dbb-4120-a810-311b697e341a'></a>\n\n<table id=\"10-1\">\n<tr><td id=\"10-2\">Electrolyte</td><td id=\"10-3\">Requirements</td></tr>\n<tr><td id=\"10-4\">Sodium</td><td id=\"10-5\">60-100 mEq/day or 1-2 mEq/kg/day</td></tr>\n<tr><td id=\"10-6\">Potassium</td><td id=\"10-7\">60-100 mEq/day or 1-2mEq/kg/day</td></tr>\n<tr><td id=\"10-8\">Chloride</td><td id=\"10-9\">As needed to maintain acid-base balance</td></tr>\n<tr><td id=\"10-a\">Acetate</td><td id=\"10-b\">As needed to maintain acid-base balance</td></tr>\n<tr><td id=\"10-c\">Calcium</td><td id=\"10-d\">10-15 mEq/day</td></tr>\n<tr><td id=\"10-e\">Phosphorus</td><td id=\"10-f\">20-40 mmol/dayor 0.25-0.5 mmol/kg/day</td></tr>\n<tr><td id=\"10-g\">Magnesium</td><td id=\"10-h\">8-20 mEq/day or 0.25-0.5 mEq/kg/day</td></tr>\n<tr><td id=\"10-i\" colspan=\"2\">*Consider lower doses for those with renal insufficiency</td></tr>\n</table>\n\n<a id='4498d3ff-bac7-418d-a93a-8bf6cf2a6e84'></a>\n\nMirtallo J et al. JPEN J Parent Enteral Nutr. 2004; 28:S39-S70.\n\n<a id='25f08d59-53cb-4fdc-8562-be73ac932cdb'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='b7dede06-35b2-465d-85fb-0d195ce4e034'></a>\n\n<::logo: Not identified\nELECTROLYTE DOSING CONSIDERATIONS\nThe logo features white text on a brown rectangular background, accompanied by a white outline illustration of an IV drip connected to a human head/throat.::>\n\n<a id='e8d4f140-6265-4af0-a93f-f890e5a44964'></a>\n\n▪ Electrolyte disorders\n  - Acute (< 48 hours) vs. chronic (> 48 hours)\n  - Rate of development, degree of abnormality and/or symptoms\n▪ Renal dysfunction\n  - Empiric dose - 50% recommended dose\n▪ Obesity\n  - Adjusted body weight (AdjBW) for weight-based electrolyte dosing\n  - AdjBW = [(weight in kg - IBW) x 0.25] + IBW\n\n<a id='febb6d3f-3744-4923-a077-313cc676c4d9'></a>\n\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82.\n\n<a id='5cd37089-ff8f-4028-a276-57e06e3cf11b'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='d4710f52-8be6-406d-91e3-362bf657848f'></a>\n\n# SODIUM\n\n*   Most abundant extracellular cation\n*   Normal serum sodium 135-145 mEq/L\n*   Primary influence on serum osmolality\n*   Changes in serum sodium are due to water balance changes\n*   Water flows from areas of lower osmolality to higher osmolality\n*   Sodium disorder diagnosis\n    *   History and physical\n    *   Laboratory analysis (serum, urine)\n    *   **Serum osmolality**\n    *   **Volume status of the patient**\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='27694181-0bf0-46e6-81b1-e2c227f1284c'></a>\n\n# HYPONATREMIA (NA < 135 MEQ/L)\n\n*   Common electrolyte disorder\n    *   28% hospitalized patients\n    *   17.2% critically ill patients\n*   Up to 6-fold increase in morbidity and mortality\n*   Wide symptomatology – neurologic in nature\n    *   None\n    *   Moderate: headache, nausea, confusion\n    *   Severe: vomiting, obtunded, seizures, coma\n\nMannesse CK et al. Ageing Res Rev. 2013; 12(1):165-73.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='50940c4e-f9af-413c-93d4-6d5a0f91c842'></a>\n\n<::DIAGNOSTIC ALGORITHM\n: flowchart::>\nNa correction for hyperglycemia = serum Na + 0.016 (serum glucose - 100)\n\nHyponatremia (Na < 135 mEq/L)\n↓\nSerum Osmolality (sOsm)\n\nBranches:\n1. Hypertonic (sOsm > 290 mOsm/kg)\n   ↓\n   Hyperglycemia\n   Mannitol infusions\n\n2. Hypotonic (sOsm < 275 mOsm/kg)\n   ↓\n   Determine volume status of the patient (next slide)\n\n3. Isotonic (sOsm 275-290 mOsm/kg)\n   ↓\n   Hyperlipidemia\n   Hyperproteinemia\n<::\nVerbalis JG et al. AmJ Med. 2013; 126:S1-S42.\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82.\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='032be8e0-4e68-4de0-aacb-34b1d720859a'></a>\n\n<::DIAGNOSTIC ALGORITHM\n: flowchart::>\n<::Hypotonic hyponatremia\n(Na < 135 mEq/L, sOsm < 275 mOsm/kg)\n: flowchart::>\n\n<::Volume status\nof the patient\n: flowchart::>\n\n<::From \"Volume status of the patient\" to three branches:\n\nBranch 1:\nHypovolemia\n↓TBW, ↓↓Total body Na\n\n  From \"Hypovolemia\" to two sub-branches:\n\n  Sub-branch 1.1:\n  Renal losses\n  uNa >20 mEq/L\n  Diuretics (thiazides)\n  Osmotic diuresis\n  Adrenal insufficiency\n  Salt-wasting nephropathy\n  Cerebral salt wasting\n\n  Sub-branch 1.2:\n  Extrarenal losses\n  uNa <20 mEq/L\n  Vomiting\n  Diarrhea\n  Third spacing\n  Pancreatitis\n  Burns/open wounds\n  Excessive sweating\n\nBranch 2:\nEuvolemia\n↑TBW, ↔Total body Na\n\n  From \"Euvolemia\" to one sub-branch:\n\n  Sub-branch 2.1:\n  uNa >20 mEq/L\n  uOsm >100 mOsm/L\n  Syndrome of inappropriate antidiuresis (SIAD)\n  Hypothyroid\n  Glucocorticoid deficiency\n\nBranch 3:\nHypervolemia\n↑↑TBW, ↑Total body Na\n\n  From \"Hypervolemia\" to two sub-branches:\n\n  Sub-branch 3.1:\n  uNa >20 mEq/L\n  Acute kidney injury\n  Chronic kidney disease\n\n  Sub-branch 3.2:\n  uNa <20 mEq/L\n  Cirrhosis\n  Nephrotic syndrome\n  Heart failure\n\nNUTRITION SUPPORT\nCERTIFICATE\n: flowchart::>\n\n<a id='42b570fa-7f18-4094-b615-04a4fcb21346'></a>\n\n<::A brown banner with the text \"SIAD\" in white on the left side. On the right side, there is a white outline illustration of a human head in profile, with an IV drip bag connected to it, suggesting a medical or healthcare context.\n: figure::>\n\n<a id='22096ca4-3d2c-47a6-970f-1fd7e7f5ea06'></a>\n\nSustained or intermittently elevated antidiuretic hormone (ADH) level inappropriate for osmotic and volume status which normally inhibits ADH secretion\n\n<a id='6ee7f8bb-803e-46ca-be3a-7aceaf899b91'></a>\n\n<table id=\"13-1\">\n<tr><td id=\"13-2\">Essential Criteria</td><td id=\"13-3\">Supplemental Criteria</td></tr>\n<tr><td id=\"13-4\">Effective sOsm <275 mOsm/kg</td><td id=\"13-5\">Serum uric acid < 0.24 mmol/L (< 4 mg/dL)</td></tr>\n<tr><td id=\"13-6\">uOsm > 100 mOsm/kg at some level of decreased</td><td id=\"13-7\">Fractional excretion of uric acid > 12%</td></tr>\n<tr><td id=\"13-8\">effective osmolality</td><td id=\"13-9\">Serum urea <3.6 mmol/L (<21.6 mg/dL)</td></tr>\n<tr><td id=\"13-a\">Clinical euvolemia</td><td id=\"13-b\">Fractional excretion of urea > 55%</td></tr>\n<tr><td id=\"13-c\">uNa > 30 mEq/L (normal sodium & water intake)</td><td id=\"13-d\">Fractional excretion of Na > 0.5%</td></tr>\n<tr><td id=\"13-e\">No adrenal, thyroid, pituitary or renal insufficiency</td><td id=\"13-f\">No change in serum Na with 0.9% NaCl administration</td></tr>\n<tr><td id=\"13-g\">No recent diuretic use</td><td id=\"13-h\">Na correction with fluid restriction</td></tr>\n</table>\n\n<a id='8c4532e2-8e79-4d68-ab8d-78d0786dbd74'></a>\n\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. AmJ Health-Syst Pharm 2005; 62:1663-82.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='a8645af1-14cf-4ad6-af59-e903279482ec'></a>\n\n# CAUSES OF SIAD\n\n*   Diagnosis of exclusion\n*   Causes\n    *   Pulmonary (small cell lung cancer, pneumonia, abscess, tuberculosis)\n    *   Neurologic (tumors, trauma, meningitis, abscess, subarachnoid hemorrhage, pain, anxiety, nausea)\n    *   Hypothyroidism\n    *   Medications\n\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. Am J Health-Syst Pharm. 2005; 62:1663-82.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='9ae21f6f-706d-40b0-82b7-51db9692d5fc'></a>\n\n<::SIAD: MEDICATIONS ASSOCIATED\n: An illustration depicting a person receiving medication through an IV drip and a nasal spray.::>\n\n<a id='a170457b-5603-4e7c-a80e-164d77a2dd25'></a>\n\n- Anticancer agents: cyclophosphamide, ifosfamide, vincristine\n- Anticonvulsants: carbamazepine, oxcarbazepine\n- Antidepressants: SSRIs, TCADs, MAOI, venlafaxine\n- Antidiabetic agent: chlorpropamide\n- Antipsychotics: phenothiazines\n- Miscellaneous: opiates, 3,4-methylenedioxy-methamphetamine (MDMA), non-steroidal anti-inflammatory drugs\n- Vasopressin analogs: desmopressin, oxytocin, terlipressin, vasopressin\n\n<a id='0e233f41-e037-4258-b347-1d6f511dfaf3'></a>\n\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='0df216f7-d596-4719-ad8e-772f094f25cb'></a>\n\n# HYPONATREMIA MANAGEMENT\n\n*   Focus on treatment of underlying cause\n*   Discontinuation of hypotonic fluids\n*   Replace sodium deficit or water excess\n    *   Change in serum Na = (infusate Na – serum Na) / (TBW + 1)\n*   Hypertonic saline for symptomatic patients\n*   Sodium correction limited to 8-10 mEq per Liter per day\n    *   Prevention of central pontine myelinolysis\n    *   Gradual onset of neurologic alterations\n\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='c9622815-d0fc-4731-8c62-5eb7a8d1b5e0'></a>\n\nCAPTION ERROR\n\n<a id='a9e4e492-a17a-4258-8a05-f69a1f361704'></a>\n\n<table id=\"15-1\">\n<tr><td id=\"15-2\">Hyponatremia Type</td><td id=\"15-3\">Treatment (plus treat or remove underlying cause)</td></tr>\n<tr><td id=\"15-4\">Hypertonic</td><td id=\"15-5\">Insulin (hyperglycemia), discontinue mannitol</td></tr>\n<tr><td id=\"15-6\" colspan=\"2\">Hypotonic</td></tr>\n<tr><td id=\"15-7\">Hypovolemic</td><td id=\"15-8\">Isotonic fluids (0.9% sodium chloride, lactated ringers), discontinue diuretics, steroids (adrenal insufficiency)</td></tr>\n<tr><td id=\"15-9\">Euvolemic</td><td id=\"15-a\">Fluid restriction ± loop diuretics, concentrate PN, ensure at least isotonic fluids, vaptan (SIAD); glucocorticoids (deficiency); thyroid hormone replacement (hypothyroid)</td></tr>\n<tr><td id=\"15-b\">Hypervolemic</td><td id=\"15-c\">Sodium and fluid restriction, vaptans, diuretics</td></tr>\n</table>\n\n<a id='179f8e36-441a-4fc8-90b4-6a40672e8f42'></a>\n\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82.\n---\n\n<a id='0702fd84-f360-4785-b999-49af0b23c935'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='69338f78-93be-4f34-ad44-7822924638c7'></a>\n\nSELF-ASSESSMENT #2\n\nWhich of the following medications increases the risk of developing hypotonic euvolemic hyponatremia?\n\nA. Hydrochlorothiazide\nB. Ondansetron\nC. Sertraline\nD. Spironolactone\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='361646a5-a30e-4cfe-a173-5f537a20d940'></a>\n\nSELF-ASSESSMENT #3\n\nWhich of the following sodium concentrations (mEq/L) is the most appropriate choice to use when formulating a parenteral nutrition plan for a patient with heart failure with hyponatremia, shortness of breath, and edema?\n\noption A. 38.5 mEq sodium per Liter: [ ]\noption B. 77 mEq sodium per Liter: [ ]\noption C. 115 mEq sodium per Liter: [ ]\noption D. 154 mEq sodium per Liter: [ ]\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='a77eb05a-ba9d-43a7-a75a-1975b50d6897'></a>\n\nHYPERNATREMIA (NA > 145 MEQ/L)\n\n*   All cases are hypertonic\n*   Less common than hyponatremia\n    *   1-7.9% hospitalized patients\n*   Up to 70% increase in mortality\n*   Symptoms – neurologic in nature\n    *   Thirst, dry mucus membranes\n    *   Mild-moderate: lethargy, weakness, confusion, irritability\n    *   Severe: twitching, seizures, coma\n\n<a id='3e9ac45e-c3cc-4f7a-8e82-6d76b9ac4c65'></a>\n\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82\n\n<a id='9dd8cd1c-bb55-4701-bb57-51f447b95973'></a>\n\nCAPTION ERROR\n\n<a id='2daf2933-be4a-4702-a5d2-ce033c786bf3'></a>\n\nDIAGNOSTIC ALGORITHM\n<::Hypernatremia (Na > 145 mEq/L)\n\nVolume status of the patient\n\nHypovolemia:\nOsmotic / Solute diuresis (hyperglycemia, mannitol, excessive protein provision)\nPost-obstructive diuresis\nVomiting\nDiarrhea or excess laxative use\nInsensible losses\n\nEuvolemia:\nCentral diabetes insipidus\nNephrogenic diabetes insipidus\nPrimary polydipsia\n\nHypervolemia:\nHypertonic saline solutions\nSodium bicarbonate solutions\nHyperaldosteronism\n: flowchart::>\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82.\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='4d178aaa-8827-42e8-91cc-f638c5e42a34'></a>\n\n# DIABETES INSIPIDUS\n\n*   Condition resulting in imbalance of water in the body due to large amounts of dilute urine excretion\n*   Central diabetes insipidus: lack of or decrease in antidiuretic hormone secretion\n*   Nephrogenic diabetes insipidus: decreased renal response to antidiuretic hormone\n    *   Medication and electrolyte causes of nephrogenic diabetes insipidus\n        *   Amphotericin B, cidofovir, foscarnet, demeclocycline, lithium toxicity\n        *   Hypercalcemia, hypokalemia\n\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. Am J Health-Syst Pharm. 2005; 62:1663-82.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='9a1a0dc6-dc54-4901-8959-b59add1f0612'></a>\n\n# HYPERNATREMIA MANAGEMENT\n\n*   Focus on treatment of underlying cause\n*   Discontinuation of hypertonic fluids\n*   Correct water deficit with hypotonic fluids\n    *   Water deficit (L) = TBW x [1 - (serum Na/140)]\n    *   Administer 50% in first 24 hours, remainder in next 48-72 hours\n*   Isotonic fluids for hemodynamic instability\n*   Sodium correction limited to 8-10 mEq per Liter per day\n    *   Prevention of cerebral edema\n\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='e540373b-4624-4da8-bc6b-1bbf6437c2cc'></a>\n\nHYPERNATREMIA MANAGEMENT\n<table id=\"18-1\">\n<tr><td id=\"18-2\" colspan=\"2\">Hypernatremia Type</td></tr>\n<tr><td id=\"18-3\">Hypovolemic</td><td id=\"18-4\">Oral water, enteral water flushes, hypotonic fluids (dextrose 5% in water, 0.45% sodium chloride, addition of sterile water to PN), insulin (hyperglycemia), amino acid dose reduction (solute diuresis)</td></tr>\n<tr><td id=\"18-5\">Euvolemic</td><td id=\"18-6\">Desmopressin (central diabetes insipidus) Thiazide diuretics, sodium restriction, calcium or potassium supplementation (nephrogenic diabetes insipidus)</td></tr>\n<tr><td id=\"18-7\">Hypervolemic</td><td id=\"18-8\">Loop diuretic, hypotonic fluids (sodium overload), adrenalectomy or spironolactone (hyperaldosteronism)</td></tr>\n</table>\n\n<a id='df9bbbc0-c13a-4379-b2ca-e59c8ff6d3a5'></a>\n\nBraun MM et al. Am Fam Physician. 2015; 91(5):299-307.\nKraft MD et al. AmJ Health-Syst Pharm. 2005; 62:1663-82.\n\n<a id='4668c1e4-df58-40d1-b90c-606187ecb351'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='42c6a93f-46f8-44e2-b177-ea5e619d9729'></a>\n\nSELF-ASSESSMENT #4\n\n*   TT is a 65-year-old patient with enterocutaneous fistula who is on parenteral nutrition providing 28 kcal/kg/day and 3 g protein/kg/day\n*   Vital signs: BP 102/62, HR 85, RR 20, Temp 38 C\n*   Physical exam: +thirst and dry mucous membranes\n*   Basic metabolic panel: Na 154 mEq/L, K 3.2 mEq/L, CI 118 mEq/L, CO₂ 23 mEq/L, BUN 30 mg/dL, Cr 0.9 mg/dL, glucose 82 mg/dL, urine urea nitrogen > 700 mg/dL\n*   Input: 2200 mL/day (31 mL/kg/day)\n*   Urine output: 5400 mL/ day (3.2 mL/kg/hour)\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='32c6e580-a16f-4528-b9b8-0bef3947e1af'></a>\n\n## SELF-ASSESSMENT #4\n\nWhich of the following is the likely type and cause of TT's hypernatremia?\n\nA. Hypervolemic hypernatremia due to excessive fluid administration\nB. Nephrogenic diabetes insipidus\nC. Syndrome of inappropriate antidiuresis (SIAD)\nD. Hypovolemic hypernatremia due to solute diuresis\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='19e9440e-94a3-4cb0-abe3-62285f4713c1'></a>\n\n<::logo: N/A\nN/A\nA white outline drawing on a brown background depicts a human head in profile with a nasal swab and an IV drip.::>\n\n<a id='5d6f7e4d-9eed-44c3-a2e6-a2545cae31e1'></a>\n\nSelf Assessment Questions and Answers\n\n<a id='0b9ec25c-d6f9-4c10-adeb-2ab4c8317ab1'></a>\n\n# SELF-ASSESSMENT #1\n\n*   MN is a 72 year-old female who is admitted to the medicine service for a non-specific complaint of general malaise. On physical exam, she has dry mucous membranes and exhibits poor skin turgor.\n*   Past medical history: HTN, osteoarthritis, and hyperlipidemia\n*   Home medications: hydrochlorothiazide, aspirin, simvastatin, calcium carbonate, vitamin D\n*   Vital signs: BP 96/52, HR 100, RR 14, Temp 37 C\n*   Laboratory values: Na 122 mEq/L, K 4 mEq/L, CI 101 mEq/L, CO2 19 mEq/L, BUN 45 mg/dL, Cr 1.5 mg/dL, glucose 115 mg/dL, magnesium 2.4 mg/dL, urine osmolality 450 mOsm/L\n\n<a id='4f5ece54-5a8f-432f-80db-ef62c71d78ed'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='33cddc38-b61e-4433-9a91-c0025f0841c8'></a>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='f8e6fe35-393e-4fb7-8168-d0a4b5ee6f55'></a>\n\nSELF-ASSESSMENT #1, CONT.\n\nWhich of the following is the most likely diagnosis for this patient's hyponatremia?\n\nA. Hypertonic\nB. Hypovolemic hypotonic\nC. Euvolemic hypotonic\nD. Hypervolemic hypotonic\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='ceee40c9-8345-4a60-a6c5-cf246a552352'></a>\n\nSELF-ASSESSMENT #1, CONT.\n\nWhich of the following is the most likely diagnosis for this patient's hyponatremia?\n\noption A. Hypertonic: [ ]\noption B. Hypovolemic hypotonic: [x]\noption C. Euvolemic hypotonic: [ ]\noption D. Hypervolemic hypotonic: [ ]\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='f8b35dfd-beb6-4581-8231-9421b46dc7c1'></a>\n\nSELF-ASSESSMENT #2 <::A white line-art illustration of a human head in profile with a feeding tube inserted through the nose, connected to an IV bag or feeding bag. This visual represents nutrition support.: figure::>\nWhich of the following medications increases the risk of developing hypotonic\neuvolemic hyponatremia?\nA. Hydrochlorothiazide\nB. Ondansetron\nC. Sertraline\nD. Spironolactone\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='5bbb55e7-c050-4935-bf60-b43ae6786ade'></a>\n\n## SELF-ASSESSMENT #2\n\nWhich of the following medications increases the risk of developing hypotonic euvolemic hyponatremia?\n\nA. Hydrochlorothiazide\nB. Ondansetron\nC. **Sertraline**\nD. Spironolactone\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='4b34e393-d430-47cd-93f9-844797677a51'></a>\n\nSELF-ASSESSMENT #3\n\nWhich of the following sodium concentrations (mEq/L) is the most appropriate choice to use when formulating a parenteral nutrition plan for a patient with heart failure with hyponatremia, shortness of breath, and edema?\n\nA. 38.5 mEq sodium per Liter\nB. 77 mEq sodium per Liter\nC. 115 mEq sodium per Liter\nD. 154 mEq sodium per Liter\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='252f7d81-664b-4dc3-87fb-e68fa40da916'></a>\n\n## SELF-ASSESSMENT #3\n\nWhich of the following sodium concentrations (mEq/L) is the most appropriate choice to use when formulating a parenteral nutrition plan for a patient with heart failure with hyponatremia, shortness of breath, and edema?\n\noption A. 38.5 mEq sodium per Liter: [x]\noption B. 77 mEq sodium per Liter: [ ]\noption C. 115 mEq sodium per Liter: [ ]\noption D. 154 mEq sodium per Liter: [ ]\n\nNUTRITION SUPPORT CERTIFICATE\n\n<a id='efe4c8b7-311a-4c9c-bb16-8b178482ebfd'></a>\n\nSELF-ASSESSMENT #4\n\n*   TT is a 65-year-old patient with enterocutaneous fistula who is on parenteral nutrition providing 28 kcal/kg/day and 3 g protein/kg/day\n*   Vital signs: BP 102/62, HR 85, RR 20, Temp 38 C\n*   Physical exam: +thirst and dry mucous membranes\n*   Basic metabolic panel: Na 154 mEq/L, K 3.2 mEq/L, CI 118 mEq/L, CO₂ 23 mEq/L, BUN 30 mg/dL, Cr 0.9 mg/dL, glucose 82 mg/dL, urine urea nitrogen > 700 mg/dL\n*   Input: 2200 mL/day (31 mL/kg/day)\n*   Urine output: 5400 mL/ day (3.2 mL/kg/hour)\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='d2f286db-1a9c-4735-8c68-15183cfbaefb'></a>\n\n## SELF-ASSESSMENT #4\n\nWhich of the following is the likely type and cause of TT's hypernatremia?\n\nA. Hypervolemic hypernatremia due to excessive fluid administration\nB. Nephrogenic diabetes insipidus\nC. Syndrome of inappropriate antidiuresis (SIAD)\nD. Hypovolemic hypernatremia due to solute diuresis\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='38b6c60a-bc53-4e0e-853c-e580271cf8c2'></a>\n\n## SELF-ASSESSMENT #4\n\nWhich of the following is the likely type and cause of TT's hypernatremia?\n\noption A. Hypervolemic hypernatremia due to excessive fluid administration: [ ]\noption B. Nephrogenic diabetes insipidus: [ ]\noption C. Syndrome of inappropriate antidiuresis (SIAD): [ ]\noption D. Hypovolemic hypernatremia due to solute diuresis: [x]\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='cf11c058-bac1-4b5f-bb12-e1e1171da971'></a>\n\nCONCLUSIONS\n\n*   A thorough history and physical, including medication review, is important for identification and diagnosis of fluid & sodium disorders.\n*   Knowledge of causes of fluid & sodium disorders will help in determining appropriate prevention and treatment plan development.\n*   Development of a nutrition care plan should be done using a systematic approach including comorbid states, medication therapy, and changes in clinical status.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='44bd7443-1170-4b1d-b40c-233bff61138d'></a>\n\nREFERENCES\n\n*   Braun MM, Barstow CH, Pyzocha NJ. Diagnosis and management of sodium disorders: hyponatremia and hypernatremia. Am Fam Physician. 2015; 91:299-307.\n*   Canada TW, Lord LM. Chapter 7 Fluid, Electrolytes, and Acid-Base Disorders. In: Mueller CM, ed. The A.S.P.E.N. Adult Nutrition Support Core Curriculum. 3rd ed. Maryland: A.S.P.E.N.; 2017:113-37.\n*   Kraft MD, Btaiche IF, Sacks GS, Kudsk KA. Treatment of electrolytes disorders in adult patients in the intensive care unit. Am J Health-Syst Pharm. 2005; 62:1663-82.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='c5cb51bf-48d5-4702-b981-234d63bcd838'></a>\n\n## REFERENCES, CONT.\n\n*   Mannesse CK, Vondeling AM, van Marum RJ et al. Prevalence of hyponatremia on geriatric wards compared to other settings over four decades: a systematic review. *Ageing Res Rev*. 2013; 12(1):165-173.\n*   Mirtallo J, Canada T, Johnson D et al. Safe practices for parenteral nutrition. *JPEN J Parent Enteral Nutr*. 2004; 28:S39-S70.\n*   Verbalis JG, Goldsmith, SR, Greenberg A et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. *Am J Med*. 2013; 126:S1-S42.\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='4dad45b2-2dab-4b44-addc-a2aa09751132'></a>\n\n<::A stylized illustration on a brown background depicts medical nutrition support. On the left, a white outline of a human head in profile shows an oral feeding tube extending into the esophagus. On the right, a white outline of an IV bag with tubing is connected to a person's arm. Faint, ghosted versions of these illustrations are visible in the background. Below these illustrations, on a white and brown diagonal band, are two logos: \"ashp\" and \"aspen\".\n: illustration::>\n\nNUTRITION SUPPORT\nCERTIFICATE\n\n<a id='81f6a452-235e-4d5e-ad54-a26ccdcba39d'></a>\n\n<::transcription of the content\n: figure::>\n\nAnne M. Tucker, Pharm.D., BCNSP\nClinical pharmacy Specialist\nUniversity of Texas MD Anderson Cancer Center\nHouston, Texas\n\nAnne M. Tucker is clinical pharmacy specialist at the MD Anderson Cancer\nCenter, Houston, Texas. She received her BS in Chemistry from the\nUniversity of Arkansas, Pharm.D. from the University of Arkansas for Medical\nSciences (UAMS) where she also completed residency training. Dr. Tucker has\nover 20 years of experience in critical care and nutrition support practice and\nparticipates in didactic and experiential training of students and post-graduate trainees. Her areas of\ninterest include fluid and electrolyte disorders, nutrition support in critically ill cancer patients, and the\npromotion of safe parenteral nutrition practices.\n\n<a id='2b2f678e-50b4-41d5-bfce-2b01a6b446b4'></a>\n\nDr. Tucker is currently the Chair of the American Society for Parenteral and Enteral Nutrition (ASPEN) Abstract Review Committee and President of the Texas Gulf Coast ASPEN Chapter. She is also a member and abstract reviewer for American Society of Health-System Pharmacists and Society of Critical Care Medicine. Past leadership includes Chair and member for the Board of Pharmacy Specialties Nutrition Support Specialty Council, Chair and Secretary of the ASPEN Pharmacy Practice Section, Chair of the ASPEN Self-Assessment Committee, Chair for the ASPEN Task Force for Revision of Nutrition Support Pharmacist Standards, and member of the ASPEN Parenteral Nutrition Safety Committee. She is a regular presenter at Clinical Nutrition Week and was most recently involved as an editor and author of the ASPEN Fluid, Electrolytes and Acid-Base Disorders Handbook.\n\n<a id='19de4395-ed5a-4891-a827-513dc02b9a7d'></a>\n\n## Relevant Financial Relationship Disclosure\n\nIn accordance with our accreditor's Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.\n\nAn ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.\n\n<a id='4a9ffc47-5272-47f5-b48a-d775bcf72877'></a>\n\nThe following persons in control of this activity's content have relevant financial relationships:\n* Phil Ayers: Fresenius Kabi, consultant and speaker\n* David Evans: Fresenius Kabi, consultant and speaker; Abbott Laboratories, consultant and speaker; CVS/OptionCare, consultant; Alcresta, consultant and speaker\n* Andrew Mays: Fresenius Kabi, speaker\n* Jay Mirtallo: Fresenius Kabi, consultant\n* Kris Mogensen: Baxter, speaker; Thrive Rx, advisory board; Pfizer, advisory board\n\n<a id='77b8b272-671f-4fb6-9f67-f0f0c328981f'></a>\n\nAll other persons in control of content do not have any relevant financial relationships with an ineligible company.\n\n<a id='193cc645-9b87-49a9-8634-c01ea4d9ad02'></a>\n\nAs required by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company, all relevant financial relationships have been mitigated prior to the CPE activity.\n\n<a id='211eb738-b192-4453-b094-e56019317b29'></a>\n\n### Methods and CE Requirements\n---\nThis online activity consists of a combined total of 12 learning modules. Pharmacists and physicians are eligible to receive a total of 20 hours of continuing education credit by completing all 12 modules within this certificate.\n\n<a id='0a3c85d9-6cbc-4e95-a393-21c4f8ab9477'></a>\n\nParticipants must participate in the entire activity, complete the evaluation and all required components to claim continuing pharmacy education credit online at ASHP Learning Center http://elearning.ashp.org. Follow the prompts to claim credit and view your statement of credit within 60 days after completing the activity.\n\n<a id='50719092-f550-47b6-ac36-87953d107e56'></a>\n\n**Important Note–ACPE 60 Day Deadline:**\nPer ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, check your NABP eProfile account to validate that your credits were transferred successfully before the ACPE 60-day deadline. After the 60 day deadline, ASHP will no longer be able to award credit for this activity.\n\n<a id='f94e68a5-d97d-448b-9a8c-e2b0560563e1'></a>\n\n## System Technical Requirements\n---\nCourses and learning activities are delivered via your Web browser and Acrobat PDF. Users should have a basic comfort level using a computer and navigating websites.\n\n<a id='52a26de7-2bd8-4bb2-986d-fc6145ae1b06'></a>\n\nView Frequently Asked Questions for more information.",
      "chunks": [
        "d049e39a-c94f-4c82-99c0-8bce010a7715",
        "cfefbf72-26fb-4401-a4c9-b22243437fb9",
        "11965d6d-6c35-4e5d-a77f-573500394dcb",
        "81e53325-9b14-47b5-8863-d65a78e294a5",
        "30de0ff1-ff7b-4b42-a0bc-66433204b260",
        "36df49d8-c092-4592-b44e-c5924c0089b1",
        "e38ce2a1-beb1-4f57-ad80-03c4a4c2f1be",
        "798bcf7c-e18d-4d82-bf6b-1019c4444d65",
        "1f13f8e3-5976-4d56-885b-207758b37bff",
        "6e976e6d-beaa-41a9-9210-ee0a66809435",
        "5e9745a6-93cb-4111-a57d-5ebb909a7097",
        "7e7f090a-19f8-4af7-97d2-e7247135f55d",
        "28315dce-2718-4e57-be54-1dd8247be5e5",
        "a1ee380f-036f-4d1a-b8ed-c1616394a409",
        "7ff14278-eb74-4149-a5ed-b621975de052",
        "b9dc5873-bd29-4f2f-9a3b-d8a2fa9bb58a",
        "4b8dde8d-2aa7-486f-b44e-3a864b8abc8a",
        "b2d284ac-571b-4892-b804-7b25250ef495",
        "4b201591-309b-4671-b647-dcd63921df30",
        "c0aa90b4-71d2-453a-9737-7d67bf4aa61f",
        "1e3adae9-3144-4b02-9283-5c693c3be28c",
        "e48bf804-3ebb-448b-8621-25ee5095bb49",
        "0bf0a6d7-6016-4ffe-a95d-e7d7fc2806d2",
        "73a8742f-ee06-42e5-8fcb-e32550380010",
        "acdf7869-baee-4aaf-a27c-41d1560ee0cd",
        "e5a86d90-1748-4268-977c-4ecbce64ab84",
        "a8d1ac93-d7a6-4b22-9a5c-e09847b9369e",
        "94969f52-4c4b-4d9d-83f6-ae18c960b1a5",
        "ef862032-fff5-4a23-92e3-abf7164aba20",
        "241fd44b-4cca-4bb8-b0f9-121e49f9c264",
        "8c68e89c-8a54-4673-9876-2f0e049fc5dd",
        "0976ad3d-ecb2-4c8d-b680-9c6f4e1bb726",
        "1598e825-27cf-47b8-96ff-66b1cdcfc71c",
        "1ec6b493-2bfd-40df-9925-a5468d31d580",
        "b03361c1-1dbb-4120-a810-311b697e341a",
        "4498d3ff-bac7-418d-a93a-8bf6cf2a6e84",
        "25f08d59-53cb-4fdc-8562-be73ac932cdb",
        "b7dede06-35b2-465d-85fb-0d195ce4e034",
        "e8d4f140-6265-4af0-a93f-f890e5a44964",
        "febb6d3f-3744-4923-a077-313cc676c4d9",
        "5cd37089-ff8f-4028-a276-57e06e3cf11b",
        "d4710f52-8be6-406d-91e3-362bf657848f",
        "27694181-0bf0-46e6-81b1-e2c227f1284c",
        "50940c4e-f9af-413c-93d4-6d5a0f91c842",
        "032be8e0-4e68-4de0-aacb-34b1d720859a",
        "42b570fa-7f18-4094-b615-04a4fcb21346",
        "22096ca4-3d2c-47a6-970f-1fd7e7f5ea06",
        "6ee7f8bb-803e-46ca-be3a-7aceaf899b91",
        "8c4532e2-8e79-4d68-ab8d-78d0786dbd74",
        "a8645af1-14cf-4ad6-af59-e903279482ec",
        "9ae21f6f-706d-40b0-82b7-51db9692d5fc",
        "a170457b-5603-4e7c-a80e-164d77a2dd25",
        "0e233f41-e037-4258-b347-1d6f511dfaf3",
        "0df216f7-d596-4719-ad8e-772f094f25cb",
        "c9622815-d0fc-4731-8c62-5eb7a8d1b5e0",
        "a9e4e492-a17a-4258-8a05-f69a1f361704",
        "179f8e36-441a-4fc8-90b4-6a40672e8f42",
        "0702fd84-f360-4785-b999-49af0b23c935",
        "69338f78-93be-4f34-ad44-7822924638c7",
        "361646a5-a30e-4cfe-a173-5f537a20d940",
        "a77eb05a-ba9d-43a7-a75a-1975b50d6897",
        "3e9ac45e-c3cc-4f7a-8e82-6d76b9ac4c65",
        "9dd8cd1c-bb55-4701-bb57-51f447b95973",
        "2daf2933-be4a-4702-a5d2-ce033c786bf3",
        "4d178aaa-8827-42e8-91cc-f638c5e42a34",
        "9a1a0dc6-dc54-4901-8959-b59add1f0612",
        "e540373b-4624-4da8-bc6b-1bbf6437c2cc",
        "df9bbbc0-c13a-4379-b2ca-e59c8ff6d3a5",
        "4668c1e4-df58-40d1-b90c-606187ecb351",
        "42c6a93f-46f8-44e2-b177-ea5e619d9729",
        "32c6e580-a16f-4528-b9b8-0bef3947e1af",
        "19e9440e-94a3-4cb0-abe3-62285f4713c1",
        "5d6f7e4d-9eed-44c3-a2e6-a2545cae31e1",
        "0b9ec25c-d6f9-4c10-adeb-2ab4c8317ab1",
        "4f5ece54-5a8f-432f-80db-ef62c71d78ed",
        "33cddc38-b61e-4433-9a91-c0025f0841c8",
        "f8e6fe35-393e-4fb7-8168-d0a4b5ee6f55",
        "ceee40c9-8345-4a60-a6c5-cf246a552352",
        "f8b35dfd-beb6-4581-8231-9421b46dc7c1",
        "5bbb55e7-c050-4935-bf60-b43ae6786ade",
        "4b34e393-d430-47cd-93f9-844797677a51",
        "252f7d81-664b-4dc3-87fb-e68fa40da916",
        "efe4c8b7-311a-4c9c-bb16-8b178482ebfd",
        "d2f286db-1a9c-4735-8c68-15183cfbaefb",
        "38b6c60a-bc53-4e0e-853c-e580271cf8c2",
        "cf11c058-bac1-4b5f-bb12-e1e1171da971",
        "44bd7443-1170-4b1d-b40c-233bff61138d",
        "c5cb51bf-48d5-4702-b981-234d63bcd838",
        "4dad45b2-2dab-4b44-addc-a2aa09751132",
        "81f6a452-235e-4d5e-ad54-a26ccdcba39d",
        "2b2f678e-50b4-41d5-bfce-2b01a6b446b4",
        "19de4395-ed5a-4891-a827-513dc02b9a7d",
        "4a9ffc47-5272-47f5-b48a-d775bcf72877",
        "77b8b272-671f-4fb6-9f67-f0f0c328981f",
        "193cc645-9b87-49a9-8634-c01ea4d9ad02",
        "211eb738-b192-4453-b094-e56019317b29",
        "0a3c85d9-6cbc-4e95-a393-21c4f8ab9477",
        "50719092-f550-47b6-ac36-87953d107e56",
        "f94e68a5-d97d-448b-9a8c-e2b0560563e1",
        "52a26de7-2bd8-4bb2-986d-fc6145ae1b06"
      ]
    }
  ],
  "grounding": {
    "d049e39a-c94f-4c82-99c0-8bce010a7715": {
      "box": {
        "left": 0.20875120162963867,
        "top": 0.09559591114521027,
        "right": 0.7846815586090088,
        "bottom": 0.13833053410053253
      },
      "page": 0,
      "type": "chunkText"
    },
    "cfefbf72-26fb-4401-a4c9-b22243437fb9": {
      "box": {
        "left": 0.22389516234397888,
        "top": 0.24062179028987885,
        "right": 0.7693560123443604,
        "bottom": 0.37845247983932495
      },
      "page": 0,
      "type": "chunkText"
    },
    "11965d6d-6c35-4e5d-a77f-573500394dcb": {
      "box": {
        "left": 0.11857008188962936,
        "top": 0.522024929523468,
        "right": 0.3557589054107666,
        "bottom": 0.6223649382591248
      },
      "page": 0,
      "type": "chunkLogo"
    },
    "81e53325-9b14-47b5-8863-d65a78e294a5": {
      "box": {
        "left": 0.4000250995159149,
        "top": 0.5069605112075806,
        "right": 0.8807059526443481,
        "bottom": 0.6218569278717041
      },
      "page": 0,
      "type": "chunkLogo"
    },
    "30de0ff1-ff7b-4b42-a0bc-66433204b260": {
      "box": {
        "left": 0.11710125207901001,
        "top": 0.6758202314376831,
        "right": 0.8817834854125977,
        "bottom": 0.7209265232086182
      },
      "page": 0,
      "type": "chunkText"
    },
    "36df49d8-c092-4592-b44e-c5924c0089b1": {
      "box": {
        "left": 0.1258067786693573,
        "top": 0.7430411577224731,
        "right": 0.8735208511352539,
        "bottom": 0.8151071071624756
      },
      "page": 0,
      "type": "chunkText"
    },
    "e38ce2a1-beb1-4f57-ad80-03c4a4c2f1be": {
      "box": {
        "left": 0.06453770399093628,
        "top": 0.0957910418510437,
        "right": 0.938981831073761,
        "bottom": 0.4703899025917053
      },
      "page": 1,
      "type": "chunkText"
    },
    "798bcf7c-e18d-4d82-bf6b-1019c4444d65": {
      "box": {
        "left": 0.0651770830154419,
        "top": 0.5295377373695374,
        "right": 0.9373146295547485,
        "bottom": 0.795698344707489
      },
      "page": 1,
      "type": "chunkText"
    },
    "1f13f8e3-5976-4d56-885b-207758b37bff": {
      "box": {
        "left": 0.07552486658096313,
        "top": 0.8207365274429321,
        "right": 0.9221546649932861,
        "bottom": 0.8654313087463379
      },
      "page": 1,
      "type": "chunkText"
    },
    "6e976e6d-beaa-41a9-9210-ee0a66809435": {
      "box": {
        "left": 0.7795380353927612,
        "top": 0.8655372858047485,
        "right": 0.9287168979644775,
        "bottom": 0.89451003074646
      },
      "page": 1,
      "type": "chunkText"
    },
    "5e9745a6-93cb-4111-a57d-5ebb909a7097": {
      "box": {
        "left": 0.06258279085159302,
        "top": 0.09448324143886566,
        "right": 0.9389452338218689,
        "bottom": 0.4703078269958496
      },
      "page": 2,
      "type": "chunkText"
    },
    "7e7f090a-19f8-4af7-97d2-e7247135f55d": {
      "box": {
        "left": 0.0628879964351654,
        "top": 0.5290356278419495,
        "right": 0.9385209083557129,
        "bottom": 0.9052333235740662
      },
      "page": 2,
      "type": "chunkText"
    },
    "28315dce-2718-4e57-be54-1dd8247be5e5": {
      "box": {
        "left": 0.06294694542884827,
        "top": 0.09469668567180634,
        "right": 0.9388382434844971,
        "bottom": 0.4695681929588318
      },
      "page": 3,
      "type": "chunkText"
    },
    "a1ee380f-036f-4d1a-b8ed-c1616394a409": {
      "box": {
        "left": 0.06304481625556946,
        "top": 0.5298891663551331,
        "right": 0.9379253387451172,
        "bottom": 0.9036560654640198
      },
      "page": 3,
      "type": "chunkText"
    },
    "7ff14278-eb74-4149-a5ed-b621975de052": {
      "box": {
        "left": 0.06262132525444031,
        "top": 0.09409670531749725,
        "right": 0.938776969909668,
        "bottom": 0.4705467224121094
      },
      "page": 4,
      "type": "chunkText"
    },
    "b9dc5873-bd29-4f2f-9a3b-d8a2fa9bb58a": {
      "box": {
        "left": 0.06324514746665955,
        "top": 0.5289539098739624,
        "right": 0.9380829334259033,
        "bottom": 0.9052681922912598
      },
      "page": 4,
      "type": "chunkText"
    },
    "4b8dde8d-2aa7-486f-b44e-3a864b8abc8a": {
      "box": {
        "left": 0.06209683418273926,
        "top": 0.09425055980682373,
        "right": 0.939359188079834,
        "bottom": 0.47037220001220703
      },
      "page": 5,
      "type": "chunkText"
    },
    "b2d284ac-571b-4892-b804-7b25250ef495": {
      "box": {
        "left": 0.0628797709941864,
        "top": 0.5290794372558594,
        "right": 0.9391229152679443,
        "bottom": 0.9054017066955566
      },
      "page": 5,
      "type": "chunkFigure"
    },
    "4b201591-309b-4671-b647-dcd63921df30": {
      "box": {
        "left": 0.0625944435596466,
        "top": 0.09476169943809509,
        "right": 0.9387773275375366,
        "bottom": 0.4698048532009125
      },
      "page": 6,
      "type": "chunkText"
    },
    "c0aa90b4-71d2-453a-9737-7d67bf4aa61f": {
      "box": {
        "left": 0.06313711404800415,
        "top": 0.5295124053955078,
        "right": 0.9384127259254456,
        "bottom": 0.904965877532959
      },
      "page": 6,
      "type": "chunkText"
    },
    "1e3adae9-3144-4b02-9283-5c693c3be28c": {
      "box": {
        "left": 0.06376007199287415,
        "top": 0.09513792395591736,
        "right": 0.9389923810958862,
        "bottom": 0.4094916880130768
      },
      "page": 7,
      "type": "chunkText"
    },
    "e48bf804-3ebb-448b-8621-25ee5095bb49": {
      "box": {
        "left": 0.06640496850013733,
        "top": 0.42754074931144714,
        "right": 0.9364492893218994,
        "bottom": 0.4669046700000763
      },
      "page": 7,
      "type": "chunkText"
    },
    "0bf0a6d7-6016-4ffe-a95d-e7d7fc2806d2": {
      "box": {
        "left": 0.06191912293434143,
        "top": 0.5285632610321045,
        "right": 0.9397450685501099,
        "bottom": 0.9057590961456299
      },
      "page": 7,
      "type": "chunkText"
    },
    "73a8742f-ee06-42e5-8fcb-e32550380010": {
      "box": {
        "left": 0.0657937228679657,
        "top": 0.09638155996799469,
        "right": 0.9358233213424683,
        "bottom": 0.17702965438365936
      },
      "page": 8,
      "type": "chunkLogo"
    },
    "acdf7869-baee-4aaf-a27c-41d1560ee0cd": {
      "box": {
        "left": 0.1372840404510498,
        "top": 0.1871037632226944,
        "right": 0.8630800247192383,
        "bottom": 0.41513538360595703
      },
      "page": 8,
      "type": "chunkTable"
    },
    "8-1": {
      "box": {
        "left": 0.14587313936695878,
        "top": 0.19391552043842997,
        "right": 0.8546263429595342,
        "bottom": 0.40751658602479957
      },
      "page": 8,
      "type": "table"
    },
    "8-2": {
      "box": {
        "left": 0.14587313936695878,
        "top": 0.19391552043842997,
        "right": 0.561951074267725,
        "bottom": 0.27465172524009374
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-3": {
      "box": {
        "left": 0.46073210893761996,
        "top": 0.19391552043842997,
        "right": 0.8547553034395747,
        "bottom": 0.24589892145622416
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-4": {
      "box": {
        "left": 0.46073210893761996,
        "top": 0.2170502279203359,
        "right": 0.561951074267725,
        "bottom": 0.24589892145622416
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-5": {
      "box": {
        "left": 0.561951074267725,
        "top": 0.2170502279203359,
        "right": 0.6627186562872822,
        "bottom": 0.24589892145622416
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-6": {
      "box": {
        "left": 0.6627186562872822,
        "top": 0.2170502279203359,
        "right": 0.7497602316279881,
        "bottom": 0.24589892145622416
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-7": {
      "box": {
        "left": 0.7497602316279881,
        "top": 0.2170502279203359,
        "right": 0.8547553034395747,
        "bottom": 0.24589892145622416
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-8": {
      "box": {
        "left": 0.14587313936695878,
        "top": 0.24589892145622416,
        "right": 0.46073210893761996,
        "bottom": 0.27465172524009374
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-9": {
      "box": {
        "left": 0.46073210893761996,
        "top": 0.24589892145622416,
        "right": 0.561951074267725,
        "bottom": 0.27465172524009374
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-a": {
      "box": {
        "left": 0.561951074267725,
        "top": 0.24589892145622416,
        "right": 0.6627186562872822,
        "bottom": 0.27465172524009374
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-b": {
      "box": {
        "left": 0.6627186562872822,
        "top": 0.24589892145622416,
        "right": 0.7497602316279881,
        "bottom": 0.27465172524009374
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-c": {
      "box": {
        "left": 0.7497602316279881,
        "top": 0.24589892145622416,
        "right": 0.8547553034395747,
        "bottom": 0.27465172524009374
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-d": {
      "box": {
        "left": 0.14587313936695878,
        "top": 0.27465172524009374,
        "right": 0.46073210893761996,
        "bottom": 0.3023895179897851
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-e": {
      "box": {
        "left": 0.46073210893761996,
        "top": 0.27465172524009374,
        "right": 0.561951074267725,
        "bottom": 0.3023895179897851
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-f": {
      "box": {
        "left": 0.561951074267725,
        "top": 0.27465172524009374,
        "right": 0.6627186562872822,
        "bottom": 0.3023895179897851
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-g": {
      "box": {
        "left": 0.6627186562872822,
        "top": 0.27465172524009374,
        "right": 0.7497602316279881,
        "bottom": 0.3023895179897851
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-h": {
      "box": {
        "left": 0.7497602316279881,
        "top": 0.27465172524009374,
        "right": 0.8547553034395747,
        "bottom": 0.3023895179897851
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-i": {
      "box": {
        "left": 0.14587313936695878,
        "top": 0.3023895179897851,
        "right": 0.46073210893761996,
        "bottom": 0.3309415037600365
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-j": {
      "box": {
        "left": 0.46073210893761996,
        "top": 0.3023895179897851,
        "right": 0.561951074267725,
        "bottom": 0.3309415037600365
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-k": {
      "box": {
        "left": 0.561951074267725,
        "top": 0.3023895179897851,
        "right": 0.6627186562872822,
        "bottom": 0.3309415037600365
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-l": {
      "box": {
        "left": 0.6627186562872822,
        "top": 0.3023895179897851,
        "right": 0.7497602316279881,
        "bottom": 0.3309415037600365
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-m": {
      "box": {
        "left": 0.7497602316279881,
        "top": 0.3023895179897851,
        "right": 0.8547553034395747,
        "bottom": 0.3309415037600365
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-n": {
      "box": {
        "left": 0.14587313936695878,
        "top": 0.3309415037600365,
        "right": 0.46073210893761996,
        "bottom": 0.35789178408211075
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-o": {
      "box": {
        "left": 0.46073210893761996,
        "top": 0.3309415037600365,
        "right": 0.561951074267725,
        "bottom": 0.35789178408211075
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-p": {
      "box": {
        "left": 0.561951074267725,
        "top": 0.3309415037600365,
        "right": 0.6627186562872822,
        "bottom": 0.35789178408211075
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-q": {
      "box": {
        "left": 0.6627186562872822,
        "top": 0.3309415037600365,
        "right": 0.7497602316279881,
        "bottom": 0.35789178408211075
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-r": {
      "box": {
        "left": 0.7497602316279881,
        "top": 0.3309415037600365,
        "right": 0.8547553034395747,
        "bottom": 0.35789178408211075
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-s": {
      "box": {
        "left": 0.14587313936695878,
        "top": 0.35789178408211075,
        "right": 0.46073210893761996,
        "bottom": 0.38266561848061986
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-t": {
      "box": {
        "left": 0.46073210893761996,
        "top": 0.35789178408211075,
        "right": 0.561951074267725,
        "bottom": 0.38266561848061986
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-u": {
      "box": {
        "left": 0.561951074267725,
        "top": 0.35789178408211075,
        "right": 0.6627186562872822,
        "bottom": 0.38266561848061986
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-v": {
      "box": {
        "left": 0.6627186562872822,
        "top": 0.35789178408211075,
        "right": 0.7497602316279881,
        "bottom": 0.38266561848061986
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-w": {
      "box": {
        "left": 0.7497602316279881,
        "top": 0.35789178408211075,
        "right": 0.8547553034395747,
        "bottom": 0.38266561848061986
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-x": {
      "box": {
        "left": 0.14587313936695878,
        "top": 0.38266561848061986,
        "right": 0.46073210893761996,
        "bottom": 0.40751658602479957
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-y": {
      "box": {
        "left": 0.46073210893761996,
        "top": 0.38266561848061986,
        "right": 0.561951074267725,
        "bottom": 0.40751658602479957
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-z": {
      "box": {
        "left": 0.561951074267725,
        "top": 0.38266561848061986,
        "right": 0.6627186562872822,
        "bottom": 0.40751658602479957
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-A": {
      "box": {
        "left": 0.6627186562872822,
        "top": 0.38266561848061986,
        "right": 0.7497602316279881,
        "bottom": 0.40751658602479957
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-B": {
      "box": {
        "left": 0.7497602316279881,
        "top": 0.38266561848061986,
        "right": 0.8547553034395747,
        "bottom": 0.40751658602479957
      },
      "page": 8,
      "type": "tableCell"
    },
    "e5a86d90-1748-4268-977c-4ecbce64ab84": {
      "box": {
        "left": 0.08522365987300873,
        "top": 0.44122186303138733,
        "right": 0.5378010869026184,
        "bottom": 0.45916083455085754
      },
      "page": 8,
      "type": "chunkText"
    },
    "a8d1ac93-d7a6-4b22-9a5c-e09847b9369e": {
      "box": {
        "left": 0.7876595258712769,
        "top": 0.4322252869606018,
        "right": 0.9246684312820435,
        "bottom": 0.4553985595703125
      },
      "page": 8,
      "type": "chunkText"
    },
    "94969f52-4c4b-4d9d-83f6-ae18c960b1a5": {
      "box": {
        "left": 0.0674339234828949,
        "top": 0.5318315029144287,
        "right": 0.9355016946792603,
        "bottom": 0.6117472648620605
      },
      "page": 8,
      "type": "chunkLogo"
    },
    "ef862032-fff5-4a23-92e3-abf7164aba20": {
      "box": {
        "left": 0.1388932168483734,
        "top": 0.6234468817710876,
        "right": 0.861810564994812,
        "bottom": 0.8474008440971375
      },
      "page": 8,
      "type": "chunkTable"
    },
    "8-C": {
      "box": {
        "left": 0.14581012183257694,
        "top": 0.6285207166728948,
        "right": 0.8543962439788455,
        "bottom": 0.8423345199227725
      },
      "page": 8,
      "type": "table"
    },
    "8-D": {
      "box": {
        "left": 0.14581012183257694,
        "top": 0.6285207166728948,
        "right": 0.561359779678174,
        "bottom": 0.7093864163930022
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-E": {
      "box": {
        "left": 0.4605928320028623,
        "top": 0.6285207166728948,
        "right": 0.854470400546667,
        "bottom": 0.6805912826917577
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-F": {
      "box": {
        "left": 0.4605928320028623,
        "top": 0.6516106154596599,
        "right": 0.561359779678174,
        "bottom": 0.6805912826917577
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-G": {
      "box": {
        "left": 0.561359779678174,
        "top": 0.6516106154596599,
        "right": 0.6623683933096896,
        "bottom": 0.6805912826917577
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-H": {
      "box": {
        "left": 0.6623683933096896,
        "top": 0.6516106154596599,
        "right": 0.7493567619859132,
        "bottom": 0.6805912826917577
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-I": {
      "box": {
        "left": 0.7493567619859132,
        "top": 0.6516106154596599,
        "right": 0.854470400546667,
        "bottom": 0.6805912826917577
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-J": {
      "box": {
        "left": 0.14581012183257694,
        "top": 0.6805912826917577,
        "right": 0.4605928320028623,
        "bottom": 0.7093864163930022
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-K": {
      "box": {
        "left": 0.4605928320028623,
        "top": 0.6805912826917577,
        "right": 0.561359779678174,
        "bottom": 0.7093864163930022
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-L": {
      "box": {
        "left": 0.561359779678174,
        "top": 0.6805912826917577,
        "right": 0.6623683933096896,
        "bottom": 0.7093864163930022
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-M": {
      "box": {
        "left": 0.6623683933096896,
        "top": 0.6805912826917577,
        "right": 0.7493567619859132,
        "bottom": 0.7093864163930022
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-N": {
      "box": {
        "left": 0.7493567619859132,
        "top": 0.6805912826917577,
        "right": 0.854470400546667,
        "bottom": 0.7093864163930022
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-O": {
      "box": {
        "left": 0.14581012183257694,
        "top": 0.7093864163930022,
        "right": 0.4605928320028623,
        "bottom": 0.7370281226126139
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-P": {
      "box": {
        "left": 0.4605928320028623,
        "top": 0.7093864163930022,
        "right": 0.561359779678174,
        "bottom": 0.7370281226126139
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-Q": {
      "box": {
        "left": 0.561359779678174,
        "top": 0.7093864163930022,
        "right": 0.6623683933096896,
        "bottom": 0.7370281226126139
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-R": {
      "box": {
        "left": 0.6623683933096896,
        "top": 0.7093864163930022,
        "right": 0.7493567619859132,
        "bottom": 0.7370281226126139
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-S": {
      "box": {
        "left": 0.7493567619859132,
        "top": 0.7093864163930022,
        "right": 0.854470400546667,
        "bottom": 0.7370281226126139
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-T": {
      "box": {
        "left": 0.14581012183257694,
        "top": 0.7370281226126139,
        "right": 0.4605928320028623,
        "bottom": 0.7656321230048775
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-U": {
      "box": {
        "left": 0.4605928320028623,
        "top": 0.7370281226126139,
        "right": 0.561359779678174,
        "bottom": 0.7656321230048775
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-V": {
      "box": {
        "left": 0.561359779678174,
        "top": 0.7370281226126139,
        "right": 0.6623683933096896,
        "bottom": 0.7656321230048775
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-W": {
      "box": {
        "left": 0.6623683933096896,
        "top": 0.7370281226126139,
        "right": 0.7493567619859132,
        "bottom": 0.7656321230048775
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-X": {
      "box": {
        "left": 0.7493567619859132,
        "top": 0.7370281226126139,
        "right": 0.854470400546667,
        "bottom": 0.7656321230048775
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-Y": {
      "box": {
        "left": 0.14581012183257694,
        "top": 0.7656321230048775,
        "right": 0.4605928320028623,
        "bottom": 0.7927339411997849
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-Z": {
      "box": {
        "left": 0.4605928320028623,
        "top": 0.7656321230048775,
        "right": 0.561359779678174,
        "bottom": 0.7927339411997849
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-10": {
      "box": {
        "left": 0.561359779678174,
        "top": 0.7656321230048775,
        "right": 0.6623683933096896,
        "bottom": 0.7927339411997849
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-11": {
      "box": {
        "left": 0.6623683933096896,
        "top": 0.7656321230048775,
        "right": 0.7493567619859132,
        "bottom": 0.7927339411997849
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-12": {
      "box": {
        "left": 0.7493567619859132,
        "top": 0.7656321230048775,
        "right": 0.854470400546667,
        "bottom": 0.7927339411997849
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-13": {
      "box": {
        "left": 0.14581012183257694,
        "top": 0.7927339411997849,
        "right": 0.4605928320028623,
        "bottom": 0.8174362778273121
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-14": {
      "box": {
        "left": 0.4605928320028623,
        "top": 0.7927339411997849,
        "right": 0.561359779678174,
        "bottom": 0.8174362778273121
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-15": {
      "box": {
        "left": 0.561359779678174,
        "top": 0.7927339411997849,
        "right": 0.6623683933096896,
        "bottom": 0.8174362778273121
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-16": {
      "box": {
        "left": 0.6623683933096896,
        "top": 0.7927339411997849,
        "right": 0.7493567619859132,
        "bottom": 0.8174362778273121
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-17": {
      "box": {
        "left": 0.7493567619859132,
        "top": 0.7927339411997849,
        "right": 0.854470400546667,
        "bottom": 0.8174362778273121
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-18": {
      "box": {
        "left": 0.14581012183257694,
        "top": 0.8174362778273121,
        "right": 0.4605928320028623,
        "bottom": 0.8423345199227725
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-19": {
      "box": {
        "left": 0.4605928320028623,
        "top": 0.8174362778273121,
        "right": 0.561359779678174,
        "bottom": 0.8423345199227725
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-1a": {
      "box": {
        "left": 0.561359779678174,
        "top": 0.8174362778273121,
        "right": 0.6623683933096896,
        "bottom": 0.8423345199227725
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-1b": {
      "box": {
        "left": 0.6623683933096896,
        "top": 0.8174362778273121,
        "right": 0.7493567619859132,
        "bottom": 0.8423345199227725
      },
      "page": 8,
      "type": "tableCell"
    },
    "8-1c": {
      "box": {
        "left": 0.7493567619859132,
        "top": 0.8174362778273121,
        "right": 0.854470400546667,
        "bottom": 0.8423345199227725
      },
      "page": 8,
      "type": "tableCell"
    },
    "241fd44b-4cca-4bb8-b0f9-121e49f9c264": {
      "box": {
        "left": 0.08483690023422241,
        "top": 0.8770254850387573,
        "right": 0.53560471534729,
        "bottom": 0.8942703008651733
      },
      "page": 8,
      "type": "chunkText"
    },
    "8c68e89c-8a54-4673-9876-2f0e049fc5dd": {
      "box": {
        "left": 0.788041353225708,
        "top": 0.8677130341529846,
        "right": 0.923505425453186,
        "bottom": 0.8900489211082458
      },
      "page": 8,
      "type": "chunkText"
    },
    "0976ad3d-ecb2-4c8d-b680-9c6f4e1bb726": {
      "box": {
        "left": 0.06264296174049377,
        "top": 0.09452053904533386,
        "right": 0.9393056631088257,
        "bottom": 0.470132440328598
      },
      "page": 9,
      "type": "chunkText"
    },
    "1598e825-27cf-47b8-96ff-66b1cdcfc71c": {
      "box": {
        "left": 0.06333649158477783,
        "top": 0.5300447344779968,
        "right": 0.9375557899475098,
        "bottom": 0.904021680355072
      },
      "page": 9,
      "type": "chunkTable"
    },
    "9-1": {
      "box": {
        "left": 0.2245260834820968,
        "top": 0.6280748291497673,
        "right": 0.7746912535822545,
        "bottom": 0.8526573872144638
      },
      "page": 9,
      "type": "table"
    },
    "9-2": {
      "box": {
        "left": 0.2245260834820968,
        "top": 0.6280748291497673,
        "right": 0.5056447527849528,
        "bottom": 0.6522967969981295
      },
      "page": 9,
      "type": "tableCell"
    },
    "9-3": {
      "box": {
        "left": 0.5056447527849528,
        "top": 0.6280748291497673,
        "right": 0.7746234616847687,
        "bottom": 0.6522967969981295
      },
      "page": 9,
      "type": "tableCell"
    },
    "9-4": {
      "box": {
        "left": 0.2245260834820968,
        "top": 0.6522967969981295,
        "right": 0.5056447527849528,
        "bottom": 0.6771187987506622
      },
      "page": 9,
      "type": "tableCell"
    },
    "9-5": {
      "box": {
        "left": 0.5056447527849528,
        "top": 0.6522967969981295,
        "right": 0.7746234616847687,
        "bottom": 0.6771187987506622
      },
      "page": 9,
      "type": "tableCell"
    },
    "9-6": {
      "box": {
        "left": 0.2245260834820968,
        "top": 0.6771187987506622,
        "right": 0.5056447527849528,
        "bottom": 0.7028886260372786
      },
      "page": 9,
      "type": "tableCell"
    },
    "9-7": {
      "box": {
        "left": 0.5056447527849528,
        "top": 0.6771187987506622,
        "right": 0.7746234616847687,
        "bottom": 0.7028886260372786
      },
      "page": 9,
      "type": "tableCell"
    },
    "9-8": {
      "box": {
        "left": 0.2245260834820968,
        "top": 0.7028886260372786,
        "right": 0.5056447527849528,
        "bottom": 0.7277830393334597
      },
      "page": 9,
      "type": "tableCell"
    },
    "9-9": {
      "box": {
        "left": 0.5056447527849528,
        "top": 0.7028886260372786,
        "right": 0.7746234616847687,
        "bottom": 0.7277830393334597
      },
      "page": 9,
      "type": "tableCell"
    },
    "9-a": {
      "box": {
        "left": 0.2245260834820968,
        "top": 0.7277830393334597,
        "right": 0.5056447527849528,
        "bottom": 0.7527836458246355
      },
      "page": 9,
      "type": "tableCell"
    },
    "9-b": {
      "box": {
        "left": 0.5056447527849528,
        "top": 0.7277830393334597,
        "right": 0.7746234616847687,
        "bottom": 0.7527836458246355
      },
      "page": 9,
      "type": "tableCell"
    },
    "9-c": {
      "box": {
        "left": 0.2245260834820968,
        "top": 0.7527836458246355,
        "right": 0.5056447527849528,
        "bottom": 0.7777072154388378
      },
      "page": 9,
      "type": "tableCell"
    },
    "9-d": {
      "box": {
        "left": 0.5056447527849528,
        "top": 0.7527836458246355,
        "right": 0.7746234616847687,
        "bottom": 0.7777072154388378
      },
      "page": 9,
      "type": "tableCell"
    },
    "9-e": {
      "box": {
        "left": 0.2245260834820968,
        "top": 0.7777072154388378,
        "right": 0.5056447527849528,
        "bottom": 0.8026783758320732
      },
      "page": 9,
      "type": "tableCell"
    },
    "9-f": {
      "box": {
        "left": 0.5056447527849528,
        "top": 0.7777072154388378,
        "right": 0.7746234616847687,
        "bottom": 0.8026783758320732
      },
      "page": 9,
      "type": "tableCell"
    },
    "9-g": {
      "box": {
        "left": 0.2245260834820968,
        "top": 0.8026783758320732,
        "right": 0.5056447527849528,
        "bottom": 0.8275965510816263
      },
      "page": 9,
      "type": "tableCell"
    },
    "9-h": {
      "box": {
        "left": 0.5056447527849528,
        "top": 0.8026783758320732,
        "right": 0.7746234616847687,
        "bottom": 0.8275965510816263
      },
      "page": 9,
      "type": "tableCell"
    },
    "9-i": {
      "box": {
        "left": 0.2245260834820968,
        "top": 0.8275965510816263,
        "right": 0.7746234616847687,
        "bottom": 0.8526573872144638
      },
      "page": 9,
      "type": "tableCell"
    },
    "1ec6b493-2bfd-40df-9925-a5468d31d580": {
      "box": {
        "left": 0.06579214334487915,
        "top": 0.09647855162620544,
        "right": 0.9356541037559509,
        "bottom": 0.17716392874717712
      },
      "page": 10,
      "type": "chunkLogo"
    },
    "b03361c1-1dbb-4120-a810-311b697e341a": {
      "box": {
        "left": 0.1919654905796051,
        "top": 0.18737369775772095,
        "right": 0.806923508644104,
        "bottom": 0.4101400375366211
      },
      "page": 10,
      "type": "chunkTable"
    },
    "10-1": {
      "box": {
        "left": 0.20066475781127313,
        "top": 0.19413939672394143,
        "right": 0.7991690967374065,
        "bottom": 0.40404457461418986
      },
      "page": 10,
      "type": "table"
    },
    "10-2": {
      "box": {
        "left": 0.20066475781127313,
        "top": 0.19413939672394143,
        "right": 0.3626358978897404,
        "bottom": 0.21789474648116514
      },
      "page": 10,
      "type": "tableCell"
    },
    "10-3": {
      "box": {
        "left": 0.3626358978897404,
        "top": 0.19413939672394143,
        "right": 0.7991008463298517,
        "bottom": 0.21789474648116514
      },
      "page": 10,
      "type": "tableCell"
    },
    "10-4": {
      "box": {
        "left": 0.20066475781127313,
        "top": 0.21789474648116514,
        "right": 0.3626358978897404,
        "bottom": 0.24153092742408333
      },
      "page": 10,
      "type": "tableCell"
    },
    "10-5": {
      "box": {
        "left": 0.3626358978897404,
        "top": 0.21789474648116514,
        "right": 0.7991008463298517,
        "bottom": 0.24153092742408333
      },
      "page": 10,
      "type": "tableCell"
    },
    "10-6": {
      "box": {
        "left": 0.20066475781127313,
        "top": 0.24153092742408333,
        "right": 0.3626358978897404,
        "bottom": 0.2641506413142629
      },
      "page": 10,
      "type": "tableCell"
    },
    "10-7": {
      "box": {
        "left": 0.3626358978897404,
        "top": 0.24153092742408333,
        "right": 0.7991008463298517,
        "bottom": 0.2641506413142629
      },
      "page": 10,
      "type": "tableCell"
    },
    "10-8": {
      "box": {
        "left": 0.20066475781127313,
        "top": 0.2641506413142629,
        "right": 0.3626358978897404,
        "bottom": 0.2873821282019495
      },
      "page": 10,
      "type": "tableCell"
    },
    "10-9": {
      "box": {
        "left": 0.3626358978897404,
        "top": 0.2641506413142629,
        "right": 0.7991008463298517,
        "bottom": 0.2873821282019495
      },
      "page": 10,
      "type": "tableCell"
    },
    "10-a": {
      "box": {
        "left": 0.20066475781127313,
        "top": 0.2873821282019495,
        "right": 0.3626358978897404,
        "bottom": 0.31076470441103154
      },
      "page": 10,
      "type": "tableCell"
    },
    "10-b": {
      "box": {
        "left": 0.3626358978897404,
        "top": 0.2873821282019495,
        "right": 0.7991008463298517,
        "bottom": 0.31076470441103154
      },
      "page": 10,
      "type": "tableCell"
    },
    "10-c": {
      "box": {
        "left": 0.20066475781127313,
        "top": 0.31076470441103154,
        "right": 0.3626358978897404,
        "bottom": 0.3340085596705329
      },
      "page": 10,
      "type": "tableCell"
    },
    "10-d": {
      "box": {
        "left": 0.3626358978897404,
        "top": 0.31076470441103154,
        "right": 0.7991008463298517,
        "bottom": 0.3340085596705329
      },
      "page": 10,
      "type": "tableCell"
    },
    "10-e": {
      "box": {
        "left": 0.20066475781127313,
        "top": 0.3340085596705329,
        "right": 0.3626358978897404,
        "bottom": 0.3573272757784416
      },
      "page": 10,
      "type": "tableCell"
    },
    "10-f": {
      "box": {
        "left": 0.3626358978897404,
        "top": 0.3340085596705329,
        "right": 0.7991008463298517,
        "bottom": 0.3573272757784416
      },
      "page": 10,
      "type": "tableCell"
    },
    "10-g": {
      "box": {
        "left": 0.20066475781127313,
        "top": 0.3573272757784416,
        "right": 0.3626358978897404,
        "bottom": 0.38063057623452323
      },
      "page": 10,
      "type": "tableCell"
    },
    "10-h": {
      "box": {
        "left": 0.3626358978897404,
        "top": 0.3573272757784416,
        "right": 0.7991008463298517,
        "bottom": 0.38063057623452323
      },
      "page": 10,
      "type": "tableCell"
    },
    "10-i": {
      "box": {
        "left": 0.20066475781127313,
        "top": 0.38063057623452323,
        "right": 0.7991008463298517,
        "bottom": 0.40404457461418986
      },
      "page": 10,
      "type": "tableCell"
    },
    "4498d3ff-bac7-418d-a93a-8bf6cf2a6e84": {
      "box": {
        "left": 0.09273004531860352,
        "top": 0.4317761957645416,
        "right": 0.5081067085266113,
        "bottom": 0.45236000418663025
      },
      "page": 10,
      "type": "chunkText"
    },
    "25f08d59-53cb-4fdc-8562-be73ac932cdb": {
      "box": {
        "left": 0.7860541343688965,
        "top": 0.4306129217147827,
        "right": 0.9255611896514893,
        "bottom": 0.4564812183380127
      },
      "page": 10,
      "type": "chunkText"
    },
    "b7dede06-35b2-465d-85fb-0d195ce4e034": {
      "box": {
        "left": 0.06531158089637756,
        "top": 0.5312110781669617,
        "right": 0.9366475343704224,
        "bottom": 0.6131035685539246
      },
      "page": 10,
      "type": "chunkLogo"
    },
    "e8d4f140-6265-4af0-a93f-f890e5a44964": {
      "box": {
        "left": 0.08082202076911926,
        "top": 0.6183733940124512,
        "right": 0.8099700212478638,
        "bottom": 0.8207000494003296
      },
      "page": 10,
      "type": "chunkText"
    },
    "febb6d3f-3744-4923-a077-313cc676c4d9": {
      "box": {
        "left": 0.09175556898117065,
        "top": 0.8661300539970398,
        "right": 0.4874323010444641,
        "bottom": 0.8883256316184998
      },
      "page": 10,
      "type": "chunkText"
    },
    "5cd37089-ff8f-4028-a276-57e06e3cf11b": {
      "box": {
        "left": 0.7824414372444153,
        "top": 0.8641707301139832,
        "right": 0.9270482659339905,
        "bottom": 0.892541229724884
      },
      "page": 10,
      "type": "chunkText"
    },
    "d4710f52-8be6-406d-91e3-362bf657848f": {
      "box": {
        "left": 0.06303399801254272,
        "top": 0.09528505802154541,
        "right": 0.9384981989860535,
        "bottom": 0.4692738652229309
      },
      "page": 11,
      "type": "chunkText"
    },
    "27694181-0bf0-46e6-81b1-e2c227f1284c": {
      "box": {
        "left": 0.06334662437438965,
        "top": 0.5305432081222534,
        "right": 0.938200831413269,
        "bottom": 0.8992806673049927
      },
      "page": 11,
      "type": "chunkText"
    },
    "50940c4e-f9af-413c-93d4-6d5a0f91c842": {
      "box": {
        "left": 0.06331431865692139,
        "top": 0.09521609544754028,
        "right": 0.9388338327407837,
        "bottom": 0.46918177604675293
      },
      "page": 12,
      "type": "chunkFigure"
    },
    "032be8e0-4e68-4de0-aacb-34b1d720859a": {
      "box": {
        "left": 0.06435686349868774,
        "top": 0.5299934148788452,
        "right": 0.938022792339325,
        "bottom": 0.9045591354370117
      },
      "page": 12,
      "type": "chunkFigure"
    },
    "42b570fa-7f18-4094-b615-04a4fcb21346": {
      "box": {
        "left": 0.06477341055870056,
        "top": 0.09655529260635376,
        "right": 0.9372446537017822,
        "bottom": 0.17785784602165222
      },
      "page": 13,
      "type": "chunkFigure"
    },
    "22096ca4-3d2c-47a6-970f-1fd7e7f5ea06": {
      "box": {
        "left": 0.08040511608123779,
        "top": 0.18647649884223938,
        "right": 0.9216471910476685,
        "bottom": 0.23641112446784973
      },
      "page": 13,
      "type": "chunkText"
    },
    "6ee7f8bb-803e-46ca-be3a-7aceaf899b91": {
      "box": {
        "left": 0.0829605758190155,
        "top": 0.23706842958927155,
        "right": 0.924452543258667,
        "bottom": 0.4231433868408203
      },
      "page": 13,
      "type": "chunkTable"
    },
    "13-1": {
      "box": {
        "left": 0.09252310473107386,
        "top": 0.24161479763589436,
        "right": 0.9179829642531789,
        "bottom": 0.419118554262111
      },
      "page": 13,
      "type": "table"
    },
    "13-2": {
      "box": {
        "left": 0.09252310473107386,
        "top": 0.24161479763589436,
        "right": 0.4954955604810918,
        "bottom": 0.2688820629785229
      },
      "page": 13,
      "type": "tableCell"
    },
    "13-3": {
      "box": {
        "left": 0.4954955604810918,
        "top": 0.24161479763589436,
        "right": 0.9178811458886837,
        "bottom": 0.2688820629785229
      },
      "page": 13,
      "type": "tableCell"
    },
    "13-4": {
      "box": {
        "left": 0.09252310473107386,
        "top": 0.2688820629785229,
        "right": 0.4954955604810918,
        "bottom": 0.30203902447327335
      },
      "page": 13,
      "type": "tableCell"
    },
    "13-5": {
      "box": {
        "left": 0.4954955604810918,
        "top": 0.2688820629785229,
        "right": 0.9178811458886837,
        "bottom": 0.30203902447327335
      },
      "page": 13,
      "type": "tableCell"
    },
    "13-6": {
      "box": {
        "left": 0.09252310473107386,
        "top": 0.30203902447327335,
        "right": 0.4954955604810918,
        "bottom": 0.3184102988886295
      },
      "page": 13,
      "type": "tableCell"
    },
    "13-7": {
      "box": {
        "left": 0.4954955604810918,
        "top": 0.30203902447327335,
        "right": 0.9178811458886837,
        "bottom": 0.3184102988886295
      },
      "page": 13,
      "type": "tableCell"
    },
    "13-8": {
      "box": {
        "left": 0.09252310473107386,
        "top": 0.3184102988886295,
        "right": 0.4954955604810918,
        "bottom": 0.33559712833224875
      },
      "page": 13,
      "type": "tableCell"
    },
    "13-9": {
      "box": {
        "left": 0.4954955604810918,
        "top": 0.3184102988886295,
        "right": 0.9178811458886837,
        "bottom": 0.33559712833224875
      },
      "page": 13,
      "type": "tableCell"
    },
    "13-a": {
      "box": {
        "left": 0.09252310473107386,
        "top": 0.33559712833224875,
        "right": 0.4954955604810918,
        "bottom": 0.3528887448988396
      },
      "page": 13,
      "type": "tableCell"
    },
    "13-b": {
      "box": {
        "left": 0.4954955604810918,
        "top": 0.33559712833224875,
        "right": 0.9178811458886837,
        "bottom": 0.3528887448988396
      },
      "page": 13,
      "type": "tableCell"
    },
    "13-c": {
      "box": {
        "left": 0.09252310473107386,
        "top": 0.3528887448988396,
        "right": 0.4954955604810918,
        "bottom": 0.3702536281604294
      },
      "page": 13,
      "type": "tableCell"
    },
    "13-d": {
      "box": {
        "left": 0.4954955604810918,
        "top": 0.3528887448988396,
        "right": 0.9178811458886837,
        "bottom": 0.3702536281604294
      },
      "page": 13,
      "type": "tableCell"
    },
    "13-e": {
      "box": {
        "left": 0.09252310473107386,
        "top": 0.3702536281604294,
        "right": 0.4954955604810918,
        "bottom": 0.38808344328008104
      },
      "page": 13,
      "type": "tableCell"
    },
    "13-f": {
      "box": {
        "left": 0.4954955604810918,
        "top": 0.3702536281604294,
        "right": 0.9178811458886837,
        "bottom": 0.38808344328008104
      },
      "page": 13,
      "type": "tableCell"
    },
    "13-g": {
      "box": {
        "left": 0.09252310473107386,
        "top": 0.38808344328008104,
        "right": 0.4954955604810918,
        "bottom": 0.419118554262111
      },
      "page": 13,
      "type": "tableCell"
    },
    "13-h": {
      "box": {
        "left": 0.4954955604810918,
        "top": 0.38808344328008104,
        "right": 0.9178811458886837,
        "bottom": 0.419118554262111
      },
      "page": 13,
      "type": "tableCell"
    },
    "8c4532e2-8e79-4d68-ab8d-78d0786dbd74": {
      "box": {
        "left": 0.08753782510757446,
        "top": 0.4269363284111023,
        "right": 0.9287866950035095,
        "bottom": 0.4651517868041992
      },
      "page": 13,
      "type": "chunkText"
    },
    "a8645af1-14cf-4ad6-af59-e903279482ec": {
      "box": {
        "left": 0.06293344497680664,
        "top": 0.530025839805603,
        "right": 0.938734769821167,
        "bottom": 0.9049234390258789
      },
      "page": 13,
      "type": "chunkText"
    },
    "9ae21f6f-706d-40b0-82b7-51db9692d5fc": {
      "box": {
        "left": 0.0636759102344513,
        "top": 0.0951918363571167,
        "right": 0.9378472566604614,
        "bottom": 0.17834696173667908
      },
      "page": 14,
      "type": "chunkFigure"
    },
    "a170457b-5603-4e7c-a80e-164d77a2dd25": {
      "box": {
        "left": 0.08277922868728638,
        "top": 0.18640479445457458,
        "right": 0.8779597878456116,
        "bottom": 0.3864469826221466
      },
      "page": 14,
      "type": "chunkText"
    },
    "0e233f41-e037-4258-b347-1d6f511dfaf3": {
      "box": {
        "left": 0.08465972542762756,
        "top": 0.42300909757614136,
        "right": 0.9236479997634888,
        "bottom": 0.4665048122406006
      },
      "page": 14,
      "type": "chunkText"
    },
    "0df216f7-d596-4719-ad8e-772f094f25cb": {
      "box": {
        "left": 0.06350347399711609,
        "top": 0.5301626920700073,
        "right": 0.9383875131607056,
        "bottom": 0.898675799369812
      },
      "page": 14,
      "type": "chunkText"
    },
    "c9622815-d0fc-4731-8c62-5eb7a8d1b5e0": {
      "box": {
        "left": 0.06617411971092224,
        "top": 0.09613700956106186,
        "right": 0.9355430603027344,
        "bottom": 0.17769384384155273
      },
      "page": 15,
      "type": "chunkLogo"
    },
    "a9e4e492-a17a-4258-8a05-f69a1f361704": {
      "box": {
        "left": 0.09159040451049805,
        "top": 0.18790757656097412,
        "right": 0.9082233309745789,
        "bottom": 0.3972018361091614
      },
      "page": 15,
      "type": "chunkTable"
    },
    "15-1": {
      "box": {
        "left": 0.09863420709280663,
        "top": 0.19406283320645057,
        "right": 0.9022157021949901,
        "bottom": 0.39123806816256845
      },
      "page": 15,
      "type": "table"
    },
    "15-2": {
      "box": {
        "left": 0.09863420709280663,
        "top": 0.19406283320645057,
        "right": 0.3295772572933089,
        "bottom": 0.2384936734088008
      },
      "page": 15,
      "type": "tableCell"
    },
    "15-3": {
      "box": {
        "left": 0.3295772572933089,
        "top": 0.19406283320645057,
        "right": 0.9022036794414632,
        "bottom": 0.2384936734088008
      },
      "page": 15,
      "type": "tableCell"
    },
    "15-4": {
      "box": {
        "left": 0.09863420709280663,
        "top": 0.2384936734088008,
        "right": 0.3295772572933089,
        "bottom": 0.2600121633660404
      },
      "page": 15,
      "type": "tableCell"
    },
    "15-5": {
      "box": {
        "left": 0.3295772572933089,
        "top": 0.2384936734088008,
        "right": 0.9022036794414632,
        "bottom": 0.2600121633660404
      },
      "page": 15,
      "type": "tableCell"
    },
    "15-6": {
      "box": {
        "left": 0.09863420709280663,
        "top": 0.2600121633660404,
        "right": 0.9022036794414632,
        "bottom": 0.31807758626325366
      },
      "page": 15,
      "type": "tableCell"
    },
    "15-7": {
      "box": {
        "left": 0.09863420709280663,
        "top": 0.2815518481953596,
        "right": 0.3295772572933089,
        "bottom": 0.31807758626325366
      },
      "page": 15,
      "type": "tableCell"
    },
    "15-8": {
      "box": {
        "left": 0.3295772572933089,
        "top": 0.2815518481953596,
        "right": 0.9022036794414632,
        "bottom": 0.31807758626325366
      },
      "page": 15,
      "type": "tableCell"
    },
    "15-9": {
      "box": {
        "left": 0.09863420709280663,
        "top": 0.31807758626325366,
        "right": 0.3295772572933089,
        "bottom": 0.36963434338279555
      },
      "page": 15,
      "type": "tableCell"
    },
    "15-a": {
      "box": {
        "left": 0.3295772572933089,
        "top": 0.31807758626325366,
        "right": 0.9022036794414632,
        "bottom": 0.36963434338279555
      },
      "page": 15,
      "type": "tableCell"
    },
    "15-b": {
      "box": {
        "left": 0.09863420709280663,
        "top": 0.36963434338279555,
        "right": 0.3295772572933089,
        "bottom": 0.39123806816256845
      },
      "page": 15,
      "type": "tableCell"
    },
    "15-c": {
      "box": {
        "left": 0.3295772572933089,
        "top": 0.36963434338279555,
        "right": 0.9022036794414632,
        "bottom": 0.39123806816256845
      },
      "page": 15,
      "type": "tableCell"
    },
    "179f8e36-441a-4fc8-90b4-6a40672e8f42": {
      "box": {
        "left": 0.09239499270915985,
        "top": 0.4265393614768982,
        "right": 0.49225807189941406,
        "bottom": 0.4645478129386902
      },
      "page": 15,
      "type": "chunkText"
    },
    "0702fd84-f360-4785-b999-49af0b23c935": {
      "box": {
        "left": 0.7859569191932678,
        "top": 0.43030476570129395,
        "right": 0.9267774224281311,
        "bottom": 0.45616400241851807
      },
      "page": 15,
      "type": "chunkText"
    },
    "69338f78-93be-4f34-ad44-7822924638c7": {
      "box": {
        "left": 0.06350037455558777,
        "top": 0.5296798944473267,
        "right": 0.9379252195358276,
        "bottom": 0.9049233198165894
      },
      "page": 15,
      "type": "chunkText"
    },
    "361646a5-a30e-4cfe-a173-5f537a20d940": {
      "box": {
        "left": 0.06251713633537292,
        "top": 0.09433616697788239,
        "right": 0.93919837474823,
        "bottom": 0.4700559377670288
      },
      "page": 16,
      "type": "chunkText"
    },
    "a77eb05a-ba9d-43a7-a75a-1975b50d6897": {
      "box": {
        "left": 0.06417819857597351,
        "top": 0.5302128791809082,
        "right": 0.9384031295776367,
        "bottom": 0.8322700262069702
      },
      "page": 16,
      "type": "chunkText"
    },
    "3e9ac45e-c3cc-4f7a-8e82-6d76b9ac4c65": {
      "box": {
        "left": 0.09160895645618439,
        "top": 0.8663098216056824,
        "right": 0.48693811893463135,
        "bottom": 0.8883495926856995
      },
      "page": 16,
      "type": "chunkText"
    },
    "9dd8cd1c-bb55-4701-bb57-51f447b95973": {
      "box": {
        "left": 0.7848127484321594,
        "top": 0.8649399876594543,
        "right": 0.9261509776115417,
        "bottom": 0.8929563164710999
      },
      "page": 16,
      "type": "chunkMarginalia"
    },
    "2daf2933-be4a-4702-a5d2-ce033c786bf3": {
      "box": {
        "left": 0.06284677982330322,
        "top": 0.09455594420433044,
        "right": 0.9392791986465454,
        "bottom": 0.47010764479637146
      },
      "page": 17,
      "type": "chunkFigure"
    },
    "4d178aaa-8827-42e8-91cc-f638c5e42a34": {
      "box": {
        "left": 0.06357371807098389,
        "top": 0.529935359954834,
        "right": 0.9381731748580933,
        "bottom": 0.9047203063964844
      },
      "page": 17,
      "type": "chunkText"
    },
    "9a1a0dc6-dc54-4901-8959-b59add1f0612": {
      "box": {
        "left": 0.0632266104221344,
        "top": 0.09594038128852844,
        "right": 0.9390454292297363,
        "bottom": 0.4677693545818329
      },
      "page": 18,
      "type": "chunkText"
    },
    "e540373b-4624-4da8-bc6b-1bbf6437c2cc": {
      "box": {
        "left": 0.06413790583610535,
        "top": 0.5311951041221619,
        "right": 0.9376298189163208,
        "bottom": 0.8037055134773254
      },
      "page": 18,
      "type": "chunkTable"
    },
    "18-1": {
      "box": {
        "left": 0.09953068633302598,
        "top": 0.6290138901937468,
        "right": 0.9011511586954697,
        "bottom": 0.7945643095256258
      },
      "page": 18,
      "type": "table"
    },
    "18-2": {
      "box": {
        "left": 0.09953068633302598,
        "top": 0.6290138901937468,
        "right": 0.9007980594593086,
        "bottom": 0.706406353576476
      },
      "page": 18,
      "type": "tableCell"
    },
    "18-3": {
      "box": {
        "left": 0.09953068633302598,
        "top": 0.651915482545462,
        "right": 0.269137315616776,
        "bottom": 0.706406353576476
      },
      "page": 18,
      "type": "tableCell"
    },
    "18-4": {
      "box": {
        "left": 0.269137315616776,
        "top": 0.651915482545462,
        "right": 0.9007980594593086,
        "bottom": 0.706406353576476
      },
      "page": 18,
      "type": "tableCell"
    },
    "18-5": {
      "box": {
        "left": 0.09953068633302598,
        "top": 0.706406353576476,
        "right": 0.269137315616776,
        "bottom": 0.7584268765391329
      },
      "page": 18,
      "type": "tableCell"
    },
    "18-6": {
      "box": {
        "left": 0.269137315616776,
        "top": 0.706406353576476,
        "right": 0.9007980594593086,
        "bottom": 0.7584268765391329
      },
      "page": 18,
      "type": "tableCell"
    },
    "18-7": {
      "box": {
        "left": 0.09953068633302598,
        "top": 0.7584268765391329,
        "right": 0.269137315616776,
        "bottom": 0.7945643095256258
      },
      "page": 18,
      "type": "tableCell"
    },
    "18-8": {
      "box": {
        "left": 0.269137315616776,
        "top": 0.7584268765391329,
        "right": 0.9007980594593086,
        "bottom": 0.7945643095256258
      },
      "page": 18,
      "type": "tableCell"
    },
    "df9bbbc0-c13a-4379-b2ca-e59c8ff6d3a5": {
      "box": {
        "left": 0.08890548348426819,
        "top": 0.8602660894393921,
        "right": 0.49039706587791443,
        "bottom": 0.8997459411621094
      },
      "page": 18,
      "type": "chunkText"
    },
    "4668c1e4-df58-40d1-b90c-606187ecb351": {
      "box": {
        "left": 0.53205806016922,
        "top": 0.8627275228500366,
        "right": 0.9275971055030823,
        "bottom": 0.9004011154174805
      },
      "page": 18,
      "type": "chunkText"
    },
    "42c6a93f-46f8-44e2-b177-ea5e619d9729": {
      "box": {
        "left": 0.06379100680351257,
        "top": 0.0969223827123642,
        "right": 0.9379626512527466,
        "bottom": 0.46621227264404297
      },
      "page": 19,
      "type": "chunkText"
    },
    "32c6e580-a16f-4528-b9b8-0bef3947e1af": {
      "box": {
        "left": 0.06367683410644531,
        "top": 0.529608428478241,
        "right": 0.937857985496521,
        "bottom": 0.9051029086112976
      },
      "page": 19,
      "type": "chunkText"
    },
    "19e9440e-94a3-4cb0-abe3-62285f4713c1": {
      "box": {
        "left": 0.7803124785423279,
        "top": 0.0976814404129982,
        "right": 0.9350668787956238,
        "bottom": 0.17684128880500793
      },
      "page": 20,
      "type": "chunkLogo"
    },
    "5d6f7e4d-9eed-44c3-a2e6-a2545cae31e1": {
      "box": {
        "left": 0.12714621424674988,
        "top": 0.2526681125164032,
        "right": 0.772436261177063,
        "bottom": 0.2917487919330597
      },
      "page": 20,
      "type": "chunkText"
    },
    "0b9ec25c-d6f9-4c10-adeb-2ab4c8317ab1": {
      "box": {
        "left": 0.0698113739490509,
        "top": 0.5297843813896179,
        "right": 0.9364829063415527,
        "bottom": 0.8478476405143738
      },
      "page": 20,
      "type": "chunkText"
    },
    "4f5ece54-5a8f-432f-80db-ef62c71d78ed": {
      "box": {
        "left": 0.5093552470207214,
        "top": 0.863138735294342,
        "right": 0.9279194474220276,
        "bottom": 0.8987649083137512
      },
      "page": 20,
      "type": "chunkText"
    },
    "33cddc38-b61e-4433-9a91-c0025f0841c8": {
      "box": {
        "left": 0.7851835489273071,
        "top": 0.4297361373901367,
        "right": 0.9263993501663208,
        "bottom": 0.4562538266181946
      },
      "page": 20,
      "type": "chunkText"
    },
    "f8e6fe35-393e-4fb7-8168-d0a4b5ee6f55": {
      "box": {
        "left": 0.06273356080055237,
        "top": 0.09420780837535858,
        "right": 0.9388109445571899,
        "bottom": 0.47049015760421753
      },
      "page": 21,
      "type": "chunkText"
    },
    "ceee40c9-8345-4a60-a6c5-cf246a552352": {
      "box": {
        "left": 0.06288021802902222,
        "top": 0.5288068652153015,
        "right": 0.9384861588478088,
        "bottom": 0.9055830836296082
      },
      "page": 21,
      "type": "chunkText"
    },
    "f8b35dfd-beb6-4581-8231-9421b46dc7c1": {
      "box": {
        "left": 0.06288734078407288,
        "top": 0.09432494640350342,
        "right": 0.9387069940567017,
        "bottom": 0.4703223705291748
      },
      "page": 22,
      "type": "chunkFigure"
    },
    "5bbb55e7-c050-4935-bf60-b43ae6786ade": {
      "box": {
        "left": 0.06319141387939453,
        "top": 0.5288724303245544,
        "right": 0.9381179809570312,
        "bottom": 0.9053660035133362
      },
      "page": 22,
      "type": "chunkText"
    },
    "4b34e393-d430-47cd-93f9-844797677a51": {
      "box": {
        "left": 0.06254515051841736,
        "top": 0.0940939337015152,
        "right": 0.9391641616821289,
        "bottom": 0.47028690576553345
      },
      "page": 23,
      "type": "chunkText"
    },
    "252f7d81-664b-4dc3-87fb-e68fa40da916": {
      "box": {
        "left": 0.06313422322273254,
        "top": 0.529196560382843,
        "right": 0.9380542039871216,
        "bottom": 0.9051079154014587
      },
      "page": 23,
      "type": "chunkText"
    },
    "efe4c8b7-311a-4c9c-bb16-8b178482ebfd": {
      "box": {
        "left": 0.06379100680351257,
        "top": 0.0969223827123642,
        "right": 0.9379626512527466,
        "bottom": 0.46621227264404297
      },
      "page": 24,
      "type": "chunkText"
    },
    "d2f286db-1a9c-4735-8c68-15183cfbaefb": {
      "box": {
        "left": 0.06367683410644531,
        "top": 0.529608428478241,
        "right": 0.937857985496521,
        "bottom": 0.9051029086112976
      },
      "page": 24,
      "type": "chunkText"
    },
    "38b6c60a-bc53-4e0e-853c-e580271cf8c2": {
      "box": {
        "left": 0.06225937604904175,
        "top": 0.09369246661663055,
        "right": 0.9394111037254333,
        "bottom": 0.47075510025024414
      },
      "page": 25,
      "type": "chunkText"
    },
    "cf11c058-bac1-4b5f-bb12-e1e1171da971": {
      "box": {
        "left": 0.06241345405578613,
        "top": 0.5289883017539978,
        "right": 0.938665509223938,
        "bottom": 0.9056381583213806
      },
      "page": 25,
      "type": "chunkText"
    },
    "44bd7443-1170-4b1d-b40c-233bff61138d": {
      "box": {
        "left": 0.0627744197845459,
        "top": 0.09519116580486298,
        "right": 0.9387767314910889,
        "bottom": 0.46940308809280396
      },
      "page": 26,
      "type": "chunkText"
    },
    "c5cb51bf-48d5-4702-b981-234d63bcd838": {
      "box": {
        "left": 0.06265199184417725,
        "top": 0.5297218561172485,
        "right": 0.9380775690078735,
        "bottom": 0.9049133062362671
      },
      "page": 26,
      "type": "chunkText"
    },
    "4dad45b2-2dab-4b44-addc-a2aa09751132": {
      "box": {
        "left": 0.06393373012542725,
        "top": 0.09545104205608368,
        "right": 0.9391051530838013,
        "bottom": 0.469993531703949
      },
      "page": 27,
      "type": "chunkFigure"
    },
    "81f6a452-235e-4d5e-ad54-a26ccdcba39d": {
      "box": {
        "left": 0.11184793710708618,
        "top": 0.0844382792711258,
        "right": 0.8806548714637756,
        "bottom": 0.3356732130050659
      },
      "page": 28,
      "type": "chunkText"
    },
    "2b2f678e-50b4-41d5-bfce-2b01a6b446b4": {
      "box": {
        "left": 0.1117754876613617,
        "top": 0.3475048243999481,
        "right": 0.8817732334136963,
        "bottom": 0.5240799784660339
      },
      "page": 28,
      "type": "chunkText"
    },
    "19de4395-ed5a-4891-a827-513dc02b9a7d": {
      "box": {
        "left": 0.08083546161651611,
        "top": 0.08916962891817093,
        "right": 0.9192482233047485,
        "bottom": 0.2603312134742737
      },
      "page": 29,
      "type": "chunkText"
    },
    "4a9ffc47-5272-47f5-b48a-d775bcf72877": {
      "box": {
        "left": 0.0807248055934906,
        "top": 0.2727087140083313,
        "right": 0.8903650045394897,
        "bottom": 0.40147292613983154
      },
      "page": 29,
      "type": "chunkText"
    },
    "77b8b272-671f-4fb6-9f67-f0f0c328981f": {
      "box": {
        "left": 0.08197873830795288,
        "top": 0.4104483723640442,
        "right": 0.8753352165222168,
        "bottom": 0.4323435425758362
      },
      "page": 29,
      "type": "chunkText"
    },
    "193cc645-9b87-49a9-8634-c01ea4d9ad02": {
      "box": {
        "left": 0.08172187209129333,
        "top": 0.4442722499370575,
        "right": 0.9015690088272095,
        "bottom": 0.4840259850025177
      },
      "page": 29,
      "type": "chunkText"
    },
    "211eb738-b192-4453-b094-e56019317b29": {
      "box": {
        "left": 0.08219799399375916,
        "top": 0.49649590253829956,
        "right": 0.9165530204772949,
        "bottom": 0.567567765712738
      },
      "page": 29,
      "type": "chunkText"
    },
    "0a3c85d9-6cbc-4e95-a393-21c4f8ab9477": {
      "box": {
        "left": 0.08215111494064331,
        "top": 0.5805759429931641,
        "right": 0.8971377611160278,
        "bottom": 0.6399573087692261
      },
      "page": 29,
      "type": "chunkText"
    },
    "50719092-f550-47b6-ac36-87953d107e56": {
      "box": {
        "left": 0.08230695128440857,
        "top": 0.6474067568778992,
        "right": 0.9057470560073853,
        "bottom": 0.7413815855979919
      },
      "page": 29,
      "type": "chunkText"
    },
    "f94e68a5-d97d-448b-9a8c-e2b0560563e1": {
      "box": {
        "left": 0.08097496628761292,
        "top": 0.7661511301994324,
        "right": 0.9178322553634644,
        "bottom": 0.8384376168251038
      },
      "page": 29,
      "type": "chunkText"
    },
    "52a26de7-2bd8-4bb2-986d-fc6145ae1b06": {
      "box": {
        "left": 0.08358009159564972,
        "top": 0.845236599445343,
        "right": 0.5035179257392883,
        "bottom": 0.8677032589912415
      },
      "page": 29,
      "type": "chunkText"
    }
  },
  "metadata": {
    "filename": "9_FluidandSodiumDisorders.pdf",
    "org_id": null,
    "page_count": 30,
    "duration_ms": 24784,
    "credit_usage": 90.0,
    "job_id": "svbhoe30ihgoweg0erauwbh9b",
    "version": "dpt-2-20250919"
  }
}